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Abstract 
The addition of antimicrobial agents to wound dressings is used to reduce the risk 
of wound infection, and help manage local wound infections, thereby facilitating 
wound progression, but their activity is impeded by biofilm tolerance. The aim of 
this work was to investigate the structure and development of wound pathogen 
biofilm, and to design a novel, challenging in vitro simulated chronic wound biofilm 
model to evaluate the antimicrobial and anti-biofilm effectiveness of several current 
wound dressings.  This study demonstrates how rapidly biofilm can form on a 
model wound that has been contaminated by contact with planktonic bacteria, 
producing structured bacterial biofilm communities with nutrient and waste 
channels and the dispersal of bacterial cells at the surface. Light Microscopy (LM), 
Transmission Electron Microscopy (TEM), Scanning Electron Microscopy (SEM) 
and Confocal Laser Scanning Microscopy (CLSM) provided structural images of 
both biofilm formation and the presence of individual bacteria within the biofilm 
structure. After 24-48 hours, biofilm had become established, and dispersal of 
biofilm bacteria was visualised as early as 48 hours. By applying various dressings 
to the model and analysing representative fields of vision, biofilm was observable 
to varying extents beneath most of the dressings tested after 24 hours, and by 72 
hours this had increased. Two dressings appeared to help prevent the growth of 
biofilm: a hydrated microbial cellulose dressing containing polyhexamethyl 
biguanidine dressing, and a next-generation antimicrobial dressing containing ionic 
silver in an anti-biofilm formulation.  The results highlight the importance of 
dressing selection to manage biofilm in chronic and acute wounds, and these 
observations should help in the development of novel and effective control of 
wound infection.   
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General Introduction 
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1.1 Bacteria and the natural order of things 
Many only know bacteria as invisible ‘creatures’ that can make us ill, or are present 
in some food products or supplements which have been commercially advertised 
as making one ‘more healthy’. But these creatures, although individually consisting 
of only a single cell, can be amazingly complex and can group together into 
structures which have both fascinated and perturbed the scientific world.  
Bacteria are known to be one of the earliest life forms and to have existed for at 
least 3,500 million years (McNamara and Awramik, 1992). Fossils of dome-shaped 
structures, consisting of layers which formed in shallow water, have been found 
dating back 2,800 million years (Olsen and Pierson, 1986). These fossils, or 
Stromatolites, are thought to be due to communities of Cyanobacteria trapping, 
binding and cementing sedimentary grains (Figure 1.1 ). Cyanobacteria are the 
largest and most diverse group of photosynthetic bacteria, and were probably 
responsible for raising the levels of oxygen in the Earth’s atmosphere from less 
than 1% to the 21% of today, allowing for the evolution of new aerobic species of 
bacteria which eventually led to the development of more complex life forms (Knoll, 
2008). 
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Figure 1.1: Stromatolites, Sharks Bay Australia, showing a biofilm-type structure 
With kind permission of the Western Australia Department of Parks and Wildlife 
The shape of the structures show a resemblance to the proposed mushroom and tower 
biofilm structures suggested by Donlan and Costerton (2003). 
(http://www.sharkbay.org.au/visiting-shark-bay/parks-and-other-
sites/hamelin_pool_stromatolites) 
 
Bacteria are a part of a group of microorganisms (often abbreviated to microbes) 
which also include archaea, fungi, algae, protozoa and viruses, and play an 
important role in maintaining aspects of life on Earth. They are found in a wide 
range of habitats in the natural world, from boiling hot to icy cold, in extremes of pH 
or sulphurous conditions (the so-called extremophiles), and are able to co-exist 
inside the bodies of plants and animals. Those existing within humans and animals 
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do so by achieving a balance, ensuring the growth and survival of the host and 
bacteria. 
Relatively few bacteria are pathogenic in animals. The majority of them are 
harmless, and many of them are beneficial or probiotic. The term probiotic is used 
to define bacteria that appear to have certain health benefits. Some of these 
bacteria are used in food products and include claims of boosting the immune 
system, as well as being helpful in treatment for conditions such as eczema, 
lactose intolerance, irritable bowel system, inflammatory bowel disease and 
persistent diarrhoea. Those affecting the digestive tract are more recognisable as 
being helpful, as until more research is done, it is not convincing enough that 
bacteria when swallowed could have any effect outside of the digestive system 
(Sanders et al., 2013). In cases of antibiotic-associated diarrhoea, these probiotics 
may have their place. Without probiotics, antibiotics tend to wipe out the protective 
bacteria of the gut, which results in diarrhoea. Typical dietary probiotics which may 
restore the natural balance include Lactobacilli and Bifidobacterium spp, as they 
are found amongst the indigenous bacteria of the human gut (Gomes and Malcata, 
1999). 
Microorganisms colonise the surface of human skin. The skin is the largest organ 
in the human body and at the moment of birth the epithelial surface is exposed to 
maternal and environmental organisms (Gregory, 2011). Studies estimate skin 
bacterial levels to be from 10 to 800,000 bacteria per square centimetre by 
adulthood (Evans et al., 1950). The estimated density of bacteria upon the skin at 
any one time depends upon the region sampled, with the variety of the multitude of 
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microorganisms being dependent upon the host characteristics, such as age, 
gender, ethnicity, anatomic location (Grice and Segre, 2011), and to a certain 
extent on the culture techniques used. This dynamic community can contain a 
variety of bacteria but those commonly isolated include Staphylococcus, 
Corynebacterium, Propionibacterium, Micrococcus, Brevibacterium and 
Acinetobacter spp. Alterations in the community type on the skin can be due to 
environmental characteristics or host demographics and the pathogenicity of 
bacteria often depends on the interaction between the bacteria and the host. 
If the host is compromised in any way, such as in immuno-suppression, it can have 
consequences regarding the health of an individual and can result in bacterial-
related disease. Conditions including psoriasis, atopic dermatitis and acne can 
affect this microbial system but it remains unclear as to how the microorganisms 
and their precise pathogenic mechanisms can influence biological processes 
(Rosenthal et al., 2011). When they do cause disease bacteria can produce 
debilitating symptoms and can often be difficult to eradicate, such as those in 
chronic wounds where they are thought to prevent healing and cause persistent 
inflammation (Grice and Segre, 2011). 
 
1.2 The development of microscopy and the elucidation of 
bacteria 
Although bacteria have existed for millions of years their discovery was only made 
in the 17th century, when work on glass lenses had gradually paved the way to the 
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invention of the light microscope. As early as the 1st century AD the Romans were 
using pieces of glass with varying thicknesses as magnifiers, or burning glasses, 
but it took until the 13th century for lenses to be adapted to be worn as spectacles. 
These magnifying lenses were one lens and one power (6 times to 10 times), but 
by the end of the 17th century much had been improved upon and numerous 
people have been credited in the development of the lens system integral to the 
compound light microscopes of today (Uluç et al., 2009). 
Some of the most noteworthy people in early microscopy are: 
Zacharias Janssen: Working with his father in 1590 as spectacle makers, they put 
several lenses in a tube and discovered that objects near the end of the tube 
appeared to be larger. 
Galileo Galilei: Perhaps more renowned for his work on telescopes, he started 
experimenting with lenses after hearing of such lens work and by 1609 had 
developed a two lens system using a bi-concave eyepiece and a bi-convex 
objective lens. By 1624 this had been improved to a three lens system, but he 
turned his attention to the stars (Figure 1.2).  
Antonie van Leeuwenhoek: A tradesman and scientist in Holland, he worked with 
magnifying glasses. By grinding and polishing he created small, rounder lenses 
with a greater magnification. He also observed animalcules in the plaque of teeth 
which were the first observations of living bacteria (Porter, 1976).  
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Figure 1.2: Galileo’s telescope 
The early work of those such as Galileo Galilei in the creation of lenses led to the gradual 
evolution of the microscope. This telescope only magnified up to x20 but was 
revolutionary. Courtesy of galileotelescope.org 
 
 
Robert Hooke: In England, he spent much of his life designing and improving 
lenses and hence the capabilities with microscopes. These microscopes were able 
to show things that no one had seen before and one can only imagine the 
excitement at the discovery of micro-organisms in droplets of water (Figure 1.3). 
The beautifully illustrated works ‘Micrographia’, published in 1665 by Hooke, 
demonstrated this to society for the first time and resulted in it becoming a best 
seller. 
The gradual development of the parts that today we take for granted in the 
compound microscope occurred over the next three centuries. These include a 
sturdy stand, binocular systems, a concave mirror to light the specimen from below 
(Culpeper, 1727), apertures for better resolution (Goring, 1824), the effects of 
cover glasses (Lister, 1827) and apochromatic correction systems (Abbe, 1879). 
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Figure 1.3: Robert Hooke’s compound microscope 
Manufactured by London Instrument maker Christopher Cock in 1665, this microscope led 
to the compilation of drawings for the Micrographia, a book describing his observations. 
Courtesy of thescientist.com 
 
Throughout the 19th century great strides were made by companies to create 
further improvements, the most famous being Carl Zeiss Jena, founded in 1847 by 
Carl Zeiss (1816–1888). Over the years the basic design of the compound 
microscope had undergone amazing changes to provide the high quality 
instruments of today’s light microscopes. 
 
An important discovery worthy of note was the work published by George Airy of 
the Cambridge Observatory who noted that light produced a series of concentric 
rings rather than a single point image (the Airy disc). If the airy discs overlap, due 
to two point sources being brought close together, there will come a point where 
they are so close that it will not be possible to distinguish or resolve the two objects 
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as separate entities. The minimum distance to achieve  resolution of two objects is 
when the first minimum of one Airy disc coincides with the central maximum of the 
other (Strutt, 1879). 
In 1873, Ernst Abbe published the formal mathematical basis for optical 
microscopy and showed this distance, d, to be: 


sin
61.0
n
d   
where d is resolution,  is the wavelength of light,  is the half angle of acceptance 
of the lens and n is the refractive index of the medium between the object and the 
lens. He recognised that the limit to resolution was due to the wavelength of light 
and not by the design of the lenses. The importance of this finding was that the 
resolution limit of the light microscope was established, so now attention could be 
turned to improving other factors. 
Over the years various staining techniques were introduced and improved upon to 
help identify cellular structures and to improve their visibility with better contrast. In 
the 1930s techniques such as Giemsa and Feulgen staining showed the presence 
of chromatin bodies and DNA in bacteria (van Iterson, 1984). The problem with 
many of the staining techniques was that the chemicals in the methods used killed 
bacteria, but in 1953 Fritz Zernike won the Nobel Prize for his invention of the 
phase contrast microscope (in 1935), then being produced by Zeiss. Its system of 
annular rings scatters some of the light and creates a phase shift of half a 
wavelength of light, resulting in the ability to view specimens which are unstained. 
This allows them to stand out in contrast to the background, and hence the ability 
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to view live specimens such as bacteria. The importance of this was that here at 
last, the bacteria could be visualized live and processes such as proliferation could 
be studied. The later development of differential interference contrast exploited 
differences in the specimen’s thickness and refractive index to produce differences 
in amplitude and colour (Normarski and Weill, 1954). It was due to these 
developments in light microscopy that the structure of bacteria and their growth 
gradually became elucidated.
1.3 Preparation of samples for light microscopy 
Colonies of bacteria may easily be sampled and smeared on to a slide for fixation 
and consequent staining to view under a microscope, but to examine the presence 
and effect of such microorganisms in tissue samples requires lengthier processing.   
Fixation has been recorded as far back as Hippocrates but it was during the late 
19th century that there was a flurry of investigation into fixatives (Mitchell et al., 
2011). Fixation prevents putrefaction and autolysis. There have been many 
different fixatives invented for different tissue types using various chemicals from 
water to alcohol-based mixtures to gaseous, and containing many chemicals such 
as aldehydes, mercury, picric acid and chloroform. Today most pathology 
laboratories advocate the use of a buffered formaldehyde fixation method, many of 
which are now supplied commercially. Once tissue samples are fixed, they are 
processed by dehydration and subsequent infiltration by a medium that can turn 
from a liquid state into a solid state, for the creation of sections for staining and 
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examination. Processing machines have been developed to do this on a mass 
scale, some processing 300 samples in 40 minutes. Routine light microscopy uses 
paraffin wax as its medium. Samples processed this way can be easily stained by 
a multitude of techniques. 
In order to differentiate different cellular structures, histological staining methods 
were developed. The Gram staining method was devised in 1884 (Musumeci, 
2014), and is still today almost always the first test performed for the identification 
of bacteria. The primary staining solution of the Gram's method is crystal violet and 
the method is based on the ability of certain bacteria to retain the crystal violet dye 
in the cell wall during solvent treatment due to a higher peptidoglycan and lower 
lipid content. These microorganisms are classified as Gram-positive, while those 
not stained by crystal violet are referred to as Gram negative.  
As the structure of tissue samples and of bacteria was studied in more detail, the 
lack of morphological differentiation between the cytoplasm and the nuclear 
material in bacteria initially caused people to believe that they were different from 
other organisms. However, ground breaking light microscopy techniques by Mason 
and Powelson (1956) and Robinow (1956) demonstrated the presence of 
chromatin bodies in bacteria. A more detailed examination would await the electron 
microscope, which allowed for high-resolution imaging at much higher 
magnifications than that obtainable with the light microscope.  
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1.4 The development of electron microscopy 
It was in  1924 that Louis De Broglie theorised that electrons were similar to light 
and travelled in waves. If the wavelength of electron beams was smaller than of 
light waves and could be utilised in the same way, then the resolution of a structure 
would be much higher and hence the magnification would be increased. In  1931 
Ernst Ruska and Max Knoll produced the first electron lens using this theory and 
recognised the potential of an electron microscope (Figure 1.4). They built their 
transmission electron microscope (TEM) in 1936 and were able to image structures 
such as cotton as small as 50 nm. In the TEM, a high voltage is passed through a 
filament, such as tungsten, which causes it to emit electrons. The electrons travel 
through a high vacuum, where controlled electromagnetic lenses focus the 
electrons into a very thin beam. The electron beam passes through the specimen 
to be studied which, depending on the specimen density, scatters some of the 
electrons which diverge from the beam. These scattered electrons hit a fluorescent 
screen giving a shadow image of the specimen studied and its differing densities. 
Increases in the accelerating voltages improved the resolution further (FEI Electron 
Optics). Many companies subsequently started to produce the TEM, from RCA in 
North America, Metropolitan Vickers in Manchester England, Siemens and Carl 
Ziess in Germany, and Japan Electron Optics Laboratories (JEOL), Hitachi and 
Toshiba in Japan (Palucka, 2002). 
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Figure 1.4: Ernst Ruska and Max Knoll with the electron microscope in 1936 
The original transmission electron microscope was designed to magnify objects 
approximately 400 times. (http://poster.sciencemag.org/sem) 
 
The scanning electron microscope (SEM) was proposed by Max Knoll, and 
Manfred von Ardenne expressed the theoretical principles of it eliminating 
chromatic aberration inherent in its system (Bell and Erdman, 2012). The SEM was 
described and developed in 1945 by Zworykin, but the design of the first prototype 
was delayed until after the end of the Second World War when Oatley began to 
build an SEM based on Zworykin’s microscope. This was followed by Smith (1956) 
who introduced non-linear amplification and a stigmator to correct lens 
imperfections. In 1960 Everhart and Thornley created a new detector, a scintillator 
to convert the electrons to light and a light pipe to send this to a photomultiplier 
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tube, which finally led to Pease and Nixon in 1963 combining all these methods 
and the marketing of the first commercial instrument by Cambridge Scientific 
Instrument Company as the "Stereoscan” (Oatley, 2004). 
As with TEM, in SEM a tungsten filament produces a high energy electron beam. 
Where the TEM has electromagnetic lenses to control a stream of electrons, the 
SEM uses magnetic coils to adjust the focus of the beam on to the specimen. An 
area of the surface is scanned. The energy lost from the electrons is randomly 
scattered and absorbed. The secondary electrons produced are ‘read’ by the SEM 
detectors and an image produced. 
Hence, in summary, in the TEM the electron beam passes through a specimen, 
producing an image of the inner structures of cells, whereas in the SEM the 
secondary electrons produce images of surfaces, resulting from an electron beam 
scanning the surface of an object. 
 
1.5 Fixation and processing for electron microscopy 
In order to examine the ultrastructure of bacteria under the TEM it was also 
necessary to preserve them by some form of fixation. Light microscopy and its 
histological techniques were not adequate. In tissue samples osmium tetroxide, 
glutaraldehyde and uranyl acetate solutions are used alone or in combinations for 
fixation.  Much progress was achieved by Ryter and Kellenberger (1958) to 
overcome bacterial fixation problems (Glauert and Thornley, August 1966). They 
examined the fine structure of the nucleus under different conditions and this 
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resulted in the development of a buffering solution, the RK conditions of fixation, 
which provided optimal preservation of the fine fibrillar nuclear material of 
Escherichia coli (Ryter et al., 1958). The method was subsequently found to give 
excellent results with many other bacteria. An improvement was found by Sechaud 
and Kellenberger (1972) who tried fixation with a combination of glutaraldehyde 
and uranyl acetate rather than osmium tetroxide alone, and found it to give good 
reproducible results and visualisation of viral structures hitherto unseen by just 
osmium tetroxide fixation. It also fixed rapidly. Schreil (1964) studied the effect of 
uranyl acetate and found that dehydration caused damage to the bacterial 
ultrastructure by forming coarse aggregates of DNA. Schreil (1964) determined 
that uranyl acetate had a stabilising effect on bacterial DNA and reduced damage 
in the dehydrations steps. For this reason, Kellenberger and Ryter (1964) 
advocated initially fixing in osmium tetroxide with calcium ions followed by uranyl 
acetate as part of the RK buffering system. Further, Silva et al (1971), by chemical 
assays, determined that the amount of lipid loss - mainly lipid phosphorous from 
membranes- was greater without uranyl acetate post fixation. With uranyl acetate 
the ultrastructure of membranes appeared well preserved and it also produced 
optimum contrast, leading to the conclusion that that it stabilised materials that 
would otherwise be lost. The stabilisation of bacterial DNA is not something that is 
experienced by the nuclear material of eukaryotes, where proteins are associated 
with the DNA structure and where fixation with aldehydes at concentrations of 2-
10% causes gelation in these proteins by crosslinking and so inherently stabilises 
the DNA (Kellenberger et al., 1958; Kellenberger et al., 1981). In prokaryotic 
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bacteria there are no proteins associated with the DNA structure and hence no 
stabilisation of the bacterial DNA is possible. Any possible stabilisation of the DNA 
comes from the source of proteins provided by the growth media, e.g. tryptone, 
and prefixing the bacterial cells with a low concentration of osmium directly in the 
medium prior to following the RK conditions of processing (Kellenberger and Ryter, 
1964). 
Various other fixation methods were used to elucidate the structure of the bacterial 
cell but every protocol has been found to have its advantages and disadvantages. 
Fixation by aldehydes and osmium tetroxide promote permeabilisation across cell 
membranes with subsequent leakage of potassium then magnesium (Moncany and 
Kellenberger, 1981; Woldringh, 1973), which together with varying the salt 
concentrations of growth media were found to induce changes in nucleoid shape 
and organisation of the DNA plasm (Hobot et al., 1985). The problem of 
maintaining the true shape and organisation of the bacterial nucleoid and DNA 
plasm was solved by using cryosubstitution techniques, where rapid freezing, 
immobilisation in ice and replacement of ice by resin avoided the dangers posed to 
bacterial structure by chemical fixation and dehydration (Hobot et al., 1985). 
Whether the cryosubstitution techniques used an osmium tetroxide /acetone mix 
followed by processing into epoxy resins, or a glutaraldehyde/acetone mix followed 
by infiltration with acrylic (methacrylate) resin at -35C, these studies showed how 
the DNA fibrils were organized in the nucleoid (Bjornsti et al., 1986), with the DNA 
containing plasma of the nucleoid being a highly hydrated gel (Hobot et al., 1985, 
1987; Hobot, 1990). The nucleoid appeared as ribosome-free areas filled with 
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grainy structures intermingled with fibrous elements, containing the double-
stranded DNA fibre with unwound, single stranded DNA at the edges of these 
areas. 
Another area in the processing of bacteria besides fixation which was found to be 
important was the embedding medium or resin. In the 1950s, the introduction of 
methacrylate-based resins was met with several problems, notably uneven 
polymerisation, shrinkage and producing cellular swelling of bacteria (Birch-
Andersen, 1960). The introduction by 1960 of epoxy resins overcame the 
drawbacks presented by the methacrylates, which were largely forgotten, and 
much of our understanding of cellular ultrastructure was elucidated by the 
increasing use of these highly stable epoxy resins (Glauert and Glauert, 1958; 
Maaløe and Birch-Andersen, 1956). In the early 1980s the methacrylates made a 
comeback by being reformulated so overcoming all previous drawbacks, (Causton, 
1984; Kellenberger et al., 1980). These allowed new processing possibilities for 
preparing bacteria, especially by reducing the dangers posed to bacterial 
structures by dehydration in organic solvents required with epoxy resin processing, 
resulting in new aspects of bacterial ultrastructure being demonstrated (Hobot et 
al., 1984; Newman and Hobot, 1987; Hobot, 1990). 
As SEM requires an intact surface that is completely dry and electrically conductive 
on the surface, preservation and processing are just as essential in SEM as in 
TEM. Non-conductive specimens will cause charging faults if not dried and coated 
correctly. Also, air drying of specimens will lead its structure to collapse on itself 
when introduced to a high vacuum. As for TEM, SEM fixation is followed by 
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dehydration with organic solvents, in order to prevent structural alterations to the 
surface. These solvents can then be replaced by a transitional phase of liquid 
carbon dioxide which is then turned into a gas phase using a critical point drier. 
The instantaneous drying preserves the three dimensional organisation of surface 
structures. More recently a final organic solvent, hexamethyldisilazane (HMDS), 
has been introduced which successfully allows specimens to be air dried (Araujo, 
2003). The results indicate that the HMDS solvent is suitable for drying samples of 
bacterial cells for examination by SEM successfully without any damage occurring 
to surface structures. 
 
1.6 Fluorescence microscopy and confocal laser scanning 
microscopy 
Fluorescence microscopy was developed by Heimstaedt (1911) and Lehman 
(1913) and used in the studying of auto fluorescence. It  until the 1930s that 
suitable staining techniques were developed and these were followed by protein 
labelling with a fluorescent dye. Dyes such as ethidium bromide and acridine dyes 
have been used since the 1950s to visualize nucleic acids with ultraviolet light 
(Bradley and Wolf, 1959). 
The fluorescent microscope relies on a light source (such as a high pressure 
mercury lamp) exciting an electron in an atom or molecule and boosting it to a 
higher energy level. When it returns to its natural state it emits a quantum of light. 
The microscope system includes excitation and contrast filters, and beam splitters. 
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One of the problems with fluorescence microscopy is that the excitation light not 
only illuminates the point of interest, it also illuminates the background (secondary 
fluorescence). By adding a pinhole this problem is solved. This pinpoint is 
conjugate to the lens focal point (confocal pinhole) (Claxton et al., 2005). 
This basic concept of confocal microscopy was patented in 1957 by Marvin Minsky 
(Minsky, 1988). In the late 1960s specimens were scanned mechanically by a 
spinning Nipkow disc (Egger and Petran, 1967) and the first confocal laser 
scanning microscope (CLSM) was built by 1973. Mechanical scanning was used 
until computer technology advanced, and by the 1980s the images were 
manipulated digitally. The confocal microscope uses a laser as the excitation light 
and the image is measured from the pinhole to a detector linked to a computer. 
Modern CLSM are equipped with high power lasers and integrated electronics 
enabling video imaging. By scanning the specimen an image can be compiled 
which is of a higher resolution than the light microscope (theoretically 0.2 to 0.5 
µm). The advantages are that with its depth of field, thicker specimens can be 
examined, and optical slices can be collated into three dimensional images, for 
example of the bacterial nucleoid (Valkenburg et al., 1985), making it ideal for 
looking at thick bacterial films – termed biofilm. 
 
1.7 From planktonic bacteria to biofilm 
The deleterious effects of microbes in wounds have been recognized for decades 
(James et al, 2008) and at first it was presumed that these bacteria were planktonic 
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in structure. Planktonic microorganisms are free-floating and individual, maintained 
in some form of liquid medium. However, the planktonic state is not usually the true 
natural state that enables bacteria to survive so adeptly. It has become 
increasingly recognised that bacteria do not normally exist as solitary cells, but are 
colonial organisms working together as a community in a three dimensional 
structure, a composition termed biofilm. This term was coined by Costerton in 1978 
as – “a microbially derived sessile community characterized by cells that are 
irreversibly attached to a substratum or interface or to each other, embedded in a 
matrix of extracellular polymeric substance that they have produced, and exhibit an 
altered phenotype with respect to growth rate and gene transcription”. 
Consequently, it is now estimated that in non-healing chronic wounds 
approximately 75 - 80% of them contain biofilm (Römling and Balsalobre, 2012; 
Hurlow et al., 2016). 
Biofilm can form on any natural or man-made surface. It is the slime forming in 
stagnant water, it grows in the lining of catheters, it is often a precursor to wound 
infections, on kidney (or struvite) stones in urinary tract infections, and can be 
found on contact lens surfaces (Proal, 2008). Antonie van Leeuwenhoek’s early 
work on dental plaque resulted in the identification of what was later realised to be 
microbial biofilm (Percival et al., 2011). 
 
The sticky or slimy nature of biofilm is due to the production of extracellular 
polymeric substance (EPS), which are found to be a common bacterial 
phenomenon. EPS is beneficial in that it protects biofilm from external threats and 
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is also important for its structural integrity (Nadell et al., 2009). EPS is not unique to 
bacteria; it can be found associated with other microbes, namely the archaea, 
algae and fungi (moulds and yeasts). Neither is all biofilm hazardous as some of 
the bacteria beneficial to humans, such as those of the gut, can form biofilm. 
Surprisingly little is still known about how the biofilm matrix of EPS is actually 
formed, but extensive research has been performed and some of the findings on 
the content and suggested formations of biofilm are highlighted below. 
Selection favours those that can protect themselves in nature, so microorganisms 
forming into such a protected community is naturally beneficial. Persistence of 
microbial infections is therefore due, in part, to the ability of microorganisms to form 
these communities and to be ensconced and protected. Microbes at the surface of 
biofilm may be more susceptible to damage than those within the biofilm itself 
(Blaschek et al., 2007). Little is still known about the exact method of EPS 
production, but it is thought to be created by microbes using substances available 
in their environment and converting them into a slimy polymeric matrix (Tokuda, 
1969). Carbohydrate strands were demonstrated to surround bacteria, and when 
the presence of polysaccharides were identified it proved that a glycocalyx is an 
essential component of biofilm structure (the earlier name of EPS was extracellular 
polysaccharide substance). The EPS forms a sticky tangled mat that enables 
microbes to stick together or to other surfaces (Tokuda, 1969). EPS varies greatly 
depending upon the microbe, the environment and nutrients, which can therefore 
lead to biofilm matrices of varying chemical composition. Other parameters such as 
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pH, temperature and levels of oxygen or nitrogen will also affect the composition 
and quality of biofilm structure (Zhang et al., 1998). 
Like their planktonic counterparts, biofilm microorganisms must have a supply of 
nutrients to grow. Reduction in nutrient concentration will slow, halt or reverse the 
development of biofilm, but once nutrient content increases the biofilm will revert 
(Von Rege and Sand, 1998). The variable nature of biofilm is such that it can be 
highly complex, comprising multispecies containing many types of EPS, or it can 
comprise of a single species with its own specific EPS (Donlan, 2002). Biofilm can 
contain up to 97% water (Sutherland, 2001a). The presence of such a high level of 
water provides a highly hydrated environment protecting the cells against 
desiccation. Up to 90% of the dry weight in biofilm is the EPS matrix, so as little as 
10% has been suggested to be microorganisms (Flemming and Wingender, 2010). 
A few biofilm matrices are cationic in nature, however most are anionic with D-
glucuronic acid being the most common anionic molecule found within most 
biofilm, although d-galacturonic and d-mannuronic acids can also be present 
(Sutherland, 2001b). Primary conformation of EPS is often polysaccharides that 
have been visualized as fine strands attached to the microbial cell surface and 
forming a complex network surrounding the cell (Sutherland, 2001b). Proteins, 
lipids, extracellular DNA (eDNA) and other molecules also add to the 
heterogeneous nature and may interact with the polysaccharides, with protein often 
being the largest fraction (Jahn et al., 1998; Jahn et al., 1999; Bjarnsholt, 2013). 
This network of polysaccharide and macromolecules traps cells and cell products 
within it giving a final tertiary structure (Sutherland, 2001b). In biofilm extracted 
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from river waters humic acids (organic matter) and hexoses are present (Aguilera, 
2008). Lectins are thought to be involved in the formation and stabilization of the 
polysaccharide matrix network and constitute a link between the microbial cell 
surface and EPS (Flemming and Wingender, 2010). 
Microorganisms can secrete enzymes and surfactants which may help in the 
building and protection of the biofilm structure (Izano et al., 2007). Staphylococcus 
aureus (S. aureus) synthesizes poly-N-acetylglucosamine (a homopolysaccharide 
composed of unbranched long polymeric chains of D-glucosamine uniformly linked 
together by α-1,6 glucosidic bonds), which is believed to be its most important 
biofilm matrix component and research links its presence to the binding of the 
biofilm to surfaces (Pamp et al., 2007). 
Flemming and Wingender (2010) stated that the biofilm acts almost like an external 
digestive system because it has the ability to keep these extracellular enzymes 
close to the cells, and by keeping the contents of lysed cells available in the matrix, 
it can also act as a recycling centre. In dental plaque, the close proximity of 
bacteria can lead to the degradation of host complex molecules, such as salivary 
mucins (Marsh and Bradshaw, 1995). Type IV pili have also been found which are 
used by a number of bacteria. By using phase-contrast microscopy to analyse a 
collection of Pseudomonas aeruginosa (P. aeruginosa) mutants defective for 
surface attachment, flagella and type-IV pili, O’Toole et al., (2000) showed that 
these structures played an important role in the early events in biofilm 
development. P. aeruginosa pili were shown to have an affinity for binding with 
DNA and, as eDNA has been found in abundance in the extracellular matrix 
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material of P. aeruginosa biofilm, it is thought that the type IV pili might act as 
cross-linkers between the cells and eDNA (Pamp et al., 2007). The generation of 
eDNA is evidently in many cases regulated by means of quorum-sensing, which is 
a mechanism that enables bacteria to monitor their cell population density through 
the extracellular accumulation of signalling molecules. Treatment of bacterial 
growth with P. aeruginosa DNase has been shown to prevent the formation of 
biofilm (Vilain et al., 2009). Vesicles, which have been found in biofilm, are thought 
to be from the outer membranes of bacteria. They contain enzymes and DNA that 
can alter the biofilm matrix properties, perhaps even competing with other 
organisms within it (Flemming and Wingender, 2010; Schooling and Beveridge, 
2006). Analysis of any of the content suggested within biofilm EPS will however be 
dependent upon the extraction methods used, be it centrifugation, sonication, 
filtration, or treatment with agents and ion exchange resins. If the cells within the 
EPS are damaged then the cellular contents will cause contamination (Aguilera, 
2008). 
There has been much thought into how the EPS helps adhesion of the biofilm. 
Tsuneda et al., (2003) examined the influence of EPS on bacterial cell adhesion 
onto solid surfaces and concluded that if the EPS amount is small, cell adhesion 
onto solid surfaces is inhibited by electrostatic interaction, and if it is large, cell 
adhesion is enhanced by polymeric interaction. Depending strongly on the forces 
acting on the EPS matrix, biofilm displays viscoelastic properties (Tsuneda et al., 
2003). 
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In humans there are many surfaces on which biofilm can grow. For example, the 
respiratory tract (Pseudomonas spp or aeruginosa), intestinal mucosa (Escherichia 
coli), teeth (streptococci) and sutured skin wounds (Staphylococcus aureus) can all 
provide the ideal surface on which bacteria can anchor and develop into colonies 
and biofilm. These bacterial examples rarely develop on their own in these 
situations. Biofilm can be single species, such as those often found in clinical 
equipment infection e.g. those lining catheters, but biofilm is usually polymicrobial, 
containing multiple, diverse species often forming an almost symbiotic form of life 
(Donlan and Costerton, 2002). Wound infections like diabetic foot ulcer (DFU) 
infections are usually polymicrobial in nature. A study in India by Malik et al., 
(2013) showed that 68.5% of DFUs were polymicrobial whilst 31.4% were 
monomicrobial. There is an increasing effort to try to understand why bacteria are 
more commonly found associated with other bacterial species rather than as 
isolated organisms. The advantages of this behaviour is probably, as with any 
community, that the biofilm bacteria can cooperate in the distribution of nutrients, 
removal of wastes, and defence against exogenous threats (Serralta et al., 2001). 
The National Institutes of Health (US Department of Health and Social services) 
have stated that biofilm is involved in 80% of all known infections (Percival et al., 
2008). 
1.8 From planktonic bacteria to biofilm 
Planktonic bacteria, free floating and swimming, will attach to a surface given the 
opportunity. The flagellar/fimbriae-dependent bacteria will revert to twitching 
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motility, instead of swimming, once in contact with a surface, and relinquish their 
planktonic state. This twitching relies on pili and will continue whilst in contact with 
other cells while forming a monolayer of growth. This contact induces gene 
expression which encourages the cells to start to secrete EPS, proteins, 
polysaccharides and eDNA, to participate in quorum sensing and gradually to 
develop biofilm (Bjarnsholt et al., 2013). 
The P. aeruginosa polysaccharide synthesis locus (expressing Psl 
exopolysaccharide, an initial component of its biofilm) is anchored, at attachment, 
on the cell surface in a helical pattern. This promotes cell-to-cell interactions and 
production of a matrix. Chemical dissociation of Psl from the bacterial surface 
disrupts the matrix as well as the biofilm structure (Ma et al., 2009). Other 
interactions such as van der Waal forces, hydrophobicity and charge, help the 
bacteria to firmly adhere to the surface (Wuertz et al., 2003). 
Biofilm morphology has been observed in vitro to be at first flat and 
undifferentiated, then differentiating into towers and mushrooms shapes that can 
fuse together, producing channels and voids to deliver nutrients and remove waste 
products (Nadell et al., 2009). This structure, suggested by Donlan and Costerton 
(2002), is one formed from considerable work and consensus and has been drawn  
from mainly CLSM images (Figure 1.5). 
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Figure 1.5: The Mushroom and Tower biofilm structure 
In high shear the micro-colonies are visco-elastic and deformable. Water channels conduct 
convective flow and deliver nutrients to most parts of the biofilm community. Adapted from 
Donlan and Costerton (2003) 
 
 
 
Figure 1.6: The Heterogeneous Mosaic biofilm structure  
Microcolony stacks on a substratum base that are well separated from each other. Often, 
in addition to the stacks, is a background of individual cells attached to the surface forming 
a thin film. Adapted from Walker et al. (1995).  
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A second structure suggested by Walker (1995) is of stacks of microcolonies that 
grow into towers but do not fuse together – the “Heterogeneous Mosaic” biofilm 
model (Figure 1.6). Much of this work has been performed upon catheter biofilms 
(Wilks et al., 2008). A third structure, described by Wimpenny and Colasanti 
(1997), is one observed in dental studies of plaque. Here a dense amorphous 
biofilm structure is suggested with little evidence of water channels and plaque, 
although some CLSM studies have found small voids and channels within them 
(Lewandowski, 2005). 
Whatever conceptual model the biofilm is thought to follow, they all have the main 
effect of immobilising constituent cells and encouraging interactions (cell-to-cell 
communication) and prolonged existence (Rice et al., 2005). Klausen et al., (2003) 
showed that P. aeruginosa had a highly differentiated biofilm that formed the stalks 
of mushrooms when grown in vitro in the presence of glucose, whereas the same 
strain formed a flat and undifferentiated biofilm in the presence of citrate. These 
adaptive strategies help bacteria overcome the stresses of their environment with 
resulting stabilisation and ecological success. Biofilm-associated cells can be 
differentiated from their planktonic, suspended counterparts by generation of an 
EPS matrix, reduced growth rates, and the up and down regulation of specific 
genes. During P. aeruginosa biofilm maturation, Psl exopolysaccharide 
accumulates on the periphery of 3-D-structured microcolonies, resulting in a Psl 
matrix-free cavity in the microcolony centre containing swimming and dead cells 
together with eDNA (Ma et al., 2009). 
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Once well established, biofilm can shed cells. This dispersal is an important stage 
in biofilm development, as it allows new biofilm to be formed. This dispersion may 
occur in response to environmental changes; it can be induced by nutrient 
starvation or sudden nutrient availability (Flemming and Wingender, 2010). 
Dispersion can be of single planktonic cells or clumps of biofilm, which spread and 
recolonise elsewhere. It has been suggested that the biofilm cells may secrete 
enzymes which break down parts of the matrix and cause changes to the structure 
(Sutherland, 2001a, 2001b). This could also cause the release of clumps of biofilm 
from the main structure, as could shearing effects from flow systems, erosion or 
abrasion. In wounds, there is some argument that slough is also biofilm released 
by a passive mechanical force (Parsek and Singh, 2003), although many regard 
slough as purely dead host (largely proteinaceous) material (Hurlow and Bowler, 
2009). 
Sometimes biofilm aggregates can be identified as opaque macroscopic flecks 
because they are so large, e.g., in the urine of patients with urinary tract infections 
due to P. aeruginosa (Costerton, 1984). In endocarditis, pace-makers can be 
susceptible to biofilm colonisation and have been found to be covered with thick S.  
aureus biofilm, which had possibly protected the organism against aggressive 
antibiotic therapy (Costerton, 1984). 
 
1.9 Quorum Sensing in biofilm 
Bacteria are thought to communicate within biofilm matrices by the use of chemical 
signalling molecules, excreted from the cells, which can elicit profound 
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physiological changes. This cell-to-cell communication continues and, once a 
critical threshold concentration has been reached (a quorum), it can initiate a 
response and  expressgenes in a cell-density-dependent manner (Winzer et al., 
2002). The term ’quorum-sensing' has been coined to describe this ability of 
bacteria to monitor cell density before expressing a phenotype (Whitehead et al., 
2001). This allows bacteria to coordinate, change and adapt to their environment. 
Wound adherent and wound non-adherent bacteria have been quantified in similar 
wounds and, although the non-adherent (planktonic) bacteria will vary more widely 
in number from wound-to-wound, the adherent (biofilm) bacteria have a narrower 
range suggesting a critical mass (Serralta et al., 2001). 
A large number of different bacterial products can be found in spent culture 
supernatants and, theoretically, each of these molecules has the potential to serve 
in a quorum sensing system as a signalling molecule. However, what defines cell-
to-cell signalling, as a phenomenon that deals with more than simply the presence 
of a toxic or nutritional molecule, is a cellular response that extends beyond the 
physiological changes that would be required to metabolise or detoxify (Winzer et 
al., 2002). 
Two quorum-sensing processes have been described for bacteria, termed auto 
inducers (AI). AI type 1 is mainly involved in intra-species communication and the 
type 2 is associated with inter-species interaction. Gram-negative bacteria are 
thought to produce and release AI molecules, which are generally N-actyl 
homoserine lactone molecules, whereas Gram-positive bacteria are thought to 
communicate with modified oligopeptides (Vu et al., 2009). 
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The microorganism on which most quorum-sensing-related studies have been 
initiated is P. aeruginosa, reflecting its significance as an opportunistic human 
pathogen. It has been found to have two quorum-sensing systems, LasI-LasR and 
RhlI-RhlR, which are thought to regulate virulence factors such as exoenzyme S 
(ExoS) and exotoxin A (ToxA). Virulence factors in S. aureus include Panton-
Valentine leukocidin (pvl), staphylococcal protein A (spa) and a-hemolysin (hla) 
(Pastar et al., 2013).  
 
1.10  The use of biofilm in Industry  
A material surface exposed in an aqueous medium will inevitably and almost 
immediately become conditioned or coated by polymers from that medium, 
resulting in a chemical modification of that surface. Upon this surface biofilm can 
then grow. On an intermediate timescale, biofilm can improve the strength of its 
structural matrix in response to mechanical stresses, such as water flow, by 
increasing its EPS production (Flemming and Wingender, 2010). The undesired 
effects of biofilm include corrosion of constructional material, heat loss in heat 
exchangers, or the decrease of product quality, as in the paper industry. Reducing 
microbially-induced corrosion is estimated to cost 3% of the world’s domestic 
product (Ikuma et al., 2013). Biofilm also have the ability to harbour enteric 
pathogens in potable water systems due to its reduced susceptibility to 
antimicrobial agents (Blokker et al., 2013). Strategies to limit the growth of 
undesired microorganisms are often the addition of chemical biocides such as 
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chlorine, mechanical cleaning, or nutrient depletion. Using these approaches can 
be costly and time consuming and there are environmental restrictions for the use 
of these often harsh chemicals (Von Rege and Sand, 1998). Biofilm cells are also 
thought to exist in different metabolic states, which could make them less 
susceptible to antimicrobials (Ferriera et al., 2010). 
A more positive finding of biofilm in industry is its biotechnological potential, such 
as the removal of toxic heavy metals ions from contaminated waters and 
sediments in chemical industries, which present an increasing hazard for all living 
organisms (Aguilera, 2008). Biofilm is used in bio-filtration to remove organic 
matter in drinking water and as a use for removing disinfection products (formed by 
reactions between disinfectants and natural organic matter) (Reinke and Sorg, 
2012). 
EPS anionic ligands have an affinity for multivalent cations such as Ca2+, Cu2+, 
Mg2+, and Fe3+ and favour mineral precipitation. Biotechnological techniques, such 
as bioleaching, rely on microbes oxidizing solid compounds, recovering heavy 
metals and resulting in soluble and extractable elements decreasing the dangers 
for ecosystems and human health (Vu et al., 2009). In such situations biofilm is 
often exposed to turbulent flows. Because of the flexibility of the matrix it has the 
ability to change shape in response to the applied force. The shear stresses can 
affect biofilm physical morphology and dynamic behaviour, with elastic-like 
recovery and this shear force style of biofilm can be seen in dental plaque 
(Sutherland, 2001a). 
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1.11 Biofilm in the Body 
Biofilm is known to grow on many surfaces of the human body including the lungs, 
intestinal tract and skin. Some play a protective role, such as those in the gut or 
vagina, but if its composition or its surroundings and nutrients alter (such as host 
immunosuppression), then biofilm can become pathogenic. As acknowledged by 
the National Institutes of Health, most chronic human infections, such as 
osteomyelitis, endocarditis, prostatitis, otitis media, sinusitis, and dental disease, 
are biofilm-based (Lasa et al., 2005). 
P. aeruginosa is adept at forming biofilm in the lungs of patients suffering from 
cystic fibrosis or in the wounds of burns patients, and it is a potent producer of 
alginate (polysaccharide) slime. A green slime and a sweet odour in a wound are 
clinical indicators of its presence, where the green colour is caused by production 
of pigments such as pyocyanin (Hurlow and Bowler, 2009). 
S. aureus, as part of the normal microflora of the skin and mucosal nasal 
passages, is harmless, but, as an opportunistic pathogen, it can be found to be a 
cause of invasive and chronic infections in medical device-related infections, and 
as biofilm in intra-operative appliances such as catheters. S. aureus biofilm can be 
indicated by a golden colour which is caused by the production of staphyloxanthin 
(Pamp et al., 2007). 
Some clinical biofilms are able to incorporate particles from the host such as fibrin, 
which has been found in infective endocarditis, and is thought to protect the biofilm 
from the leukocytes of the host. Valve dysfunction injury promotes thrombus 
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formation to which the bacteria attach. Eliminating platelets from a fibrin-rich matrix 
can reduce bacterial formation, especially of S. aureus, as can inhibiting platelet 
aggregation by aspirin treatment (Parsek and Singh, 2003). Urinary catheters 
colonised by biofilm are known to become blocked by mineral encrustations due to 
biofilm organisms hydrolysing urea and the resulting high level of ammonia 
resulting in this precipitation (Donlan, 2002). 
From the above it can be seen that biofilm can form and give rise to infections in 
many areas of the human body. It has been estimated that biofilm is associated 
with 65% of all hospital-related infections and, as such, is a great drain on the 
National Health Service (NHS) budget (Bowler and Percival, 2004). Treatments 
must be targeted at suppressing biofilm but not damaging host tissue or the host 
immune response cells. 
Biofilm has been known for some time to be able to detach from surfaces as large 
aggregates (Costerton, 1984), each of which could grow up as individual colonies. 
Routine cultures grown from swabs of colonised catheters and intrauterine 
contraceptive devices are usually negative. This is mostly likely because the 
traditional culture techniques, which have been employed for years, will usually 
only detect planktonic bacteria. Even if the culture technique reports a predominant 
bacterium, there is no guarantee that this is the pathogenic bacteria that is causing 
the problem (Costerton, 1984). Ideally the colonised surfaces of such infections, 
including those of wounds, should be scraped to detach not only planktonic 
bacteria, but any biofilm-associated cells. These scrapings should be examined by 
laboratory techniques such as Fluorescence In-Situ Hybridisation (FISH) or 
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Polymerase Chain Reaction (PCR). However, using these forms of technical 
investigations on a regular basis would be costly for the NHS compared to the 
usual culture techniques, and also presumes the clinic is aware that they should be 
looking for biofilm (Oates et al., 2014). Looking at this problem of costs, thought 
has been given to looking at EPS as a marker, but due to its biochemical diversity 
it is unlikely that one staining approach could be used, as each group of 
compounds would need to be targeted separately (Neu and Lawrence, 2014). 
 
1.12 The Effect of biofilm on the National Health Service  
Biofilm has great importance for public health because of its suspected role in 
infectious diseases and the connection with a variety of device-related infections. 
Antimicrobials employed must manage the bacterial infection but be gentle to the 
host, unlike in the industrial environment where harsher chemicals can be 
employed, but these gentler antimicrobials may not penetrate biofilm efficiently 
(Lima et al., 2001). 
Antibiotic resistance is becoming increasingly higher on the agenda in healthcare 
and the media. Most of the public have heard of the term “MRSA” even if they are 
not aware of exactly what it is. Patients are given preoperative swabs from the 
nasal passage and groin to look for Methicillin-Resistant S. aureus (MRSA) and, if 
positive, are given preoperative antibiotics. Antibiotics might suppress planktonic 
bacteria but they usually fail to eradicate those embedded within a biofilm. It has 
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been estimated that biofilm bacteria are up to 1,000 times more resistant than 
planktonic bacteria (Martineau and Dosch, 2007).  
Are bacteria transferring antibiotic resistance genes via biofilm to other bacteria, or 
are enzymes being produced by one antibiotic-resistant cell type and simply 
protecting neighbouring non-resistant cells purely by their mutual vicinity? Are they 
also causing previous relatively harmless bacteria to be converted into highly 
virulent forms? This is probable, due to the presence of vesicles from the outer 
membranes of bacteria which have been found in biofilm (Schooling and 
Beveridge, 2006), but it could also be due to the nature of the structure of the 
biofilm matrix itself preventing the antibiotics from attacking the safely protected 
bacteria. It may simply act as a barrier. If biofilm is disrupted then the bacteria 
become more susceptible to antibiotics and antimicrobials (Miller and Miller, 2011). 
Deeper within biofilm, where there is less access to nutrients, bacteria may be 
entering a spore-like state in which they can survive for years (Costerton and 
Wilson, 2004; Ferriera et al., 2010), protected from the effects of antibiotics or 
antimicrobials. Those bacteria deep within biofilm are thought to accumulate in 
anaerobic niches, where concentrations of molecules and changing pH will be 
different for internal bacteria than those accumulated in more external or surface 
layers. This could effect the diffusion, thus penetration, of antibiotics deeper in to 
biofilm (Stewart and Costerton, 2001). These metabolically differing areas of 
biofilm therefore present many challenges to effective clinical treatment. One 
reason for biofilm resistance may simply be that some antibiotics, like penicillin, 
target cell wall synthesis and kill bacteria that are actively growing, those near to or 
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on the surface, but cannot kill those in a sessile state deeper within the biofilm 
(Costerton et al., 1999). These persisiter cells may survive and hence are tolerant 
to antibiotics without undergoing genetic change, and can result in relapse of 
persistent infections. 
Another aspect that affects the NHS is the cost to the patient; not just in monetary 
value but also in physical and mental health. Estimates suggest that up to one third 
of patients who develop a foot ulcer experience depression (Malik et al., 2013). 
With an increase in the number of obese people worldwide, there has been an 
increase in the number of people developing conditions such as diabetes and 
cardiovascular disease. These groups of people are at more risk of having poor 
circulation and developing chronic wounds, i.e. wounds that have not healed after 
6 weeks, such as venous leg ulcers. Venous insufficiency, ischaemia and hypoxia 
have a major impact on wound chronicity (Hunt et al., 2000). Diabetic foot ulcers 
are a burden on the patient and the health care system (Malik et al., 2013). 
It has been estimated that up to 1-2% of the worldwide population are suffering 
from a non-healing wound (Bjarnsholt, 2008). Chronic wound management is 
complex and prolonged. Ulcers that become colonised by biofilm are often difficult 
to eradicate and patients can suffer with them for years. Amputation sometimes 
results and this impacts on the physical and mental health of the individual. 
Patients who undergo amputation can suffer with depression, post-traumatic stress 
disorder and phantom limb pain (Bhuvaneswar et al., 2007). 
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The cost to the NHS is therefore substantial due to the length of time these wounds 
can exist and the differing treatment the patients have to undergo, including visits 
to or from community care settings to change dressings, and with ever more limited 
resources on health services it creates a considerable financial burden. Posnett 
and Franks (2007) estimated that the cost to the NHS of caring for patients with a 
chronic wound was circa 2.3–3.1 bn per year (at 2005–2006 costs); around 3% of 
the total estimated expenditure on health for the same period. Posnett and Franks 
(2008) estimated the cost of venous leg ulceration to the NHS of £168–198 million 
per year, while Kerr (2012) estimated that nearly £700 million is spent each year on 
foot ulcers and amputations. In the Government’s Quality, Innovation, Productivity 
and Prevention agenda 2012, it identified that the NHS had to make significant 
savings. It focused on reducing harm and expenditure in wound care, especially 
around pressure ulcer formation, which in 2010 was estimated to cost over 
£140,000 per case. In Wales £330 million is spent on wound care annually – 6% of 
the NHS budget (Cardiff University Wound Healing Research Unit September 
2014). These costs begin to explain the amount of time and effort being used in 
research into biofilm in order to produce an evidence-based approach to clinical 
interventions. 
 
1.13 Biofilm and Wounds 
Biofilm is known to persist in wounds, and once it is has been disrupted or 
removed by methods such as debridement and cleansing, it can and often does re-
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form quickly (Wolcott et al., 2008) (Figure 1.7). A greater understanding of biofilm 
processes should lead to novel, effective strategies for biofilm control and a 
resulting improvement in patient management (Donlan, 2002). 
Wounds often have a wide range of pathophysiological origins and, when 
colonising chronic wounds, bacteria are most likely to exist as biofilm communities 
(James et al., 2008) and hence treatment should target these specifically. These 
chronic wound biofilm communities will inevitably form immature, microscopic 
biofilm that the host defences may be able to deal with, but once the balance is 
tipped in favour of the bacteria, wound healing will be compromised, i.e. the wound 
becomes critically colonised. James et al., (2008) light (LM) and electron 
microscopy (EM) studies showed 60% of chronic wound samples examined 
contained biofilm whereas they were present in only 1 of 16 acute wounds 
sampled. Scientific research often examines biofilm formed by one type of bacteria 
in vitro but clinical research such as this has noted that wound biofilm is usually 
polymicrobial. Recently, research groups in the US and Europe (Bjarnsholt et al., 
2008) also observed biofilm microscopically in approximately 60% of all chronic 
wounds and suggested that it is implicated in at least 80% of all human bacterial 
infections (Nusbaum et al., 2012). 
There is still controversy amongst some as to whether biofilm can actually be seen 
in wounds. In the Journal of Wound Care in 2010 three of the world's leading 
researchers on biofilms told an audience that, in their view, biofilms are the main 
cause of wound chronicity (Cowan, 2011). And yet in 2012 Professors Keith 
Cutting and Richard White submitted differing articles on how “there is, as yet, no 
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conclusive clinical or in vivo proof that wound biofilms exist” (Cutting and White, 
2012; Cowan, 2012). Some clinical cues which may be indicative of biofilm 
presence are (Metcalf et al., 2014; Percival et al., 2012): 
• Excessive moisture 
• Poor quality granulation tissue 
• Signs of local infection 
• A history of antibiotic failure, or recurring infection as therapy ceases 
• Culture-negative swabs despite clinical suspicions 
• Wound remaining recalcitrant despite antimicrobial interventions 
• Malodour  
• Polymicrobial microbiology 
•  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Schematic stages of biofilm formation within a wound 
If a host is compromised biofilm may form and this progresses in steps. Planktonic 
bacteria become irreversibly attached to the surface and begin to excrete EPS, forming a 
protective matrix in which microcolonies can grow, to eventually produce a mature biofilm 
with further dispersal of bacteria (by kind permission, Dr. Daniel Metcalf, ConvaTec Ltd, 
2014) 
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1.14 The management of wounds 
Health care has increasingly become patient-centred, involving a balance of 
medical treatment with the rights and needs of a patient, as well as the 
responsibilities of all the stake holders and constituents in the health care system 
(Omi, 2007). Clinicians, healthcare organisations and industry all have important 
roles in ensuring that care is delivered effectively and takes account of the complex 
needs of individuals living with wounds (Wounds International, 2012 International 
Consensus). The risk of a wound becoming infected will be increased in any 
condition that will cause debilitation, immune suppression or decreased vascular 
supply, such as renal impairment, circulatory disease, respiratory disease, obesity, 
malnutrition, rheumatoid arthritis, steroid treatment, malignancy, or poor personal 
hygiene (Guo and Dipietro, 2010). A challenge with examining wounds in a clinical 
setting is that some patients may present to a clinic with infected wounds that may 
have been present for varying times and may have had previous antimicrobial 
treatment as well as antibiotics. There is no doubt that there is growing microbial 
resisitance to antibiotics when used over long periods (Malik et al., 2013).  
Inefficient eradication of the the infecting pathogens may also contribute to a lack 
of wound healing (Bjarnsholt et al., (2008). 
Four factors are important in patient wound care: 
I. Inflammation 
By forming a biofilm matrix, microbial cells can also escape engulfment by host 
defences. Mammalian host phagocytic cells have difficulty ingesting them because 
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they are within this complex structure and often firmly attached to a surface (Ma et 
al., 2009). The polysaccharide component also blocks complement activation 
(Percival and Bowler, 2004; Malik et al., 2013). The structure of biofilm is such that 
only the exposed surface bacteria can be efficiently attacked by the host response. 
Biofilm releases antigens which stimulate the production of antibodies from the 
host, but these antibodies will only respond to the surface antigens and will often 
fail to penetrate into the matrix of the biofilm and will cause host tissue damage 
(Davis et al., 2006). The host’s polymorphonucleocytes, in response to not being 
able to ingest biofilm, will release pro-inflammatory enzymes, proteases (e.g. 
matrix metalloproteinases and cytokines). This chronic inflammatory response 
unfortunately does not destroy the biofilm, but causes more damage to the 
surrounding host tissue (Hurlow and Bowler, 2009). This in turn becomes inflamed 
and susceptible to bacterial attack and hence more biofilm growth and, whereas 
the biofilm is thought to re-grow quickly, the host tissue is much slower to reform 
(Percival and Bowler, 2004). With host tissue damage present, it is difficult to treat 
the patient without causing more trauma and pain (Figure 1.8). 
Research into fibroblasts by Pastar et al., (2013) has shown that they produce 
keratinocyte growth factor 1 which can act via a receptor, found on keratinocytes, 
to produce increased proliferation in wound healing and epithelial growth. 
Suppression of keratinocyte growth factor 1 and other factors, by the presence of a 
mixed species biofilm in a porcine in vivo model, reduced the keratinocyte 
migration and proliferation, delaying wound healing. Suppression was found to be 
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higher in polymicrobial wounds compared to that produced by single species 
biofilm (Pastar et al., 2013).  
II. Exudate 
By inducing an inflammatory response, the bacterial biofilm encourages the wound 
to produce more exudate (Parsons and Metcalf, 2014). Exudate effectively acts as 
a culture medium, supplying the bacteria with moisture and nutrients. Hence, if 
there is excessive, uncontrolled moisture in a wound it is likely to be supporting 
biofilm. Effective exudate management can promote healing (Keast et al., 2014). 
Exudate is an aqueous fluid usually with a composition of protein-degrading 
enzymes, electrolytes and nutrients, growth factors and cells which can support 
cell proliferation and assist healing in an acute wound (Miller-Keane Encyclopedia 
and Dictionary of Medicine, 2003). Some moisture is conducive to healing but 
when exudate becomes excessive in a chronic wound it can be corrosive and 
prevent a wound from healing (Bianchi, 2012). New devices and techniques 
(pumps and dressings) in negative wound pressure therapy have been developed, 
to help control exudate in wounds, with the intention of preparing the wound bed 
for closure, and promoting granulation tissue formation (Gupta et al., 2007). This 
technique utilises a sealed dressing with a vacuum pump, which applies controlled, 
sub-atmospheric pressure to the surface of a wound, which draws out the exudate. 
III. Debridement 
Dental plaque biofilm on teeth, gums and the tongue can be removed by regularly 
brushing and flossing to help prevent tooth decay and gum disease. Logic would 
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therefore dictate that the removal of wound biofilm would help an infected wound to 
heal. Clinical procedures recommend the removal of devitalised tissue, slough, 
fibrin, or infected tissue by trained, qualified nurses, as part of a regime of biofilm 
based wound care, although there appears to have been few randomized 
controlled trials that show that debridement speeds healing or reduces infection in 
chronic wounds (Edwards and Stapley, 2010) as they are challenging to conduct. 
Wolcott et al., (2008) performed a retrospective study on diabetic limb ulcer 
patients which included the use of debridement and antibiofilm agents of xylitol and 
lactoferrin and concluded that biofilm based wound care significantly increased 
healing rates in patients. Debridement of a wound to remove unwanted tissues 
(including biofilm, when present) can be done in different ways and several 
techniques are employed in the clinical environment. 
Mechanical debridement with saline wet-to-dry dressings is not considered an 
effective debridement, but irrigation with safe irrigating fluids can be used (Keast 
and Lindholm, 2012). Sharp debridement employs the use of a clinical implement 
such as a curette or sharp blade by qualified nurses. Other methods include 
enzymatic debridement (Ramundo and Gray, 2011), high-pressure irrigation, ultra-
sonication, or applying a dressing that pertains to helping break up biofilm, creating 
a balanced level of moisture, and promoting autolytic debridement. Debriding 
cloths or pads, based on newer monofilament fibre technology (Haemmerle et al., 
2011), have been recommended for use in clinics (Meads et al., 2015). Methods 
including hydro-surgery and ultrasound are expensive to use and require specific 
skills (Sainsbury, 2009). The method used will depend upon the patient’s pain 
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tolerance levels (and possible suitability for anaesthesia) and the anatomical 
location, as well as the particular clinic’s preference and nurse qualifications. 
In 2009 Lead Researcher, Professor Keith Harding, from the Welsh Wound 
Innovation Centre, teamed up with a commercial producer of medicinal-quality 
larvae for a 12-month trial with 200 patients across 8 hospitals, to examine the 
efficiency of maggots at debriding wounds (Mudge et al., 2014). The larval 
treatment in this study was shown to be more effective at debriding the wound than 
hydrogel alone. Although maggot therapy is an ancient method (Sherman et al., 
2000) it is the research into larval secretions that has had resurgence in research 
(Smith et al., 2006); a topic even discussed in a House of Commons debate in 
2007, such is the need to find replacements for failing antibiotic therapy.  
There is still some debate as to whether slough, found on the surface of an 
exposed wound, is linked to, comprised of, a component of, or a consequence of 
biofilm. Research is still on-going into its precise nature, but if slough is seen in a 
wound there is a possibility that it is due to the presence of biofilm, and thus the 
wound is usually treated as such (White, 2011). Slough is relatively easy to remove 
in most patients with dry gauze (Hurlow and Bowler, 2009), but if it is adjoining the 
underlying wound tissue it can be more difficult to remove. The material observed 
in a wound may be a combination of slough, biofilm, host devitalised tissue and 
fibrin (Metcalf et al., 2014). No method as yet debrides a wound completely of 
bacteria, so biofilm will still be likely to exist (Young, 2011). Debridement must 
therefore be done regularly for some wounds (Wolcott et al., 2009) and as such 
should be performed by qualified experienced healthcare workers. Skilful film 
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removal can inflict minimal harm to the wound bed, and in some wounds thick film 
can be removed almost completely in one piece (Hurlow and Bowler, 2009). Even 
the most experienced of clinical staff will find it difficult to distinguish biofilm in a 
necrotic wound from slough. 
IV. Pain 
Pain, associated with other inflammatory factors such as redness, odour, swelling 
or heat in a wound, can be indicative of the presence of a biofilm (Metcalf et al., 
2014). Biofilm can be a precursor to infection and, if associated with a history of 
recurrence and antibiotic failure, a wound should be treated as biofilm-
compromised (WUWHS, 2008). Operational pain (the pain caused when a 
dressing is changed or during debridement) can cause trauma to the wound and 
the patient. This acute wound pain has been the focus of dressing related 
procedures as in the European Wound Management Association Position 
documents (EWMA 2002-2008). These documents, and other similar documents, 
aim at giving strategies to assist in dressing application, removal and change. 
Some patients have been found to suffer with pain for 2 hours after the application 
of dressings (Tredget et al., 2002). The introduction of hydrocolloid based 
dressings has been noted to alleviate the pain and discomfort suffered by patients 
(Percival and Bowler, 2004). 
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Figure 1.8:  A stage IV pressure ulcer with a heavily colonised wound bed 
Stage IV pressure ulcers are decribed as full thickness tissue loss with exposed bone, 
tendon or muscle. Slough or eschar may be present on some parts of the wound bed. In 
this image there may be a thin layer of suspected biofilm over some of the wound bed, 
particularly on the right side of the wound where this substance appears to be slightly 
thicker and opaque (by kind permission, Dr. Daniel Metcalf, ConvaTec Ltd, 2014) 
 
1.15 Skin Treatments and Wound Dressings 
In clinical practice there are recommendations in the use of various wound care 
accessory products to treat wounds. Topical formulations such as sugar paste 
have long been used in some countries for pressure ulcers (Biswas et al., 2010), 
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as it creates low water activity and inhibits microbial growth. In an in-vitro study, 
plasma coagulation was said to be inhibited at 70% sucrose, while attachment of 
S. aureus was suppressed in the presence of 10% NaCl or 10% sea salt, and 
atopic dermatitis lesions were suppressed by 5% zinc oxide (Akiyama et al., 1998). 
Skin cleansers may be considered for use around the wound to clear the peri-
wound region of contaminants but must not be used on the actual wound. Ideally 
the act of wound cleansing should be performed prior to debridement to aid 
inspection of the wound, and then post-debridement (Wolcott and Fletcher, 2014). 
A cleanser should help prevent infection while doing no harm. Water is as effective 
as saline but tap water purity is an issue (Fernandez and Griffiths, 2012). Sodium 
hypochlorite solutions, chlorhexidine, potassium permanganate and dilute acetic 
acid use remains controversial, but in resource-poor settings they may be the only 
available means of managing bioburden in chronic wounds (Keast and Lindholm, 
2012). Hypochlorous acid cleansing solution is available commercially based on 
the fact that immune cells produce hypochlorous acid in their defence mechanisms 
(Bullough and White, 2014). 
Skin moisturisers can be used to hydrate, soften and protect the skin, whilst 
moisture barrier ointment can add protection from infection by other bodily fluids. 
They typically contain zinc to help dry the denuded skin, dimethicone to provide a 
protective layer and petrolatum providing a resistant layer (Wound Source 
Overview, 2016).  
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Gauze type dressings were used for many years, but in recent decades there has 
been much research into the use of other types of wound dressings. Many new 
dressings are available on the market and these provide functions such as 
protection from further injury or infection, together with providing an environment 
with conditions necessary to promote healing. According to the Wirral Community 
NHS Trust 2013 Wound Management Formulary and Guidelines the dressing 
choice is determined by a number of factors. These guidelines are similar to many 
in the U.K.: 
 level of exudate  
 tissue type  
 depth of wound  
 anatomical location  
 malodour  
 condition of peri-lesion skin 
 pain  
 quality of life  
 activities of daily living  
 fragility of skin  
 temperature  
The requirements of a wound dressing will often depend upon  
 bacteria colonising the wound 
 the amount of exudate and if negative wound pressure therapy is required 
 its ability to help debride the wound and  
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 the patient health status 
 
There are a plethora of different wound dressings available to clinics which can 
vary in materials, structure, absorbency, antimicrobial formulation, and the nature 
of attachment to the tissue surrounding the wound, an area which can be 
vulnerable. Typical antimicrobials in dressings include silver, iodine, honey and 
polyhexamethylene biguanide. The choice is sometimes ultimately what is 
available in a clinic. Ideally the clinic should be patient centred/empowered and 
achieving the highest quality of care. Often the reality is that the necessity to 
change dressings on a regular basis drives up the perceived cost of dressing 
usage, particularly if the dressings do not effectively support wound progression, 
and points to choice based upon financial restraints (Oates et al., 2014). 
 
1.16  Investigating the Efficacy of Novel Dressings 
So where could future research lead us and how could it help to prevent and 
reduce the presence of biofilms, therefore reducing infected and chronic wounds in 
a clinical situation? How quickly does the biofilm form in a situation where there is 
constant exudate and a risk of infection even after debridement in a wound? One 
main thrust of some of the novel dressings that have been introduced in recent 
years, is their ability to form a gel matrix on contact with wound exudate and 
absorb it or, if containing antimicrobial agents, to kill any bacteria present. How 
effective are they against not only planktonic bacteria, but against biofilm 
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microorganisms, and in the prevention of biofilm formation or re-formation? Various 
dressings claim to be the best at tackling biofilm, but at what stage should these 
often more expensive dressings be considered to best suit both the patient and the 
clinic’s budget, and for how long can these dressings remain in place on the wound 
before they become ineffective?  
These are some of the questions that this research aims to address. 
 
1.17 Aims and Hypothesis 
The presence of biofilm is now acknowledged to be one of the leading causes of 
delayed wound healing and wound infection, so effective anti-biofilm products are 
urgently required to improve standards of care (Bjarnsholt et al., 2008). The aim of 
this work was firstly to investigate the structure and development of wound 
pathogen biofilm in vitro, and to structurally differentiate between biofilm-
associated organisms and their planktonic counterparts. Secondly, a novel, 
challenging in vitro simulated chronic wound model was developed that could be 
processed intact, and examined by a combination of Light Microscopy (LM), 
Transmission Electron Microscopy (TEM), Scanning Electron Microscopy (SEM) 
and Confocal Laser Scanning Microscopy (CLSM).  Finally, the model was used to 
evaluate the antimicrobial and anti-biofilm effectiveness of several current wound 
dressings by these microscopical methods. By quantifying the amount of microbial 
growth, the dressings were evaluated to compare the respective dressings, as well 
as demonstrating which dressings were the most effective against biofilm 
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formation, the null hypothesis being that there is no difference in biofilm growth 
between the different dressings and all antimicrobial dressings are as effective as 
each other. Such research might provide further evidence to help clinicians have a 
greater understanding of which is the most appropriate antimicrobial dressing to 
apply to a chronic non-healing wound, in which a biofilm presence is suspected. 
This could help create appropriate wound care treatments to kill biofilm bacteria 
and/or prevent biofilm re-formation as part of protocols of care in more effective 
wound management. Overall these studies aimed to show how specific biofilm-
forming wound pathogens can be controlled by the application of specifically 
targeted topical medical devices. 
 
The main aims of this study were: 
 To obtain the best methods of preservation and processing, for the 
visualisation of bacteria by various microscopy techniques; 
 to trial surfaces for suitability for use with all the microscopy methods and to 
use one to develop a novel, challenging in vitro model for growing biofilm; 
 to use the model to test the efficacy of different dressings against biofilm 
formation. 
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Chapter 2 
Microscopy protocols, evaluation of surfaces 
and development of a biofilm wound model 
 
  
  
53 
 
2.1 Introduction 
2.1.1 The choice of organisms for in vitro studies 
The bacterial species chosen for these studies Pseudomonas aeruginosa (P. 
aeruginosa) and Staphylococcus aureus (S. aureus). 
P. aeruginosa is a ubiquitous opportunistic human pathogen and has been used in 
many laboratory studies (Gómez and Prince, 2007; Brockhurst et al., 2005). It is a 
Gram-negative rod shaped bacterium, which, although usually found growing in an 
aerobic environment, is capable of adapting to proliferate in situations where 
oxygen is partially or totally depleted (O’Neil et al., 2003). P. aeruginosa has a 
large number of genes involved in catabolism, transport and the efflux of organic 
compounds, and its genome complexity and virulence factors allow it to adapt and 
thrive in a diverse range of environments, and to resist antimicrobial substances 
(Stover et al, 2000). 
P. aeruginosa is the most common gram-negative bacterium found in nosocomial 
infections (Delden and Iglewski, 1998), it has accounted for over 1 in 10 of all 
hospital-acquired infections (NNIS, 2004), and an additional 10-60% of infections 
may present after discharge (IFIC, 2011). P. aeruginosa outbreaks in burn units 
have been associated with high (60%) death rates (Chamoux et al., 1994). The 
International Federation of Infection control (IFIC) states that it has survival rates 
on dry surfaces of between 6 hours to 16 months, and that a European Centre for 
Disease Prevention and Control (ECDC) survey involving 12 countries in 2008 
found 18.2% of ICU-acquired pneumonia was associated with P. aeruginosa, as 
well as catheter associated urinary tract infections. It is often associated with 
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infections of immunocompromised patients, particularly those suffering from AIDS, 
or severe burn wounds (Whitehead et al., 2001), and undergoes genetic change 
during chronic airway infection of cystic fibrosis patients (D'argenio et al., 2007). 
Although an uncommon cause of community-acquired pneumonia, P. aeruginosa 
is a common cause of hospital-acquired pneumonia. This is associated with the 
mechanical ventilation that is a necessity for patients with respiratory difficulties. 
Oxygen exposure vastly increases the occurrence of P. aeruginosa infections 
(Fujitani et al., 2011). P. aeruginosa produces a diverse array of virulence factors 
but usually requires a substantial break in the host defences, such as damage to a 
normal barrier (e.g. mucosal or epithelial), disruption of the normal host flora, or a 
lowering in the normal host immune defence (Delden and Iglewski, 1998). Once 
compromised, disease may establish, especially in the biofilm mode of growth, 
which impairs antibiotic activity (Fux et al., 2005). Virulence factors include 
exotoxins such as pyocyanin, alkaline phosphatise, elastase, exotoxin A, 
exenzyme S and phospholipases, lipopolysaccharie, alginate, adhesions (Seth et 
al., 2012, Bomberger et al., 2009). 
Following severe thermal injury, the damage to the skin compromises the patient’s 
immune defences to sub-protective levels due to the burn causing extensive 
breaches in the skin barrier, and hence the compromise of host defence (Felts et 
al., 1999). One of the main survival strategies of P. aeruginosa in hostile 
environments (Bjarnsholt et al., 2008) is to form its mucoid, alginate biofilm 
creating a three-dimensional structure, (Nivens et al., 2001). It acts as a scavenger 
of free oxygen radicals, which may favour survival (Simpson et., 1989). It also 
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prevents phagocytosis, and reduced diffusion and activity of antimicrobials (Allison 
et al., 1992).  
S. aureus is a similarly ubiquitous bacterium and is a Gram-positive coccus found 
on skin and in wounds. It is renowned for being associated with hospital acquired 
infections, especially in the form of methicillin-resistant S. aureus (MRSA), a so 
called ‘superbug’ (Foster, 2004). It has been demonstrated to produce a variety of 
virulence factors, which help with adhesion, secretion and the organism’s 
pathogenic ability to inactivate and evade the hosts defence systems (Dunman et 
al., 2001). It can produce numerous toxins that can cause unique presentations 
such as toxic shock syndrome (Kuroda et al., 2001). It’s many virulence factors 
include membranes damaging toxins (leukotoxins, leukocidins, hemolysin, lipase), 
exotoxins (TSST, EFT, SEA-G, toxin 1, cytolysins, serine proteases, cysteine 
proteases, aureolysin), phagocytic inhibitors (protein A, coagulase) and invasins 
(hyaluronidase, staphylokinase) (Jarraud et al., 2002). 
It is the second most frequent cause of nosocomial blood infections, accounting for 
13% of blood infections. Wertheim et al., (2004) studied 14,000 patients carrying 
nosocomial S. aureus, and found they were three times more likely to develop 
bacteraemia, although bacteraemia-related death was higher in non carriers than 
carriers. S. aureus is usually controlled by the host immune response (Archer et 
al., 2011), but the immunocompromised host will be more susceptible to 
nosocomial infection than the normal host. If an internal epithelial breach occurs, it 
can spread via the circulatory system, and catheter-related infections can pose a 
serious threat of sepsis, with a mortality rate of up to 25% (Hann and Raad, 2005). 
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Immunosuppressed patients, such as cancer patients, are at high risk of sepsis 
(Danai et al., 2006). In humans, S. aureus is often present in the anterior nares, 
such that approximately 25% of populations are persistently colonized (Boost et al., 
2008). The nasal carriage provides an opportunity for these bacteria to disseminate 
to other areas of the body (Brown et al., 2013). Preoperative nasal carriage of S. 
aureus has been identified as a significant risk factor in patients developing wound 
infections. A study of almost 2000 patients found that S. aureus was present in 
swabs from sternal wounds of 40 patients after cardiac surgery (Kluytmans et al., 
1995). It has been reported as a predominant organism in many clinical 
investigations, with its presence being indicated in 43-88% of leg ulcers (Fazli et 
al., 2009), and is most commonly found in chronic wounds (Halcón and Milkus, 
2004). The S. aureus bacterial biofilm is a matrix composed primarily of 
exopolysaccharides such as polysaccharide intercellular adhesion, which can 
significantly reduce the penetration and activity of glycopeptides such as 
Vancomycin ( Chang et al., 2003).  
P. aeruginosa and S. aureus are common wound pathogens and are often 
associated with delayed healing and infection (Oates et al., 2014). These specific 
strains are known to produce potent virulence factors and proteases that destroy 
tissue and impair healing (Koziel et al., 2013). What is important to a clinic, is that 
these bacteria are more tolerant or resistant to antimicrobial treatment in the biofilm 
form than in the planktonic form. Most antibiotics target a specific cellular or 
metabolic function and bacteria can adapt genetically to become resistant. 
Antiseptics target more areas on a microbes surface and hence it is less likely to 
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become resistant to antiseptics as it would have to adapt by changing multicellular 
areas. As mentioned in Chapter 1, biofilm is protected physically by EPS. Due to 
microbes being embedded deep within this biofilm structure, and where there is 
more likely to be concentrations of molecules and changing pH, bacterial biofilm 
can become tolerant. These areas of biofilm therefore present many challenges to 
effective clinical treatment. 
One reason for biofilm resistance may simply be that some antibiotics, like 
penicillin, target cell wall synthesis and kill bacteria that are actively growing, those 
near to or on the surface, but cannot kill those in a sessile state deeper within the 
biofilm (Costerton et al., 1999). These persisiter cells may survive and hence are 
tolerant to antibiotics without undergoing genetic change, and can result in relapse 
of persistent infections. 
Consequently, along with their escalating involvement in infections, their exhibition 
of multiple-antibiotic resistance, and their ability to transform an acute infection to 
one that is persistent, chronic and recurrent, especially in wounds, this warrants 
these particular bacteria a considerable amount of attention (Wong et al., 2013). 
This indicates the reason for choosing these two bacteria for the in vitro studies of 
this thesis.  
 
2.1.2 Preliminary techniques and preparation of bacteria for 
microscopy 
Understanding and visualising the differences between planktonic and biofilm 
bacteria are important considerations when discussing bacterial tolerance. 
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As part of this thesis, basic microbiology techniques were used to ensure good 
quality results, and this was an essential first step. The preliminary experiments of 
the project therefore concentrated on microbiological techniques that included 
learning aseptic methods, autoclaving, and the plating of cultures to maintain a 
constant supply of available and viable bacteria. Once achieved, the growth and 
physiology of chosen bacteria for these studies were examined, including the 
monitoring of growth of a bacterial culture to determine harvesting points 
accurately. 
A variety of fixation and processing protocols were employed in order to prepare 
samples for the microscopy techniques to be used in the study, and to optimise 
high quality images of planktonic cells. These included preparation for 
Transmission Electron Microscopy (TEM) and Scanning Electron Microscopy 
(SEM).  Bacteria were prepared for TEM and SEM, in order to observe the external 
structural appearance of planktonic cells. This was in preparation for later sections 
of this Chapter, when the structure and development of biofilm was investigated, so 
that suitable protocols would be available to determine differences in appearance 
between planktonic and biofilm bacteria. 
Several explanations have been put forward as to why microbial biofilms are more 
tolerant to antimicrobials than planktonic bacteria, and some studies have 
attempted to compare the susceptibilities of both types (Cerca et al., 2005). An 
antimicrobial is defined as an agent that kills microorganisms or inhibits their 
growth, and antimicrobial agents have been used for many years in the 
preservation of food (Delaquis, and Mazza, 1995). Natural remedies include acetic 
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and lactic acid as well as sulphites, and many herbs are known to have some 
antimicrobial properties, especially in the form of their essential oil. Other natural 
remedies include sugar paste and honey. A well-known antimicrobial is silver. As 
silver is used in many modern wound dressings claiming antimicrobial properties 
(Newman et al., 2006), silver nitrate was chosen as a suitable antimicrobial for the 
demonstration of the effects on bacterial growth in planktonic cultures of this study. 
The effect of the addition of silver nitrate was studied on planktonic bacteria and 
with TEM, to demonstrate the changes induced in bacteria treated with an 
antimicrobial agent. 
 
2.1.3 Establishing and characterising a biofilm 
A biofilm is defined as being a community attached to a surface and enclosed in a 
matrix of EPS, and its formation is a multi-step process from attachment, to micro-
colony, to maturation, and detachment (Snyder et al., 2009). The bacterial 
concentration for the initiation of growth of a biofilm appears to differ in the 
literature and ultimately appears to be the choice of the researcher. Loh et al., 
(2009) and Walker et al., (2011) started with a concentration of 105 cells/ml, whilst 
Percival et al., (2008) used 106. However, many do not state the concentration. 
Preliminary work in this study required the investigation of growing varied initial 
concentrations of bacteria, to ascertain if an optimal concentration was needed to 
form a biofilm. 
Another consideration is how quickly a biofilm is likely to form under the right 
conditions. Planktonic bacteria attach to a surface and develop an initial EPS. 
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Some suggest that this growth can occur within hours (Phillips et al., 2010; Koseki, 
2014). Others state that biofilm only forms after 24 hours (Proal, 2008). This raised 
the question, should biofilm growth only be studied and observed after 24, 48 or 
even 72 hours, as most studies are performed, or should it be from as early as 1-3 
hours? If bacterial growth could be visualized in the earliest hours, then it would be 
possible to ascertain how quickly bacteria start to group together in the first stages 
of biofilm formation. This would possibly present the best start time for future 
growth experiments. 
It is suggested that a biofilm may to be able to grow on just about any surface 
given the opportunity: rocks in streams, ship hulls, pipelines, catheters, implants, 
and on internal and external living tissue (Dunne, 2002). Any surface placed into a 
fluid environment acquires a conditioning film, comprised of primarily 
proteinaceous material that is present from that fluid (Donlan, 2001). A surface 
coated with a protein or mucin is classed as conditioned, and on this surface, a 
biofilm may develop (O'Toole, 2000). However, in order to visualise a series of 
grown biofilms with the respective microscopy techniques, any surface for this 
study needed to be suitable to grow a biofilm, yet still be able to survive the 
preparatory techniques in Light Microscopy (LM), Transmission Electron 
Microscopy (TEM), Scanning Electron Microscopy (SEM) and Confocal Laser 
Scanning Microscopy (CLSM). The processing methods for these techniques are 
different from each other and most include the use of agitation and harsh 
chemicals. For this reason, various surfaces, some more tried and tested than 
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others in research studies, would be investigated for their suitability to promote 
biofilm growth.  
Glass is one of the most common surfaces on which to grow a biofilm, and studies 
have included glass tubing (Davies et al., 1993, Stoodley et al., 1999, Wilson, 
1999), glass slides (Lawrence et al., 1991; Lewis, 2001, Prakash et al., 2003) and 
glass coverslips (Lembke et al., 2006; Khan et al., 2012), the latter used probably 
because they are easy to obtain and relatively inexpensive. Glass surfaces such as 
these lend themselves well to CLSM and SEM methods that are often used in 
biofilm studies. Glass was an adequate surface to use for the preliminary biofilm 
growth experiments, but due to initial difficulties with the glass coverslips this 
required changing methods to a more suitable surface. 
According to some, the quality of a surface used to grow biofilms can decide the 
time course of attachment (Hänsch, 2012; Zeraik and Nitschke, 2012). Although 
bacteria attach readily to surfaces such as glass, many investigations have 
reported that bacteria can attach more rapidly to nonpolar surfaces, such as 
plastics (Donlan, 2002), and that S. aureus and P. aeruginosa, in particular, attach 
to strongly hydrophobic surfaces (Sinde and Carballo 2000).  
ThermanoxTM plastic coverslips have been used extensively in studies into biofilm 
growth (Sladek et al., 2007; Braga et al., 2008; Espinal et al., 2012), and are more 
pliable than glass which may make them more preferable for use. Therefore in this 
series of experiments as well as evaluating biofilm growth, an inoculum 
concentration for future studies was also performed using plastic coverslips, as 
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well as some studies to evaluate initial biofilm growth over an initial six hour period. 
However, other surfaces were required to be tested that would be more adaptable 
in the differing methods of microscopy (LM, TEM, SEM and CLSM) used in the 
study. 
During these studies “slough-like” material was observed in some of the early 
studies and therefore it is important to differentiate this term from biofilm.  Some 
clinicians use the terms “biofilm” and “slough” interchangeably, and incorrectly. 
However, biofilm is defined as a living community attached to a surface and 
enclosed in a matrix of EPS, and its formation is a multi-step process from 
attachment to microcolony, to maturation and detachment (Snyder et al., 2009). 
Slough on the other hand is defined as ‘a mass of dead tissue in, or cast out from, 
living tissue’ (Medical Dictionary, thefreedictionary.com). The World Union of 
Wound Healing Societies and the European Wound Management Association 
positioning papers always associate slough with necrotic tissue (World Union of 
Wound Healing Societies’ Expert Working Group, 2004, 2007, 2008)  . However, 
some researchers have stated that, by using quorum sensing, the biofilm is 
detached and dispersed, and that this is “slough” (Rice et al., 2005). Some propose 
that programmed host cell death and autolysis are critical for the proper timing of 
biofilm development and dispersion, suggesting that a lot of the slough will contain 
dead cells as well as biofilm (Ma et al., 2009).  
When biofilm is grown, using even small quantities of nutrient broth, a layer of 
“slough-like material” (possibly flocculated biofilm waste) may appear on the 
surface. Distinguishing between actual biofilm and this slough-like material, by 
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comparing methods of collection of biofilm growth on coverslips, was necessary to 
confirm what would constitute true biofilm growth on various model systems. 
Processing techniques for microscopy often include agitation, which can cause the 
removal of biofilm and from the surface of a sample. Wrapping small histological 
samples in specialist tissue paper, or containing them in fine mesh containers, 
improves retention of friable tissues. However, these techniques do not prevent the 
moving of surfaces that are friable, but merely aim to contain the fragments with 
the main specimen. In order to prevent moving and detachment of biofilm from a 
surface, the surface of biofilm needs a protective cover. 
In order to process very small and cytological samples into paraffin wax or resin, 
routine histological laboratories (in light and electron microscopy methods) 
commonly use agar or low melting point agarose. Agarose, in the warm liquid 
phase (melting point of 37°C, as opposed to agar’s 45°C), can be poured on to, 
and mixed with, samples and allowed to set before processing. Pouring the liquid 
phase agar over biofilm might allow for the processing of biofilm whilst it is intact. If 
biofilm could survive the technique on a suitable surface, it may be possible to 
compare the structure of biofilm as it grows by LM and TEM methods with those of 
SEM.  
In a natural environment, bacteria frequently form biofilm. Many different models 
have been used to try to mimic this environment, some in vivo, some in vitro. In 
vivo work has favoured the porcine, murine and lupine wound models (Sullivan et 
al., 2001), of which there are many examples (Roche et al., 2012; Phillips et al., 
  
64 
 
2013; Gurjala et al., 2011; Thompson et al., 2014; Walton et al., 2014), but 
practical, ethical and moral concerns have made in vitro models an indispensable 
tool.  There is a need for effective models, in the studying of biofilm and their 
infections, for testing novel dressings and other therapeutics methods. The use of 
data collection by non-invasive techniques is of substantial interest in order to 
decrease the number of animal numbers required for testing (Walton et al., 2014). 
Examples of in vitro models have been varied. Some models have involved glass 
and/or plastic such as the Lubbock model (Sun et al., 2008). This model was 
simple in surface but the media was complex, containing various broths and a 
chopped meat-based media formulation. Others have used various growth 
chambers, such as Thorn and Greenman (2009), which included cellulose support 
matrices and used a system relying on eluates to ascertain the growth rate. Some 
have used gels, such as that examined by Gilbert et al (1998), who grew P. 
aeruginosa on poloxamer hydrogel and found it mimicked many of the properties of 
other biofilm types grown in vitro. Poloxamer is a thermo-reversible matrix that is 
inert and non-ionic and can be dissolved in medium at temperature below 15°c. 
Once the temperature is increased to 37°c the matrix becomes semi-solid. This 
can then be reversed, which allows recovery and analysis of the biofilm (Benjamin 
et al., 2016). Clutterbuck et al., (2007) suggested that this model could be an 
alternative medium on which to conduct antibiotic susceptibility testing and Percival 
et al. (2007) used it to test silver dressings. 
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Although many of these models have had SEM or TEM performed upon them, the 
structure of biofilm in relation to testing a wound dressing is not always the primary 
result required. Once the examination of the growth and structure of biofilm in this 
study was complete and understood, the intention of the final series of studies in 
this section was to evaluate a new, and novel, in vitro model that could be 
addressed by the various modes of microscopy, and specifically to examine the 
effect of dressings upon biofilm development (the subject matter of Chapter 3). 
 
2.2 Aims and objectives 
In order to observe biofilm in later studies planktonic bacteria were examined, and 
the best methods for their growth and visualisation by the various microscopy 
techniques were determined. A range of surfaces were evaluated for their 
suitability to be used in subsequent in vitro studies to develop a model to be used 
to evaluate antibacterial wound care dressings.  
Specifically the following objectives were proposed: 
 To demonstrate the physiology of growth cultures to find the exponential 
point, and the effect of the addition of an antimicrobial agent 
 To find a suitable processing protocols and observe planktonic bacteria by 
LM, TEM, SEM 
  To observe the effect of silver nitrate on bacterial ultrastructure by TEM 
 To establish an appropriate concentration of bacteria to provide a confluent 
biofilm  
  
66 
 
 To investigate the stages of initial biofilm growth 
 To examine surface-associated material from the surface of nutrient 
 To evaluate physical surfaces that would allow adequate biofilm growth  
 To process biofilm intact for all microscopy methods microscopy (i.e. LM, 
TEM, SEM, and for viewing with CLSM) 
 To evaluate a novel in vitro ‘biological’ wound model ( the subject of a more 
in depth appraisal in Chapter 3) 
 
2.3 Materials and Methods 
2.3.1 Media preparation and maintenance of cultures 
Cultures of P. aeruginosa (NCIMB 8626) and S. aureus (NCIMB 9518), used for 
this study, were maintained on plates of tryptone soy broth (TSB, 30g/L, Lab M, 
Bury, UK) in 2% w/v agar (Oxoid Ltd., Basingstoke, UK) (Appendix 1). Initial growth 
was at 37ºC overnight, with storage afterwards at 4ºC. The appropriate quantity of 
media (TSB for culture studies or TSB and agar for culture plates) was weighed, 
and dissolved, in deionised water in flasks (Thermo Fisher Scientific, 
Loughborough, UK). The mouth of flasks were plugged with cotton wool, and 
covered with aluminium foil, then placed in an autoclave (Dixons Express 
Autoclave, Dixons Surgical Ltd, Wickford, UK) for sterilisation of the media at 
121°C for 15 minutes (Appendix 2). Flasks of TSB media were removed and stored 
at 4ºC, 20ml of the TSB/agar media was poured into sterile Petri dishes 
(ThermoFisher, Loughborough, UK), and allowed to solidify, then stored at 4ºC. 
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2.3.2 Overnight cultures and exponential growth of planktonic 
bacteria 
For growing an overnight culture, a flask containing a 50 ml volume of TSB was 
prepared. The flask was inoculated with either P. aeruginosa or S. aureus by a 
plastic disposable, sterile loop (ThermoFisher, Loughborough, UK), from a 
previously grown, plated culture. Incubation was in a water bath (Grant 
Instruments, Royston, UK) at 37ºC with aeration supplied via a pipette and tubing 
attached to an air pump (Dymax 5, Charles Austen Pumps Ltd, West Byfleet, UK). 
For exponential growth, fresh medium (100 ml) was inoculated with a 1/200 dilution 
from an overnight culture and growth monitored with a spectrophotometer (Helios 
Epsilon wavelength 610nm, Thermo Fisher Scientific, Loughborough, UK). Use of 
spectrophotometry is a common procedure to measure bacterial density. The 
spectrophotometer gives a measure of light absorbance, which is directly 
proportional to the bacterial density. The data consisted of measurements of 
bacterial population density at 20 minute time points and continued until the 
measurements decreased in steps which indicated a slowing down in bacteria 
growth. The growth curves served as a guide to the estimated number of 
organisms in a culture, in order to estimate more accurately the exponential growth 
point for each experiment. The growth rate was monitored by estimation of optical 
density. 
 
2.3.3 Planktonic growth cultures and effect of silver 
1/200 dilution of overnight cultures of P. aeruginosa and S. aureus were introduced 
into fresh TSB flasks (4 x 100 ml, for each bacterial culture). After 2 hours 20 
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minutes (P. aeruginosa) and 2 hours (S. aureus) (see Results Section 2.4.1), the 
exponentially growing cultures were treated as follows: 
(1) Control cultures – No change. Continued growth for a further 4 hours at 
37C. 
(2) Cultures treated with silver –1 ml of silver nitrate (Sigma-Aldrich, Gillingham, 
UK) added (stock sol. 1 mg/ml, final concentration in TSB culture 10 µg/ml) 
for 4 hours at 37C. 
2 ml aliquots of culture were taken from the cultures at 20 minute intervals over 6 
hours, and the optical density as absorbance measured in a spectrophotometer. 
 
2.3.4 Fixation and harvesting of planktonic bacteria for TEM 
For TEM P. aeruginosa and S. aureus were cultured in separate flasks of TSB (2 x 
100 ml for each bacterial culture), and treated as a control or treated with silver as 
in 2.3.3 above. Growth was continued in both flasks for 1 hour. The flask treated 
with silver nitrate was fixed in a final dilution of 2.5% v/v glutaraldehyde (25% v/v 
stock solution, TAAB Laboratories Equipment Ltd., Reading, UK). 
The contents of the control flask was divided into six Universal containers (Thermo 
Fisher Scientific, Loughborough, UK). Each container was allocated one fixative 
protocol from the list below, to give a total of six different types of fixation, in order 
to choose the best protocol for future use. The fixatives were prepared in Ryter-
Kellenberger (RK) buffer (Ryter et al., 1958; Appendix 3). Bacteria were harvested 
from the cultures by a filtration system attached to a vacuum mechanism (Hobot et 
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al., 1985). A cellulose nitrate filter, 47 mm diameter, pore size 0.2 µm, (Whatman, 
Thermo Fisher Scientific, Loughborough, UK) which is smaller than the organism to 
be captured was used. Some of the culture was poured in – enough to fill up to 5 
ml approximately, and the vacuum turned on. When the culture had filtered the 
vacuum was switched off, and using a spatula, gently scraped off the filter and re-
suspended in universals containing fixative. 
 
The choice of fixation protocols were: 
 2.5% v/v glutaraldehyde (25% v/v stock solution) added directly into the 
culture, for 24 hours, then harvested by filtration 
 2.5% v/v glutaraldehyde added directly into the culture, for 24 hours, 
harvested by filtration, and followed by fixation in 0.5% w/v uranyl acetate 
prepared in RK buffer, for 2 hours 
 2.5% v/v glutaraldehyde added directly into the culture, for 24 hours, 
harvested by filtration, and followed by fixation in 0.1% w/v uranyl acetate 
prepared in RK buffer, for 2 hours 
 1% v/v glutaraldehyde added directly into the culture, for 24 hours, 
harvested by filtration, and followed by fixation by 0.5% w/v uranyl acetate 
prepared in RK buffer, for 2 hours 
 1% v/v glutaraldehyde added directly into the culture, for 24 hours, 
harvested by filtration, and followed by fixation by 0.1% w/v uranyl acetate 
prepared in RK buffer, for 2 hours 
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 harvested by filtration then fixed with 0.5% w/v uranyl acetate prepared in 
RK buffer, for 2 hours, followed by 2.5% v/v glutaraldehyde, for 24 hours 
 
For each sample, molten aqueous 3% w/v agarose (low melting point 37ºC, Sigma-
Aldrich, Gillingham, UK) was prepared and small drops placed in 1.5 ml 
microcentrifuge tubes tubes . The agarose was kept molten by placing the tubes in 
a heating block at 45ºC (Thermo Luckman, Thermo Fisher Scientific, 
Loughborough, UK). In all cases after the final fixation step the bacterial sample 
was filtered as before, washed with double distilled water, re-filtered, and gently 
scrapped off the filter paper. This was placed into the molten agarose in the 
microcentrifuge tubes (Thermo Fisher Scientific, Loughborough, UK) and gently 
stirred. When the agarose had set, it was cut into small pieces (approximately 1 
mm3) for processing into resin for TEM or paraffin wax for LM. 
 
2.3.5 TEM Processing and Observation 
TEM processing was by partial dehydration into the acrylic resin London Resin 
White (LR White, hard grade, TAAB Laboratories Equipment Ltd., Reading, UK) 
following the protocol of Newman and Hobot (1987; 2001) as in  Appendix 4. All 
steps were at room temperature with agitation. After overnight infiltration with resin 
the agar blocks were placed into gelatine capsules (size ‘0’/vol 0.68 ml, TAAB 
Laboratories Equipment Ltd., Reading, UK) to which had been added cold (0C) 
LR White resin with accelerator (15 µl per 10 ml of resin), to allow for Cold Catalytic 
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Polymerisation at 0C for 24 hours, followed by 2 hours at 50C. The gelatine 
capsules were then removed and the blocks were ready for sectioning.  
Semithin sections (400nm) were cut on a Reichert Jung Ultramicrotome (Leica 
Microsystems, Milton Keynes, UK), with glass knives (Leica Microsystems, Milton 
Keynes, UK), placed on water droplets on slides and dried on a hot plate (Corning 
Life Sciences, Tewkesbury, UK). Sections were stained with 0.5% Toluidine Blue in 
1% borax (Sigma-Aldrich, Gillingham, UK) for 5-10 seconds, before rinsing in tap 
water and drying. Once the semithin sections had been examined, and a suitable 
area of interest chosen, ultrathin sections were cut (100nm), and picked up on 
hexagonal 300 mesh copper grids (TAAB Laboratories Equipment Ltd., Reading, 
UK). Once dry, these were stained with 4% w/v aqueous uranyl acetate (TAAB 
Laboratories Equipment Ltd., Reading, UK) for 5 minutes, washed in three drops of 
deionised water, stained with a lead citrate solution (Sigma-Aldrich, Gillingham, 
UK) for 30 seconds, water washed again, and air dried. Sections were viewed in a 
JEOL 1200 EXII TEM operating at 80 kV with a tungsten filament, using a SIS 
MegaView III digital camera, (JEOL UK Ltd, Welwyn Garden City, UK). 
 
 
 
2.3.6 LM processing and observation 
For LM, samples were processed with a routine histological laboratory processing 
protocol (Appendix 5) on a Thermo Scientific Excelsior Tissue Processor (Thermo 
Fisher Scientific, Loughborough, UK) (all steps were under vacuum with agitation), 
and blocks were embedded into Cell Wax (CellPath Ltd., Newton, UK), using a 
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tissue embedding station (Blockmaster II, Raymond A. Lamb Ltd., Eastbourne, UK) 
and stainless steel moulds (Thermo Fisher Scientific, Loughborough, UK). From 
these blocks 5 m sections were cut on a Leica rotary microtome (Leica RM2155, 
Leica Microsystems, Milton Keynes, UK), and picked up on to glass slides. 
Histological sections were stained with a Harris’s Haematoxylin (Shandon™, 
Thermo Scientific) and Eosin Y cytoplasmic counterstain (Shandon™, Thermo 
Scientific) (H&E) which was performed on a Leica ST5010 XL autostainer 
(Appendix 6). Slides were mounted with coverslips by hand and viewed by LM 
using an Olympus BX51 microscope (Olympus, KeyMed Ltd, Essex, UK), with 
attached AxioCam HRC and Axiovision software (Carl Zeiss Microscopy, 
Cambridge, UK). 
 
2.3.7 SEM Processing and Observation 
For SEM P. aeruginosa and S. aureus were cultured in TSB as in 2.3.2. After 
exponential growth, an aliquot of 25% v/v glutaraldehyde was added to give a final 
concentration in the medium of 2.5% v/v glutaraldehyde. Fixation continued for 24 
hours at 37ºC after which the cells were harvested as for TEM, washed on the filter 
with double distilled water and processed for SEM with a protocol using 
Hexamethyldisilazane, (Sigma-Aldrich, Gillingham, UK) (Appendix 7). All steps 
were performed at room temperature in a glass petri dish. Filters were then placed 
onto self-adhesive carbon tabs (25 mm diameter, Self-adhesive carbon conductive 
tabs, Agar Scientific Ltd., Stanstead, UK), which had been adhered to the surface 
of an aluminium stub (32 mm x 10 mm, Agar Scientific Ltd., Stanstead, UK). 
  
73 
 
Specimens were sputter coated with gold for 2.5 minutes (EMscope sputter coater, 
Leica Microsystems, Milton Keynes, UK) (Appendix 8), and examined in a JEOL 
840A SEM operating with a tungsten filament at 5 kV, using SIS analysis software 
(JEOL UK Ltd, Welwyn Garden City, UK). 
In order to examine some of the techniques throughout the following studies 
described in this Chapter, P. aeruginosa only was used in the following studies, 
unless otherwise stated  
 
2.3.8 Glass as a surface for growing biofilm 
Square glass coverslips (32 x 32mm, Thermo Fisher Scientific, Loughborough, UK) 
were etched with a diamond marker in the top left hand corner before autoclaving, 
to demonstrate the top surface, then placed in 5 cm diameter sterile Petri dishes, 
one coverslip per dish. A 9 ml volume of the exponential phase culture was 
pipetted over the glass coverslips and the Petri dishes were allowed to incubate at 
37C for 72 hours. The culture medium was removed and a 5 ml volume of 2.5% 
v/v glutaraldehyde in RK buffer (pH 6) was added to each dish and fixed for 2 
hours. The samples were then processed for SEM. 
 
2.3.9 Plastic coverslips as a surface for growing biofilm 
Round plastic coverslips (13 mm diameter, Thermo Fisher Scientific, 
Loughborough, UK) were placed inside the wells of plastic, sterile culture plates 
(12 well, diameter 22.1 mm, Corning Life Sciences, Tewksbury, UK) and a 2.25 ml 
volume of the exponential phase bacterial culture was added to the wells. These 
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were then incubated for 72 hours at 37C, after which time, a 0.25 ml volume of 
25% v/v glutaraldehyde was added to each well to give a final concentration of 
2.5% v/v glutaraldehyde per well. Fixation was overnight at room temperature, 
before the samples were processed for examination with SEM. 
In a second series of studies larger plastic, sterile culture plates (34.8 mm well 
diameter, Corning Life Sciences, Tewksbury, UK) were used, with the same sized 
coverslips as above, the prepared culture of P. aeruginosa added to each well, and 
incubated at 37C, with gentle agitation of 50 rpm, on a flat-bed mini orbital shaker. 
After 72 hours the contents were fixed with the addition of 0.5 ml of 25% v/v 
glutaraldehyde in 2 ml of TSB. Each culture was processed for SEM, LM or TEM 
techniques. 
 
2.3.10 Determination of inoculum concentration for optimum biofilm 
growth 
To determine the optimum seeding for the biofilm development, bacterial counts 
were performed and a set of serial dilutions prepared. Biofilm was grown then each 
dilution was examined by SEM, to see the differing growth rates and to decide at 
which dilution future biofilm should be grown.  
P. aeruginosa cells were taken from the exponential phase bacteria. After 2.5 
hours, the population density of bacteria in the culture was determined using a 
Helber counting chamber (Scientific Laboratory Supplies, Nottingham, UK) 
(Appendix 9) as follows: 
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1) It was estimated that the growing culture would have a concentration of 
around, 2-4 x 108 bacteria/ml; 
2) By counting the number of particles in a grid of known volume on a Helber 
chamber the number of microorganisms per cm3 can be calculated. The 
factor for the Helber chamber is 2 x 107; 
3) Therefore, to obtain a sufficient number of bacterial cells to count per square 
(approx. 10-20), the culture was diluted 1:10 by adding a 1ml volume of 
culture to a 9 ml volume of sterile TSB. 
4) The dilution was added to the Helber chamber, and the number of bacterial 
cells per square was calculated by counting 32 squares and calculating the 
average number of cells per square (n). 
5) At a dilution of 1:10, 54 cells were counted per 32 squares, 
i.e. average no. per square = 1.6875 
Therefore, taking the dilution factor into consideration, n = 16.875 
6) The actual concentration of bacteria in the growth culture was then 
calculated by using the following formula, taking the dilution factor into 
consideration: n x 2 x 107. 
7) Number of bacterial cells per ml = 16.875 x 2 x 107 = 33.75 x 107 = 3.38 x 
108 
8) Number of bacteria per ml in the growth culture at 2.75 hours = 3.38 x 108 
 
Appropriate dilutions of the growth culture were prepared to give final 
concentrations of 1 x 107, 1 x 106, 1 x 105, 1 x 104, 1 x 103, and 1 x 102. This was 
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achieved by adding 9 ml volumes of sterile TSB to each of six autoclaved Pyrex® 
test tubes (Corning Life Sciences, Tewksbury, UK). Next, 1 ml volumes of the 
exponential phase growth culture were added to the first tube and mixed. A 1 ml 
volume was taken from this tube, added to the second tube, and mixed. Then, a 1 
ml volume was taken from this tube, added to the third tube, and mixed, and so on 
to the last tube. Each dilution was 1:10. 
2.5 ml volumes of each of the six dilutions was added to six wells of culture plates 
(well diameter of 34.8 mm) containing the coverslips, and incubated for 72 hours at 
37C. After 72 hours, the culture medium was removed and 5ml of 2.5% v/v 
glutaraldehyde in RK buffer (pH 6) was added to each dish. Fixation was for 2 
hours at room temperature and the samples were processed for SEM. 
 
2.3.11 Timed growth of biofilm from 1-6 hours 
The previous experiment (2.3.10) had investigated the preparation and growth of 
inoculua. A bacterial population density of 1 x 107cells/ml was chosen as the 
standard. A 1:10 dilution was prepared from exponential phase bacterial cultures of 
P. aeruginosa, in sterile TSB by adding a 2 ml volume of the exponential growth 
culture, 1 x 108/ml, to an 18 ml volume of sterile TSB in an autoclaved test tube. 
Plastic coverslips were placed inside the wells of plastic, sterile culture plates (34.8 
mm well diameter) and a 2.5 ml volume of the prepared culture added to each well, 
which was then incubated at 37C for 1, 2, 3, 4, 5 and 6 hours. Three similar plates 
were prepared. At each time point, a 0.5 ml volume of 25% v/v glutaraldehyde was 
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added to a 2 ml volume of TSB. This 2.5 ml fixative solution was added to the 
appropriate well to give a 2.5% final dilution of fixative. After fixing overnight at 
room temperature, the fixative was gently replaced by RK buffer and the coverslips 
processed for SEM using. Images were recorded and measurements were taken 
from 10 samples using the SEM Analysis software. Any clumps of bacteria were 
encircled and the total number of areas added for comparison with other time 
points. Growth of bacteria that had developed into three-dimensional groups were 
measured but not those that were only dividing in a flat two-dimensional group. 
 
2.3.12 Analysis of “slough-like” surface associated material 
A 1:10 dilution was prepared from exponential phase bacterial cultures of P. 
aeruginosa, in sterile TSB. Plastic coverslips were placed inside the wells of one of 
three sterile, plastic 6-well culture plates (34.8 mm well diameter). Prepared culture 
(2.5ml) was added to each well of all three plates which were then incubated at 
37C for 1, 2, 3, 4, 5 and 6 hours. After each time was ended 0.5 ml of 25% v/v 
glutaraldehyde in 2 ml of TSB was added to the appropriate well to give a 2.5% 
final dilution of fixative. 
After growth and fixation, the coverslips were placed into the base of the wells of 
the second plate. In the third plate, the coverslips were used to collect 
“debris”/”slough-like” material from the surface of the wells and these were placed 
in a new, clean 6 well plate. The samples were then processed for SEM. Some of 
the surface debris was also processed for TEM for further examination. 
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It was observed that these coverslips were hard, could not easily be cut and were 
not infiltrated by resin. To overcome these problems in TEM, the coverslips were 
placed in a Petri dish and LR White resin poured in until the coverslip was just 
covered. The edge of a gelatine capsule was placed quickly into a layer of LR 
White resin accelerator then placed immediately onto the coverslip. This enabled it 
to stick and seal immediately. To enable filling with premixed LR White resin and 
accelerator using a pipette, a small hole was made at the top of the capsule. The 
block was set at 5ºC. The next day the coverslip was carefully removed, with the 
intention of leaving a biofilm on the capsule surface, such that when this end was 
sawn off, and cut in half, the two film edges could be placed face to face, before 
putting onto a fresh capsule of LR White resin and allowed to set. 
 
As suggested in the introduction, a biofilm can grow on just about any surface. 
Other surfaces were tested for their suitability in growing biofilm and adaptability in 
the respective microscopy techniques of LM, TEM, SEM and CLSM. 
 
2.3.13 Agar as a surface for growing biofilm 
A prepared plate of 3% TSB in 2% w/v agar (as in 2.3.1) was covered in a thin 
layer of the P. aeruginosa culture by a metal lawn plate spreader, previously 
sterised by autoclaving, and colonies allowed to grow at 37C. After 24 hours, 
plates were flooded with 2.5% v/v glutaraldehyde in TSB medium and fixed 
overnight. Next day, thin slices of agar plus colonies were gently placed in RK 
buffer. These were then processed for SEM.  
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After viewing, smaller culture growths were attempted by growing for only 6 hours 
on thinner layers of 3% TSB in 2% w/v agar. When a few small groups of bacteria 
were visible, the plates were flooded with fixative as before and thin slices were 
processed and examined by SEM. 
 
2.3.14 Gauze as a surface for growing biofilm 
A 1:10 dilution was prepared from exponential phase bacterial cultures of P. 
aeruginosa and S. aureus, in sterile TSB. Two 2.5 cm diameter discs of pre-cut 
sterile gauze dressing (NA Gauze; Systagenix, Gatwick,UK) were placed into a 
100 ml aseptic Universal container and 20 ml of TSB added. The broth was 
inoculated with 50 µl of each culture and placed on a shaker (Stuart Scientific, 
Stone, UK) in an incubator (Grant Instruments, Royston, UK ) at 37C for 48 hours 
(50 oscillations per minute). Broth was changed aseptically after 24 hours to 
refresh nutrient availability. After 48 hours, the biofilm-attached gauze was 
removed and washed briefly by immersion for 15 seconds into a Universal 
container containing 20 ml of sterile saline, then placed into a CLSM specimen-
viewing chamber. BacLightTM Viability Kit (BVK, Thermo Fisher Scientific, 
Loughborough, UK) for live/dead bacterial staining (live bacteria stain green, dead 
bacteria red) was prepared in 5 ml sterile saline, then poured gently over the gauze 
and left for 10 minutes at room temperature in the dark. The BVK is comprised of 
two dyes; a green (SYTO 9TM) which will pass through bacterial cell walls 
regardless as to whether they are alive or dead. The red dye (Propidium Iodide 
[PI]), will only enter the bacterial cell if the cell wall has been damaged. These are 
  
80 
 
both stains for nucleic acids and the red PI dye actively competes for the same 
sites as the green dye and replaces it. Consequently, it is possible to determine 
which bacteria have died.  
The prepared chamber, with stained gauze biofilm and excess stain, was placed 
onto the stage of a CLSM for imaging. Images were taken using a Leica TSC SP2 
DM IRE2 Confocal Laser Scanning Microscope (Leica Microsystems, Milton 
Keynes, UK), lasers included the argon laser (488nm) and the helium/neon laser 
(543 nm). A Plan-Apochromat 40x/1.25 oil objective was used. Images were 
prepared using Leica AF Lite software.  
Once viewed by CLSM, the sample was removed from the chamber and placed in 
a Universal container containing 20ml of 2.5% v/v glutaraldehyde in RK buffer to 
fix. A few pieces of the sample were cut and processed for all other types of 
microscopy. Prior to processing for LM and TEM, samples were wrapped gently in 
tissue processing paper (Biowraps, Leica Microsystems, Milton Keynes, UK ) to 
protect them from loss of content during the processing cycles. For LM, samples 
were processed with the previously described protocol on the Thermo-Excelsior 
Tissue Processor (all steps were under vacuum with agitation).  5 m sections 
were cut, stained and viewed as per the agar blocks in the previous studies.  
 
2.3.15 PTTE cell culture inserts 
0.4μ PTTE membrane cell culture inserts (Falcon®, Corning Life Sciences, 
Tewksbury, UK) were placed inside the wells of 6-well culture plates. A 1:10 
dilution was prepared from an exponential phase bacterial culture of P. aeruginosa 
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in sterile TSB. A 100 µl volume of the bacterial dilution was added to the inside of 
each insert. The outer area of the well was gently filled with 2.5 ml of TSB (Figure 
2.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: 0.4 m PET track-etched membrane cell culture insert in culture well 
The insert was placed inside a culture well containing nutrient and the bacterial culture 
pipetted on to the surface of the insert 
 
The plates were incubated with agitation of 50 rpm on a flatbed mini orbital shaker 
(Stuart Scientific, Stone, Staffordshire, UK), at 37C for 24 hours. The outer culture 
media was then removed and 2.5 ml of 2.5% v/v glutaraldehyde in TSB was 
added, drop by drop, into the well and gently inside the surface of the well. This 
was left for 3 hours then gently removed and replaced by enough RK buffer to 
almost fill the well, approximately 10ml.  
Cell culture well
Bacterial culture Insert
Broth
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Two of the membrane inserts from each plate were processed for SEM within the 
wells. When dry the membrane was stuck on to a stub using a self-adhesive 
carbon tab. A scalpel was used to cut around the edge of the membrane in order to 
remove the hard plastic surround, leaving the thin membrane ready to sputter coat. 
The other inserts were taken for processing for LM and TEM (Appendix 3 and 5.7). 
Both LM and TEM samples were wrapped in hard tissue paper to help prevent 
biofilm loss during processing. 
 
2.3.16 PTTE/Agar “sandwich” model 
A 1:10 dilution was prepared from exponential phase bacterial cultures of P. 
aeruginosa and S. aureus, in sterile TSB. 0.4 μm PTTE inserts were placed inside 
the wells of two 6-well culture plates. One plate was designated for P. aeruginosa, 
one for S. aureus. A 100 µl volume of the bacterial dilution was added to the inside 
of each insert in the appropriate plate. The plates were incubated with agitation of 
50 rpm on a flatbed mini orbital shaker, at 37C for 24 hours. The outer culture 
media was then removed and 2.5 ml of 2.5% v/v glutaraldehyde in TSB was 
added, drop by drop, into the well and gently inside the surface of the well. This 
was left for 3 hours then gently removed and replaced by enough RK buffer to 
almost fill the well, approximately 10ml. Two of the membrane inserts from each 
plate were processed for SEM within the wells, and when dry the membrane was 
stuck on to a stub, then the plastic surround removed to leave the thin membrane 
ready to sputter coat. The other inserts were treated as follows: 
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A 3% w/v solution of agarose in distilled water was prepared, heated until the 
agarose dissolved and allowed to cool but not set. The RK buffer was carefully 
removed from the well area outside each insert, and then from the inside of the 
insert, by pipette. Whilst still fluid, the agar solution was gently dropped inside the 
insert until the whole surface was covered by a layer of agar (Figure 2.2a). This 
was allowed to set. The insert was removed from the well and inverted. 
 
 
Figure 2.2: a, b and c: The stages of creating the Agar Model 
Biofilm growth on an insert was removed from the well (a), agar was placed over 
the growth (b), then the insert and film was removed and the other side coated in 
agar to encapsulate the growth (c) 
 
 
A scalpel was run around the edge of the thin film to cut through it and the 
underlying agar. Using a stereomicroscope, the film was gently peeled away to 
leave the biofilm embedded in the agar. Another layer of molten agar was added to 
Agar
Bacterial growth Bacterial growth
Agar Sandwich
Bacterial growth
a.
b. c.
Insert
Insert
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this surface to sandwich the biofilm in the agar (Figure  2.2b) Once set this 
structure was bisected carefully to see if the layer of biofilm could be seen within it 
(Figure 2.2c). Two agar ‘sandwiches’ were then taken from each plate to be 
processed by TEM, and the remainder were processed for paraffin wax 
embedding, section cutting and staining with H&E, and viewed by LM.  
This was repeated for a 48 hour growth using three 6-well culture plates. One plate 
was designated for P. aeruginosa, one for S. aureus, and the third for an equally 
mixed culture of both organisms. A 100 µl volume of the bacterial suspension was 
added to the inside of each insert in the appropriate plate, and 50 µl of each culture 
was added to the insert in the plate designated for a mixed culture. The plates 
were then treated as above, but as a 48 hour growth. 
  
2.3.17 A novel wound model 
The model chosen was more representative of a wound environment and was 
used to allow biofilm to grow more naturally in a simulated wound setting. Ethanol 
sterilised pork belly slices were pre-trialled alongside back bacon for bacterial 
growth (Sainsbury’s Cardiff, UK), which occurred in both methods.  Back bacon 
was therefore chosen due to its consistency in thickness and being obtained from 
the same batch,  and the model subsequently called the meat model. PTTE inserts 
(0.4 μm ) were placed inside the wells of three 6-well culture plates. One plate was 
designated for P. aeruginosa, one for S. aureus, and the third for an equally mixed 
culture of both organisms. A piece of back bacon, was sterilised by submerging 
briefly in ethanol (confirmed by analysis of controls), and  placed on a previously 
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ethanol sterilised plastic chopping board (Sainsbury’s Cardiff, UK) . A thin slice (3 
mm)  was cut from the meat, using a number 8 (13 mm diameter) cork borer 
(Sigma-Aldrich, Gillingham, UK ) and placed on the inside film surface of each 
insert. 1:10 dilution was prepared from exponential phase bacterial cultures of P. 
aeruginosa and S. aureus, in sterile TSB. 100 µl of the bacterial dilution was added 
to the centre of the meat in the appropriate plate, and 50 µl of each culture was 
added to the centre of the meat in the plate designated for a mixed culture (Figure 
2.3). Some meat models were designated controls and not inoculated. 
The outside well area of the insert was filled with 2-3 ml of TSB broth until the 
insert was about to float. Incubation of the plates was at 37C for 72 hours with 
gentle agitation (50 rpm on a flatbed mini orbital shaker). At 24 and 48 hours the 
TSB culture was aseptically topped up in the well outside the insert. After 72 hours 
the remaining TSB was pipetted from the 
outer area and drops of 2.5% v/v glutaraldehyde in TSB were added into the insert, 
to gently flood the inside but not disturb the biofilm, and in the outer area of the 
well. This was left for 24 hours, to ensure fixation of the meat, and fixative was then 
gently replaced by RK buffer.  
In one culture plate the RK buffer was carefully pipetted from outside and inside 
the insert, removing as much excess fluid as possible from the inside of the insert. 
The meat was lifted out of the insert, the insert was removed, and the meat placed 
in the well to process in situ for SEM. For the other culture plates, a 2% w/v 
agarose solution was prepared and allowed to cool but not set. The RK buffer was 
carefully pipetted from the outside area within the well and from the area inside the 
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inserts. Once this fluid had been removed, the insert was taken out and placed on 
absorbent paper hand towels (Tork, SCA Hygeine Products, Dunstable, UK). This 
removed any further fluid that could drain through the base of the insert. The slice 
of meat was carefully removed and the base of the meat placed on the absorbent 
paper towels to remove excess fluid. Using fine-forceps the meat was carefully 
tilted and the base finely coated with a thin layer of tissue marking dye (Cancer 
Diagnostics, CellPath Ltd., Newton, UK) using an cocktail stick, then placed back 
on to the absorbent tissues for a few minutes. This was to help distinguish the base 
of the biofilm from the surface after processing. 
Whilst still fluid, the agar solution was gently poured inside a watch-glass (Thermo 
Fisher Scientific, Loughborough, UK ) and the meat was placed into the agar, 
biofilm-side down, but not touching the base of the glass, taking care not to include 
bubbles. The agar was allowed to start to set, and then more agar was poured over 
to completely cover the meat. This whole model was left until set, then removed 
from the watch-glass and placed in 2.5% v/v glutaraldehyde in RK buffer and fixed 
for 24 hours at room temperature. The whole meat/agar model was processed and 
cut for LM as in 2.3.16. A punch biopsy was taken from the centre of one core 
using a 6 mm Stiefel biopsy punch (eSupplies Medical, Newport, Wales, UK) and 
pieces processed for TEM. 
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Figure 2.3: The Meat Model 
Biofilm was grown on a meat surface, constantly supplied with nutrient through the pores 
of an insert. The whole meat model was placed in agar. 
 
2.3.18 Statistical analysis 
The increase in growth of the biofilm from 24 to 72 hours was confirmed 
quantitatively by taking LM images at x4 magnification and measuring the area of 
biofilm using Image J software. Two-sample t-tests and Analysis of Variance 
(ANOVA) statistical tests were conducted using Minitab 17 software to compare 
the means of biofilm areas. 
 
 
Bacterial culture
Meat
Insert
Nutrient BrothCulture well
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2.4 Results 
2.4.1 Physiology, Growth and the Effect of Silver 
Although the plating of cultures and the growth of exponential bacteria in a medium 
are basic microbiology techniques, they are also an essential step in the 
beginnings of any research studies utilising bacteria. Separate cultures of P. 
aeruginosa and S. aureus were incubated in TSB culture medium at 37ºC with 
aeration to observe their growth and find their exponential point. 
The results of bacterial growth for both organisms as recorded by the 
spectrophotometer, are shown graphically in Figure 2.4 and Figure 2.5. 
 
Figure 2.4: Absorbance v time showing growth curve for P. aeruginosa 
Absorbance vs time showing growth curve for P. aeruginosa: with silver nitrate addition to 
culture at 2 hours, 20 minutes. Note the sharp cessation of growth upon addition of the 
silver solution. 
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Figure 2.5: Absorbance v time growth curve for S. aureus 
Absorbance vs time growth curve for S. aureus: silver nitrate addition to culture at 2 hours. 
Note the sharp cessation of growth upon addition of the silver solution 
 
It was determined that the exponential growth of P. aeruginosa started to decrease 
slightly at around 3 hours. S. aureus growth started to decrease slightly after 2 
hours. Growth continued to rise for both cultures, but at a slower rate. As a result, 
the time of 2 hours 20 minutes was chosen as the best time point for harvesting 
exponentially grown P. aeruginosa, and the time of 2 hours was chosen as the best 
time point for harvesting exponentially grown S. aureus, for microscopy and for 
future experiments. These exponential time points were also selected as the best 
time for the addition of the silver nitrate solution. The results of the addition of silver 
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nitrate are included in Figure 2.4 and Figure 2.5, where it was observed that the 
addition of silver nitrate to both cultures resulted in rapid cessation of bacterial 
growth. 
 
2.4.2 TEM of Planktonic Bacteria and the Effect of Silver Nitrate on 
Bacterial Ultrastructure 
Preparatory methods for TEM can cause cellular damage, so various fixation 
protocols were examined in order to find the best method for ultrastructural 
preservation of the bacteria. 
Fixation initially with 0.5% w/v uranyl acetate followed by 2.5% v/v glutaraldehyde 
resulted in a disruption of the cytoplasm causing large empty spaces to appear 
throughout the cell. In all other fixation methods there was preservation of bacterial 
cells, with the nucleoid observed as a ribosome free area within the cytoplasm and 
containing the DNA fibres (Figure 2.6). TEM of bacterial cells fixed with 2.5% v/v 
glutaraldehyde reveaed a similar cellular appearance as the other fixatives (Figure 
2.6) but with less background precipitation. For future TEM protocols, fixation with 
2.5% v/v glutaraldehyde was chosen. 
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Figure 2.6: TEM of P. aeruginosa and S. aureus with varying protocols of fixation 
Top left - P. aeruginosa fixed with 0.5% uranyl acetate followed by 2.5% glutaraldehyde –
note the empty space throughtout the whole cell, disrupting the structure (x40k, bar 
500nm) 
Top right – P. aeruginosa fixed with.5% glutaraldehyde followed by 1% uranyl acetate – 
ultrastructure appeared to be well preserved with preservation of the nucleoid (x100,bar 
200nm) 
Lower left – P. aeruginosa fixed with 2.5% glutaraldehyde followed by 0.5% uranyl 
acetate – ultrastructure appeared to be well preserved with preservation of the nucleoid 
(x40, bar 500nm) 
Lower right – S. aureus fixed with 2.5% glutaraldehyde – ultrastructure appeared to be 
well preserved with preservation of the nucleoid (x100k, bar 200nm) 
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To distinguish bacteria and the effect of antimicrobials, silver nitrate was added to 
samples of both exponentially grown bacteria which were then processed for TEM. 
Adding silver to the bacterial cultures caused disruption of the nucleoid of both 
bacterial species (Figure 2.7).  
 
 
Figure 2.7: TEM images of P. aeruginosa and S. aureus untreated and with addition 
of 1% silver nitrate at the the exponential point for 220 minutes, fixed in 2.5% 
glutaraldehyde in RK buffer and processed for TEM 
Top - untreated P. aeruginosa (left) and S. aureus (right)  
Lower - with addition of 1% silver nitrate, P. aeruginosa (left) and S. aureus (right) 
Note the more condensed fibrils of DNA in both treated cells. (x100k, bar marker 200nm) 
  a    b 
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The nucleoid, or ribosome free area, became more condensed in appearance and 
the DNA fibres were tending to become coarser and thicker. 
2.4.3 SEM of Planktonic Bacteria 
Samples of planktonic bacterial cultures were processed and viewed by SEM, in 
order to be able to distinguish them from biofilm bacteria in the following chapters, 
and to ensure the success of the preparatory methods chosen. SEM imaging 
showed the distinctive shapes of both the rod-like P. aeruginosa and the spherical, 
coccus shaped S. aureus (Figure 2.8a and b). As the bacteria were from the 
filtration of a planktonic culture, no EPS was evident.
 
 
Figure 2.8a: SEM of planktonic bacteria P. aeruginosa 
(bar marker 10µm) bacterium appeared in clusters but showed no EPS 
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 Figure 2.8b: SEM of planktonic bacteria S. aureus 
(bar marker 10µm) bacterium appeared in clusters but showed no EPS 
 
2.4.4 Biofilm growth on glass coverslips 
Glass coverslips were chosen as the preliminary surface to start biofilm growth and 
examination before choosing a surface that could lend itself to all the techniques of 
microscopy to be used. A thick layer of biofilm development was observed on the 
glass surfaces. The bacteria were in a thick mat of cells with occasional bacterial 
clusters and the presence of faint traces of an extracellular matrix (Figure 2.9).
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Figure 2.9: 72 hour biofilm growth on glass coverslips by SEM 
Faint traces of EPS were present within the thick biofilm growth (bar marker 1µm) 
 
Noticeably, the glass coverslips stuck to the bottom of the Petri dishes and were 
very difficult to remove, if at all. Removal was usually by the breakage of part of the 
coverslip, such that the whole coverslip could not be observed in the SEM. The 
larger volumes of solution and bacteria used were suited to the Petri dishes but, for 
ease of use and handling in multiple tests in all subsequent experiments, culture 
plates were used instead of Petri dishes.  
 
2.4.5 Biofilm growth on plastic coverslips 
Plastic coverslips proved more pliable than glass, and were chosen as a preferred 
surface. Six-well culture plates with a well diameter of 34.8 mm were preferential 
for use. Using culture dishes with more wells, and thus smaller well diameters, 
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(e.g. 12-well, diameter 22.1 mm; 24-well, diameter 15.6 mm), was not conducive to 
keeping biofilm adhering to the Thermanox surface. The smaller wells, upon 
addition and removal of solutions during SEM processing, created currents/flows 
that more readily removed or disturbed the biofilm than that found when using the 
large 6-well diameters. 
Biofilm development was present in each well after 24 hours (Figure 2.10). 
 
Figure 2.10: 72 hour biofilm growth on plastic coverslips by SEM 
Biofilm was present on plastic coverslips as a thick layer of growth (bar marker 10µm) 
 
When adding the fixative (glutaraldehyde in buffer) to the wells it created some 
swirling movement due to the thickness of the growth and the aqueous nature of 
the fixative. There was a variation in thickness of the biofilm formed within the 
wells, judged by increased opacity of the biofilm, which was visually assessed by 
stereo microscope. There also appeared to be some form of growth/debris on the 
surface of the nutrient. As the steps for SEM processing were performed the 
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surface growth moved up and down over the coverslips. Therefore, it was not 
certain if the coverslips were covered in biofilm grown on its surface below the 
nutrient, or if it also included this surface growth/debris. 
 
2.4.6 The effect of inoculum concentration 
Preliminary experiments were performed, to decide upon the optimum 
concentration for future experiments in this study, and grown for 72 hours to 
visualise any differences in the growth in wells of each inoculum concentration. A 
layer of biofilm was present in each well on the coverslip surfaces, and again 
surface growth/debris on the broth surface. Once fixed and processed, the biofilms 
were examined by SEM, to decide which dilution should be used for future biofilm 
growth. Surface views of bacterial coverage in all samples showed the 
ultrastructural appearance of individual planktonic cells in all wells, and of areas of 
general coverage of bacteria appearing indistinct due to being enmeshed in a 
matrix, i.e. biofilm (Figure 2.11).  
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Figure 2.11: SEM of wells 1-6 with inoculum concentrations from 3.4 x107 to 3.4 x 102  
Images of the plastic coverslips with growth at different inoculum concentrations (3.4 x107 
to 3.4 x 102: images 1-6) Regardless of the concentration the biofilm, growth appeared 
similar with varying areas of thick growth plus clusters and ‘mats’ of biofilm (bar marker 
10µm)  
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2.4.7 Timed growth of biofilm from 1-6 hours 
To ascertain how quickly bacteria start to group together in the first stages of 
biofilm, and present the best start for initial sampling time for future growth 
experiments, bacterial growth was examined during the first 6 hours (Figure 2.12).  
 
Figure 2.12: 3-6 hour biofilm growth by SEM  
Grouping of bacteria at 3 hours (A), 4 hours (B), 4 hours (C), 5 hours (D), 6 hours (E), 
and 6 hours growth (F). Clusters of bacteria and ‘mats’ of biofilm growth were seen to 
gradually increase from the 1-6 hour period (bar marker 10µm) 
 
 
A B 
C D 
E F 
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This work was performed in triplicate. The first 1-3 hours showed a gradual 
increase in bacteria, with grouping occurring by 3 hours. Clusters of bacteria, 
probably immature biofilm, were present after 4 hours.There also appeared to be 
mats of biofilm containing numerous bacteria at 4-6 hours which appeared folded 
over in places. At 5-6 hours a lot of growth was apparent, with almost complete 
coverage within 6 hours. Calculating the mean growth from measurements of the 
areas of three-dimensional grouping showed a gradual increase in the grouping of 
bacteria with a marked increase at 5-6 hours (Figure 2.13). The dilution of 
glutaraldehyde in TSB prevented problems of swirling and pooling of the biofilm 
and was used as the method of primary fixing of the biofilm in situ. 
Figure 2.13: Statistical Analysis of bacterial growth over a 1-6 hour period 
The mean areas of all three-dmensional growth present in 10 samples was measured and 
compared. After 4 hours it could be seen that there was a sharp increase in the presence 
of biofilm clusters (or colonies) and by 6 hours much of the coverslip was covered in early 
bioflm growth
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2.4.8 Surface associated material: biofilm or slough? 
By comparing methods of collection of biofilm growth, biofilm on coverslips could 
be distinguished from biofilm/debris from the fluid surface. The plates containing 
coverslips which were placed into the base at the start of growth and processed in 
situ, produced clusters of bacteria, especially in the 4-6 hour. When the second set 
of coverslips were simply slid into the solution, dropped into the base and then 
processed, the resulting images showed sheets of cells as before, but also a 
background of planktonic bacteria.  
 
Figure 2.14: 6 hour growth with methods of biofilm collection (bar marker 10µm) 
Top left and top right - placing coverslips in the base of the nutrient and allowing growth 
showed both clusters and mats after processing  
Lower left – growing in wells then placing a coversip in the base before processing 
showed a similar appearance of clusters and mats 
Lower right – collecting the surface-associated material with a coverslip and processing 
revealed mats of biofilm 
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The third set of coverslips, which were used to scoop up the surface associated 
material, had a generally cleaner background, but contained sheets of cells as
biofilm in 3-6 hours (Figure 2.14). Observation of the surface material using TEM 
showed bacteria in various stages, from live to dead, with granular material and 
fine fibres in between (Figure 2.15). 
 
 
 
Figure 2.15: TEM of surface-associated material after 6 hours of growth 
Elements of biofilm were present as fine strands and granular material but appeared 
loosely packed. Some cells appear to have disrupted (bar marker 500nm) 
 
 
2.4.9 Biofilm growth on surfaces for LM, TEM and SEM 
2.4.9.1 Agar 
Bacteria grown on agar plate cultures for 24 hours did not produce individual, 
discrete colonies, but appeared as a unified smear culture. When repeated on 
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thinner agar, colonies were present as discrete areas.  In SEM, bacteria appeared 
to be in biofilm formations (Figure 2.16).  
 
Figure 2.16: Biofilm grown on the surface of a TSB/agar plate 
Discrete colonies were observed plus background planktonic bacteria by SEM 
(x500) 
 
Processing the small pieces of agar was extremely difficult due to it curling, so 
making observation in the SEM difficult. Those processed with some success 
looked similar to the biofilms previously produced. However, the method for 
producing them on agar demonstrated difficulties and so was not considered 
practical. 
2.4.9.1 Plastic coverslips 
As shown e, SEM of biofilm grown on plastic coverslips produced good images. 
However, for TEM, the block when cut had not sealed well at both edges and kept 
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coming apart, which made resin microtomy difficult. Sectioning of the coverslips 
was difficult even with a diamond knife, and on examination no biofilm could be 
visualised. Microtomy of wax blocks proved that the plastic was too hard for this 
method and no sections could be produced. 
2.4.9.2 Gauze 
Cultures grown overnight on gauze, treated with a live/dead stain (BacLightTM 
Viability Kit) and viewed under the CLSM, showed small clumps of bacterial biofilm 
on the strands of the gauze framework. Light microscopy, also demonstrated 
biofilm. The tough gauze fibres within the wax blocks were sectioned during 
microtomy, but not without some difficulty. Viewing with SEM showed the same 
appearance of biofilm, with EPS around the bacteria. However, for TEM the gauze 
had been poorly infiltrated by the resin, which caused viewing at higher powers to 
cause the section to tear apart under the electron beam. Further, the sections 
being, by necessity for TEM, only 100 nm thick, were too thin to show much of the 
biofilm as the small clumps, as demonstrated by LM, were spread apart throughout 
the gauze surfaces  (Figure 2.17). 
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Figure 2.17: Biofilm growth on gauze, viewed by LM, CLSM, SEM and TEM 
Top left - Stained with H&E, a section from a paraffin wax block viewed by LM, showing 
small colonies of bacterial biofilm on the gauze (x100) 
Top right – CLSM showing mainly live bacteria (green) using a BacLightTM viability kit 
(x40) 
Lower left – SEM showing biofilm growth within the fibres (bar 100µm) 
Lower right - TEM of biofilm on gauze. The gauze was not infiltrated by the resin 
thoroughly, making it difficult to section (bar 10µm) 
 
2.4.9.1 0.4 μm PTTE cell culture inserts 
The inside surface of the 0.4 μm PTTE cell culture inserts, which were constantly 
being provided with nutrients and moisture, appeared to allow biofilm to form. 
Processing for LM and TEM necessitated the removal of the porous film from the 
 
  
  
106 
 
upright hard plastic. During processing for microscopy, the film had a tendency to 
curl up, causing difficulty in embedding in either wax or resin. Also this surface was 
not easy to cut during microtomy, as neither wax nor resin could infiltrate it. 
Viewing with SEM demonstrated bacteria contained within an amorphous matrix, 
presumably biofilm (Figure 2.18). 
 
 
Figure 2.18: Biofilm growth on PTTE inserts viewed by SEM  
Clusters of biofilm growth with EPS were observed on the surface of the inserts (x2000) 
 
 
2.4.10 Development of an agar model to protect the delicate nature of 
biofilm and process it intact 
In order to prevent moving and detachment of biofilm from the insert surface, 
molten agar was used to envelop the biofilm. Initially, some of the bisected models 
split during processing. Further models were therefore processed whole and sliced 
upon embedding. Deep embedding moulds were used which helped minimise the 
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amount of slices required. Paraffin blocks were easily sectioned, although 
extended times on the water bath surface caused some of the sections to split. 
Staining by the H&E method showed a thin layer of biofilm at 24 hours, with some 
possible channels visible (Figure 2.19; Figure  2.20).  
 
 
Figure 2.19: 24 hour agar model of P. aeruginosa by LM 
Growth on inserts and processed using the agar model to sandwich the growth in the agar 
layers (x2) 
 
 
 
Figure 2.20: 24 hour agar model of S. aureus by LM 
24 hour growth on inserts and processed using the agar. Possible channels were visible 
by LM (x40) 
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Even though some of the layers had split during section cutting, the whole of the 
layer was present. The sample taken from the agar, and processed to TEM 
showed the biofilm was mainly intact and interspersed with fine vesicles (Figure 
2.21).  
 
Figure 2.21 - The 24 hour biofilm growth in the agar model by TEM 
Top - 24 hour P. aeruginosa Bacteria were interspersed with fine strands (green arrows) 
and vesicles (blue arrows) (x15k)Lower - 24 hour S. aureus The bacteria were 
interspersed with fine strands and granular material (x15k) 
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When repeated at 48 hours, channels and bacterial dispersal was evident. The 
stained sections showed what appeared to be different layers and possible 
microcolonies (Figure 2.22).  
 
 
Figure 2.22: 48 hour biofilm growth in agar models by LM  
Top left: 48 hours of the mixed bacterial growth  
Sections showed the appearances of channels, layers and of dispersal of bacteria 
Top right: 48 hour S.aureus  
Sections showing the appearances of channels, layers and of dispersal of bacteria (x100) 
Lower: 48 hour P. aeruginosa  
Sections show the appearances of channels (black arrows), layers and of dispersal of 
bacteria (blue arrow) (x100) 
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These layers were present in the single cultures and in the mixed culture. Some of 
the layers appeared to be denser. TEM showed some bacteria to have fine strands 
between them. In places, fine channels could be seen within this structure which 
corresponded with the channels seen in the H&E sections (Figure 2.23). 
 
Figure 2.23: TEM of 48 hour biofilm in the agar model with channels 
Top - TEM of 48 hour P. aeruginosa biofilm Lower - TEM of 48 hour S.aureus biofilm  
Fine channels were observed within the biofilm in both biofilm models (black arrows) 
(x2500, bar 10µm) 
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2.4.11 The meat model 
Surrounding the meat and biofilm with agar afforded the delicate biofilm surface 
protection. In some models the paraffin wax sections split slightly when floating on 
the 45ºC water bath. This was due to the length of time it was required to leave 
them on the surface, in order to straighten out the meat muscle fibres within the 
section. Despite this the H&E stained sections contained all the layers of biofilm 
and muscle, and the biofilm area could still be quantified (Figure 2.24).  
 
 
Figure 2.24: Intact 72 hour biofilm on the meat model by LM 
Models had intact biofilm with the appearance of layers. There was also occasional 
invasion of the biofilm into the surface of the tissue (x10) 
 
The 72 hour growth appeared thicker than the 24 and 48 hour layers from the agar 
model, as would be expected. Once again, waste/nutrient channels and areas of 
bacterial dispersal in P. aeruginosa, S. aureus and mixed cultures were found 
(Figure 2.25; Figure 2.26).  
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Figure 2.25: Waste/nutrient channels in 72 hour biofilm on meat model by LM 
Channels were visible within the layers of growth (black arrows) (x100) 
 
 
Figure 2.26: Bacterial dispersal on 72 hour biofilm on meat model by LM 
Layers were present within the biofilm. The surface showed looser layers and areas of 
bacterial dispersal below the agar covering (x20) 
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There appeared to be differing layers within the biofilm, the deeper layers adjacent 
to the meat appearing denser than the upper layers (Figure 2.27; Figure 2.28).  
 
 
Figure 2.27: Differing biofilm layers on the 72 hour meat model by LM 
Varying layers were seen within the biofilm growth, some appearing denser than others 
(x100) 
 
 
Figure 2.28: Layers of 72 hour biofilm on meat model by LM 
Left - Showing deeper, denser layers of growth in the areas nearer to the biofilm/tissue 
interface. Fewer channels could be seen by LM in these layers (x100) 
Right – Showing upper layers of biofilm growth which appeared more open and less dense 
than the lower layers of growth (x100) 
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Occasional groups/microcolonies of bacterial cells were found within the thick 
biofilm. Observation of the H&E sections showed the biofilm to be growing down 
into folds in the meat surface and deeper into the tissue, suggesting bacterial 
invasion (Figure 2.29). 
 
Figure 2.29: Biofilm micro-colonies and channels in 72 hour biofilm by LM 
Micro-colonies (green arrows), and channels were present in many areas of biofilm (x40) 
 
 
The structure of the TEM images showed similar evidence of dense layers of tightly 
packed dormant-appearing biofilm bacteria at the meat-biofilm interface (Figure 
2.30), with less tightly packed layers of bacteria further towards the surface (Figure  
2.31).  
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Figure 2.30: TEM of lower dense biofilm layers at 72 hours 
Lower layers of biofilm growth showing deeper, denser layers at the tissue/biofilm interface 
by TEM. Some possible channels existed but were small (15k) 
 
 
 
Figure 2.31: 72 hour biofilm upper layers on meat model by TEM 
The upper layers of biofilm growth nearer to the surface presented a looser, less densely 
packed appearance than the deeper layers. Fine strands of EPS were seen around the 
cells (bar marker 5µm) 
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The bacteria in the upper areas appeared to have more structure. Small channels 
were seen within the layers of biofilm and also larger channels containing clusters 
of individual bacteria (Figure 2.32). 
 
Figure 2.32: Channel detail of the 72 hour biofilm by TEM 
Channels were observed within the biofilm, some longer than others, lined by several 
individual bacteria (bar marker 2 µm) 
 
The thickened areas contained bacteria in biofilm with EPS, when examined by 
TEM, some of which included bacterial budding (Figure 2.33). 
 
  
 
Figure 2.33: TEM of thickened areas of biofilm in the 72 hour model 
Bacterial biofilm with EPS was present (left, bar marker 10 µm) and bacterial budding 
(right, bar marker 500nm) 
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Any increase in growth of the biofilm from 24 to 72 hours was confirmed 
quantitatively by taking LM images at x4 magnification and measuring the area of 
biofilm using Image J software. Two-sample t-tests and Analysis of Variance 
(ANOVA) statistical tests were conducted using Minitab 17 software to compare 
the means of biofilm areas. Statistical analysis (a two-sample t-test) of the means 
at 24 and 48 hour showed a significant difference (p= 0.000), as did the 24 and 72 
hours (p= 0.000), and the 48 and 72 hour comparisons (p= 0.001). Using a one-
way ANOVA test, a Tukey Pairwise comparison of the 24 and 48 hour means of 
the standard deviations showed the means to be similar, but that the 72 hour 
growth was significantly different. An interval plot of the pooled standard deviations 
demonstrated that the differences between the 24 and 48 hour means were 
probably not significant. (Figures 2.34-36). 
 
 
Figure 2.34: Equal variance tests of biofilm growth at 24 48 and 72 hours 
The consistency in standard deviations of the biofilm growth areas showed the 24 hour 
growth to be the most consistent. This comparison also demonstrated that the 72 hour 
growth was significantly different to the 24 and 48 hour growths 
 
Biofilm 72
Biofilm 48
Biofilm 24
0.300.250.200.150.100.050.00
P-Value 0.000
P-Value 0.000
Multiple Comparisons
Levene’s Test
Test for Equal Variances: Biofilm 24, Biofilm 48, Biofilm 72
Multiple comparison intervals for the standard deviation, α = 0.05
If intervals do not overlap, the corresponding stdevs are significantly different.
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Figure 2.35 an 2.36: Interval plot and Tukey plot of biofilm growth at 24 48 and 72 
hours 
Showing a mean increase in biofilm growth areas on the interval plot, at 24 and 48 hours 
the interval lines overlap showing the difference not to be significant. The 72 hour growth 
was significantly different from the 24 and 48 hour growth.  
       
 
 
Biofilm 72Biofilm 48Biofilm 24
0.4
0.3
0.2
0.1
0.0
D
a
ta
Interval Plot of Biofilm 24, 48, 72 hour
95% CI for the Mean
The pooled standard deviation is used to calculate the intervals.
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2.5 Discussion 
2.5.1 Growth and the Effect of Silver 
Under controlled conditions (e.g. when nutrients are plentiful and the starting 
number of bacteria is small), bacterial growth will be optimal and provide rapid 
exponential growth within a matter of hours. However, this type of environment 
cannot sustain an infinite population of a species and there will come a point when, 
as the population size increases, available nutrients and space are depleted and 
there will be a slowing down of growth, termed the stationary phase (Todar, 2012). 
To obtain a substantial sample for experimentation that is still actively growing but 
not slowing down, it is best to harvest a natural population at its maximum point of 
exponential growth (Math Insight.org). Knowing when to harvest exponentially 
growing cells either for the best culture of planktonic cells or for biofilm 
development is crucial, as it is important to have healthy and actively growing cells 
for any microbiological experiments. Monitoring growth of a bacterial culture allows 
this determination to be made accurately. The physiological experiments showed 
how exponential growth rates could be used to point consistently to the best time 
for harvesting bacteria in order to obtain a substantial sample for future 
experiments. This best time point for harvesting exponentially grown bacteria could 
be checked against the bacterial density, by taking spectrophotometer readings at 
the collection time points mentioned in the results section (2.4.1), so providing 
similar readings and hence a similar concentration of bacteria.  
Bacteria readily lend themselves to study by EM and advances in specimen 
preparation for EM have improved the preservation of their ultrastructure (Newman 
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and Hobot, 2001). This has given rise to new perspectives on our understanding of 
the structure of the bacterial cell (Hobot, 1990; Hobot, 2015). For these studies it 
would be necessary to distinguish between planktonic and biofilm bacteria within 
wounds. Therefore, it was important to analyse bacterial structure in culture media 
in preparation for the more clinically relevant wound model that was one of the 
objectives of the study.  
The addition of silver nitrate at 10 µg/ml (i.e. 1%), is known to be an effective 
concentration. This is the minimum inhibitory concentration (MIC), which is defined 
as the lowest concentration that kills at least 99.9% of a planktonic or biofilm 
bacterial population (Choi et al., 2008). The addition of silver nitrate to actively 
growing cultures resulted in a very rapid cessation of growth in both P. aeruginosa 
and S. aureus. This confirmed the earlier work of silver’s effect on P. aeruginosa by 
Hobot et al. (2008), and the claims of the effect of silver nitrate on S. aureus by 
Jung, et al. (2008), and on Gram positive and negative bacteria by Furr, et al. 
(1994). 
Understanding the effects of silver will be of benefit for the studies presented in 
Chapter 3 using different types of wound dressings on biofilm development, 
especially those containing silver (Newman et al., 2006). 
 
2.5.2 TEM of Planktonic Bacteria and the Effect of Silver on Bacterial 
Ultrastructure 
Bacteria readily lend themselves to study by EM and advances in specimen 
preparation for EM have improved the preservation of their ultrastructure (Newman 
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and Hobot, 2001). This has given rise to new perspectives on our understanding of 
the structure of the bacterial cell (Hobot, 1990; Hobot, 2015). For these studies it 
was necessary to distinguish between planktonic and biofilm bacteria within 
wounds. Therefore, it was important to analyse bacterial structure in culture media 
in preparation for the more clinically relevant wound model that was one of the 
objectives of this study. Comparing preparatory techniques for the study of 
bacterial cells with TEM was important as deleterious changes to ultrastructure can 
occur. For example, harvesting cells by centrifugation can lead to conditions of 
anoxia and cause leakage of ions across the bacterial membranes (Moncany and 
Kellenberger, 1981). This can have consequences on the structure of the bacterial 
nucleoid and is why harvesting cells by filtration avoids these problems (Hobot et 
al., 1985). It has been found that centrifugation can affect the structure and 
organisation of the bacterial cell wall (Hobot et al., 1984).  
Fixation with osmium tetroxide, initially introduced as part of the RK conditions of 
fixation by Ryter et al. (1958), has been shown to have an adverse effect on the 
shape of the bacterial nucleoid depending upon the salt content of the growth 
media (Kellenberger and Ryter, 1964). They examined the fine structure of the 
nucleus under different conditions and this resulted in the development of a 
buffering solution which obtained optimal preservation of the fine fibrillar nuclear 
material (RK buffer: veronal-acetate buffer, pH6.15; Ryter et al., 1958). Osmium 
tetroxide has also been implicated in damaging protein structures (Baschong et al., 
1984). However, this has not been reported for glutaraldehyde and consequently 
the bacteria for TEM were harvested by filtration and fixative solutions using RK 
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buffer avoiding osmium tetroxide. This ensured that a similar appearance of the 
bacterial nucleoid under the various growth conditions, displayed a dispersed 
ribosome free space within the cytoplasm (Hobot et al., 1985).  
Various combinations of glutaraldehyde and uranyl acetate were tried. It had been 
shown that uranyl acetate solutions could, in vitro, stabilise bacterial DNA by 
gelation (Schreil, 1964). Using uranyl acetate prior to fixation with glutaraldehyde 
was not successful, resulting in severe damage to the cytoplasm and nucleoid. 
Glutaraldehyde followed by uranyl acetate fixation, showed no real advantages 
over using 2.5% glutaraldehyde alone, which was therefore chosen as the fixative 
of choice for this study. The choice of LR White, an acrylic resin, which allows for a 
partial dehydration of cells, was based upon results indicating that this protocol 
was advantageous for the preservation of both cellular tissues and bacterial cell 
ultrastructure (Hobot, 1990; Newman and Hobot, 1987; 2001). 
Addition of silver nitrate to bacterial cultures caused exponential bacterial growth to 
cease. This may have been due to damage to the cell structure by the silver. This 
was demonstrated by TEM, in the adverse effect seen on bacterial ultrastructure. 
Most notably the nucleoid shape changed from a more dispersed appearance to 
one more condensed and lying throughout the central region of the cells. This 
confirmed the findings of Hobot et al., (2008) for P. aeruginosa. The DNA fibres 
became coarser and thicker in P. aeruginosa and more so for S. aureus, a bacteria 
not studied by Hobot et al., (2008). The change in shape and appearance of the 
DNA fibres resembled those changes in appearance seen after fixation with 
osmium tetroxide (Hobot et al., 1985).  
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As previously discussed osmium tetroxide is known to alter the permeability 
properties of bacterial membranes allowing for ionic leakage to occur (Woldringh, 
1973) and results in a loss of bound ions from the DNA (Moncany and 
Kellenberger, 1981). Similar results have been observed in the images of the 
effects that silver has on bacterial structure (Figure 2.7), and suggests that silver 
ions, upon entering a bacterial cell, can cause similar permeability changes in the 
bacterial membranes leading to ionic loss from nuclear areas (Hobot et al., 2008). 
It therefore provides an interesting hypothesis of how silver kills bacterial cells 
quickly and effectively, by binding to the DNA and changing its structural 
organisation within the cell. As silver is now a popular additive to wound dressings, 
and claimed to be an effective anti-bacterial agent (Newman et al., 2006; Percival 
et al., 2008), it is important to understand a possible mechanism by which silver 
ions kill bacteria. It may also lead to a better understanding of how silver may work 
effectively in a wound environment that could chemically impede the action of 
silver.  
2.5.3 SEM of Planktonic Bacteria 
In SEM images of planktonic bacteria, the cells are clearly visible as individual 
entities, even though the images showed a mass of bacteria (Figure 2.8a and b). 
No EPS was visible throughout the bacterial populations for both P. aeruginosa 
and S. aureus, as would be expected in the non-biofilm phenotype. The rather 
short infiltration times used during the SEM preparation protocol where chosen as 
it was observed in previous biofilm studies, that longer infiltration times can lead to 
detachment of biofilm from its substrate (Fischer et al., 2013). In agreement with 
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the previous findings of Araujo et al. (2003), using HMDS instead of critical point 
drying was superior in preserving the outer appearance of the bacterial cells, and 
therefore was the method of choice for future SEM examination of biofilm 
development and structure.  
Investigating and understanding the behaviour of P. aeruginosa and S. aureus in a 
liquid medium has been a focus in wound microbiology in the past, and 
consequently for many years the majority of quantitative evidence for the efficacy 
of antimicrobial dressings has been based upon in vitro studies of planktonic 
bacteria (Bowler et al., 1999; 2004; Jones et al., 2004). However, in chronic 
wounds there is increasing evidence that the wound bioburden consists of 
planktonic and biofilm bacteria (Malone et al., 2017; James et al., 2008; Kirketerp-
Møller et al., 2008; Rhoads et al., 2008). As biofilm is defined as being microbial 
communities attached to a surface, or to each other, and enclosed in a matrix of 
EPS, it followed that the next stage of the project would be the growing and 
examination of biofilm attached to a surface. 
 
2.5.4 Establishing and characterizing biofilm growth 
More than a decade of evidence has discussed around how microorganisms can 
exist as biofilm communities in the wound environment and not as previously 
thought, as just planktonic microbes (Metcalf and Bowler, 2013). With such 
evidence it would seem that the culturing of biofilm in vitro should be relatively 
simple. However, biofilm needs certain conditions to enable them to develop, such 
as nutrients and a suitable surface. Once grown, flow rate, shear force, chemical 
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gradients, diffusional processes and surface type and topography, can all affect 
biofilm structure (Korber and Lawrence 2004). 
Culturing the biofilm models in a TSB at 37C with gentle agitation resulted in 
successful biofilm development, and it was decided that the same broth and 
agitation conditions would be used throughout all the remaining studies. The larger 
volumes of solution and bacteria used were suited to the Petri dishes but, for ease 
of use and handling in multiple tests in all subsequent experiments, culture plates 
with wells were used instead of Petri dishes. Trialling different sized culture wells 
showed how fluid flow and currents can affect both the growth and how biofilm can 
be removed/disturbed. As one of the objectives was to process a biofilm intact, 
larger diameter wells were used rather than the smaller well plates as they were 
found to create fewer disturbances to the biofilm during processing. The first of 
these studies, on the glass, provided thick biofilm with EPS evident (Figure 2.9), 
but the glass was prone to breakages and was only suitable for SEM or CLSM 
viewing. Plastic coverslips have been embedded in resin for thin section studies in 
TEM (Espinal et al., 2012), and these were tried as a different surface for the next 
set of studies. 
Despite initial concerns over obtaining the correct optimisation of the initial 
bacterial concentration, this appeared not to be of great significance. Overall there 
appeared to be no difference to the amount or thickness of bacterial coverage on 
coverslips. The bacterial population, regardless of the inoculum concentration, 
repeatedly grew to produce a colony that quickly established itself as a biofilm 
community. Therefore, actual biofilm formation was independent of the initial 
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bacterial cell number used as an inoculum. For this reason, a starting 
concentration of 1 x 107 bacteria ml-1 was chosen as providing a reasonable 
number to initiate biofilm formation and simply involving a one-step dilution from 
the 1 x 108 bacteria ml-1 present in mid-exponential phase. 
There was some early hypothesising concerning the presence of biofilm in chronic 
wounds (Costerton et al., 1999; Serralta et al., 2001) but most of these studies 
examined established biofilms only at 72 hours and did not look into the earlier 
times during which biofilm can form. Harrison-Balestra et al. (2003) showed, by 
suspending plastic coverslips in an inoculated TSB broth and staining and viewing 
with LM, that the EPS of developing biofilm may be visible in 5 hours after 
inoculation and that mature biofilm characteristics, such as a dense coating of 
EPS, might be found by 10 hours. 
The results from the preliminary experiments (performed in 2.4.7) showed that, by 
viewing with SEM, bacteria were not only dividing rapidly but were starting to form 
small clusters of immature biofilm within only 4 hours. There were the beginnings 
of strands of EPS between them, with some enmeshed in EPS at 5-6 hours 
(Figures 2.13; 2.14). The structure at this point may not be mature biofilm, with 
channels and layers, but the speed with which these groups begin to form in the 
simplest of environments must surely reflect how quickly biofilm can start to form 
within a wound, if a patient is immunocompromised.  
Changing the glutaraldehyde fixative diluent, from buffer to TSB, prevented the 
earlier problems of pooling of the biofilm and was used as the method of primary 
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fixing of the biofilms in situ. The movement of the surface associated material, 
during processing, made it uncertain whether the coverslips were covered in 
biofilm grown on its surface below the nutrient, or if it also included surface 
growth/debris.  By placing coverslips on the base of the well, and growing biofilm 
beneath the nutrient, then comparing these to coverslips dropped into a well of 
growth, and coverslips used to scoop up the surface-associated growth, it was 
hoped to clarify whether the surface material was having an effect on the results. 
The bacterial coverage on coverslips used to scoop up the surface-associated 
material contained thick folded mats of biofilm when viewed by SEM, which was 
probably surface-associated biofilm. To be certain of the nature of such material it 
was viewed with TEM. Observation of the surface-associated biofilm using TEM 
showed loosely grouped bacteria, with granular material and fine fibres in between 
(Figure 2.15). The granules and fibres between the cells were most likely 
extracellular DNA, a component of EPS.  
The appearance of folded mats of biofilm on the other coverslips raised the 
question of surface-associated biofilm being present. Some of this may 
inadvertently have come to rest on the coverslip during processing, where there 
had been removal of solutions from one step to another. Webster et al. (2006) 
incubated coverslips half submerged in a culture of bacteria and found that biofilm 
formed on the submerged glass, as well as on the glass surface exposed to air. 
From the careful examination of the movement of the surface during processing for 
microscopy detailed in the results of 2.4.8, it might be concluded that some of the 
material in this study was biofilm. Scooping up the surface material and comparing 
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it to the other coverslips showed that when coverslips are submerged and then 
processed, they run the risk of accumulating surface biofilm and debris during 
processing.  
The ability of bacteria to form biofilm was demonstrated clearly by growth on the 
array of differing surfaces trialled. Some surfaces appeared to be better than 
others, not for the speed of biofilm formation, but for ease of use and handling.  
This study includes different types of microscopy, and the growth surfaces were 
tested for adaptability for use with all techniques. Therefore, the processing 
methods for the various techniques were applied to biofilm growth on the plastic 
coverslips, agar, gauze and 0.4μ PTTE membrane cell culture inserts. 
The three most common ways of growing bacteria in vitro are as planktonic 
cultures, colonies on agar plates, and biofilm in continuous-flow systems 
(Mikkelsen et al., 2007). Agarose, when set as a solid gel, acts as a support 
medium for cells in histological processing techniques into paraffin wax and 
electron microscopy processing techniques into resin (in-house methods). It was 
therefore considered that it might be possible to process biofilms grown on agar 
plates, for all microscopy methods. Some authors state that bacterial growth on 
agar is not representative of how bacteria grow in tissue sites, and that any results 
from tests are open to error (Costerton et al., 2003; Clutterbuck et al., 2007). It is 
suggested that they grow more as a smear culture. The nutrient source is thought 
to become eventually depleted beneath them (McBain, 2009). However, because 
of the nature of the agar plates and the way in which they reacted by curling during 
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the processing steps, it was not an ideal surface to use. Therefore, the use of the 
agar plates was discounted from the study. 
Cotton gauze has been used to grow biofilm in various studies. Lipp et al. (2010), 
Rowlands et al. (2013) and Parsons (2014) all grew bacterial biofilm on gauze 
dressings to add to a wound model; CLSM confirmed the presence of biofilm within 
the gauze structure, growing around the fibres. Tachi et al. (2004) using an 
infected animal wound model demonstrated that by covering full thickness wounds 
with gauze, infections persisted. Biofilm growth on gauze provided useful images 
with LM, with the presence of biofilm within the gauze structure being confirmed 
using CLSM.  Unfortunately, it did not process into the resin adequately, and gave 
too small a surface area to section and view with TEM. However, the growth within 
the gauze gave an insight into how easily biofilm may begin to grow within a gauze 
dressing on a wound. Despite gauze having been a traditional agent it is still used 
in clinics due to its low cost, sometimes as a primary dressing, but often as a 
secondary dressing to hold topical treatments in place. (Harding et al., 2000). 
Some antimicrobial dressings still use gauze as its structure (Honey - 
ManukaDress,  TheraHoney®; PHMB - Kerlix-AMD, Curity™ AMD). The rationale 
behind the use of gauze is that it can absorb exudate and keep the wound dry 
(Eaglstein, 2001) but moist healing has been advocated since the 1960s (Winter, 
1962). In studies it has been shown to be ineffective in dealing with chronic 
infections and some consider it ethically questionable to use gauze in trial 
situations when it does not provide optimal healing conditions (Jones et al., 2006). 
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Polyethylene terephthalate track-etched (PTTE) inserts are claimed to have a 
higher resistance to most organic solvents than other filters making them suitable 
for testing with all the processing techniques (guidelines for using Falcon® cell 
culture inserts, PD104401 Rev. 01, Corning Life Sciences). Culture well inserts 
have a membrane base with regular pore size, and have been in use for some 
years for growing bacteria (Anderl et al., 2000; Kirker et al., 2009). Fluid seeps in 
gently through the pores without flooding the inside of the insert. These inserts 
proved the best technique for biofilm growth. The nutrient provision proved 
sufficient without the bacteria being fully immersed below the fluid, and being more 
comparable to the way bacteria might form biofilm in a wound while being supplied 
with wound exudate.  
A wound produces exudate in response to tissue damage; it is part of the natural 
healing process and is present in both acute and chronic wounds. Bacteria and 
biofilm within these wounds are surrounded by this exudate, but are not submersed 
in a depth of fluid, as was also the case with the inserts. Providing the bacteria 
have access to a surface (i.e., the insert’s membrane) that is, or can become, 
conditioned by a thin nutrient layer, it facilitates accessibility and anchorage of 
bacteria to it, and biofilm may form (Garrett et al., 2008). Fluid can also evaporate 
from a wound causing the exudate concentration to increase, which may affect its 
viscosity (Cochrane et al., 1999). Insert surfaces were also subject to evaporation, 
even though constantly supplied with nutrient from fluid through the pores. Inserts 
therefore seemed to provide a close comparison to the conditions that might be 
expected for biofilm to experience in a chronic wound. Further, they were 
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supportive of growth and supplied the bacteria with nutrients (TSB) but did not 
submerse them in too deep a layer of the broth, eliminating the possibility of false 
measurements due to surface associated biofilm coming to rest on the surface 
during processing, as had been previously encountered (2.4.8).  
Protecting bacterial growth and biofilm with agar proved successful, providing there 
was enough growth of biofilm to stay in the upper layer of agar before the insert 
film was removed. There was no guarantee that the entire biofilm layer had been 
removed from the plastic film, but viewing of the 24 hour growth showed a good 
layer of biofilm and examining the insert film by stereomicroscopy showed no 
visible remnants of growth. Biofilm grown for 48 hours presented with channels, the 
development of which may allow flow of waste and nutrients, and are therefore 
thought of as a simple system of fluid transport (Wilking et al., 2013; Proal, 2008). 
The biofilm appeared to be thicker than the 24 hour growth, and was forming layers 
of differing densities with occasional clusters of cells. This was even more 
pronounced in the mixed cultures.  
 
2.5.5  A novel model  
The 24 and 48 hour models were grown and placed in agar successfully, however 
the meat model was considered the best model due to its ability to demonstrate 
biofilm growing into lower tissue layers. After 72 hours of growth on the meat 
model, the resulting images showed how the bacteria grew gradually into the 
crevices in the meat which, if in a clinical wound, would make the biofilm more 
difficult to access for debridement. This demonstrates the accepted theory that it is 
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unrealistic to believe that a wound can be completely debrided and kept sterile 
(Bjarnsholt et al., 2008). Biofilm covered the entire upper meat surface to the 
edges, and although there was some infiltration deeper into the meat, the bacteria 
had not seeped from the edges to the underside of the meat, which would mean 
that there would not be false growth in the model from the base up, when tested 
against dressings.  
The structure within the biofilm under LM appeared to be in discrete layers, with 
occasional microcolonies of bacteria present. Some studies have demonstrated 
that P. aeruginosa are frequently located in aggregates or microcolonies within 
biofilm or tissue (Kirketerp-Møller et al., 2008). Fazli et al. (2009) found using PNA-
FISH analysis that S. aureus aggregates were located close to a wound surface, 
whereas P. aeruginosa aggregates were located deeper in the wound bed. This 
would suggest that P. aeruginosa are capable of colonising deeper into the wound 
bed, although viewed by TEM in this study P. aeruginosa were observed 
throughout the biofilm thickness. Each biofilm grown using this meat model had a 
similar structure, whether it was single or two- species biofilm, with evidence of 
dense layers of tightly packed biofilm bacteria at the meat-biofilm interface, with 
less tightly packed layers of living bacteria further towards the surface. This would 
suggest the upper layers contain more metabolically active biofilm versus the 
denser and less active biofilm beneath. 
This layered structure could represent what may be an optimal arrangement of 
structure to allow the transfer of nutrients and waste. In TEM, there were channels 
lined with a few single cells. It has been demonstrated that biofilm channels permit 
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the flow of fluid around and over cell clusters (Stoodley and Lewandowski, 1994). 
Cells such as these may be active due to the nutrient transport in these channels, 
or newly divided cells. However, these cells may be present due to nutrient 
depletion/limitation deep within the biofilm layers, causing biofilm to revert to 
planktonic forms and travel down the channels to disperse (Delaquis et al., 1989; 
Sauer eta al., 2004). Several P. aeruginosa cells were producing what are 
sometimes termed extracellular or membrane vesicles (Stubbs et al, 1999). The 
presence of membrane vesicles would suggest a possible stress response. 
McBroom et al. (2007) found that release of vesicles increased directly with the 
level of protein accumulation in the cell envelope, which occurs under stress 
conditions.  Membrane vesicles are spherical and formed from the outer 
membrane without loss of its integrity (Schwechheimer et al., 2013). They are 
thought to transport bacterial products to the biofilm environment, and have been 
suggested in the delivery of proteins, hydrolytic enzymes (such as phospholipase 
C, proteases, hemolysin and alkaline phosphatise), quorum-signalling molecules, 
lipids, virulence factors in pathogenesis, and to affect proteolytic activity and 
antibiotic binding (Kulp and Kuehn, 2010; Kadurugamuwa and Beveridge, 1995). 
They allow the delivery of such to reach distant targets in a concentrated, protected 
and targeted form. Membrane vesicles are also thought to differ in planktonic and 
biofilm forms. Once liberated, those from the planktonic bacteria parent cell 
migrate, whereas membrane vesicles found in biofilm tend to accumulate in groups 
(Schooling and Beveridge, 2006).  
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When the biofilm area measurements for 24, 48 and 72 hours were compared 
using two-sample T-tests, these demonstrated that the different growth periods 
were statistically significant from each other (with greater than 95% confidence). 
Performing a one-way ANOVA test using the Tukey confidence intervals confirmed 
that it was necessary to have grown the biofilm to 72 hours to differentiate it from 
shorter time periods, as 72 hours resulted in significantly more biofilm development 
(Figures 2.35-2.37). The interval plot performed showed that the differences 
between the 24 and 48 hour growth were probably not significant due to the 
overlap of the interval bars. A test for equal variances revealed that the 24 hour 
growth, which had a close grouping, was more consistent.  
 
2.6 Conclusion 
All of the objectives were achieved, as covered in the discussion, and from this 
there are several conclusions. The preliminary experiments showed how 
exponential growth provided a constant and consistent supply of bacteria that 
could be readily reproduced throughout the undertaken study periods. The best 
time point for harvesting exponentially grown bacteria was confirmed by the 
bacterial density by taking spectrophotometer readings at selected time points. The 
growth curves served as a guide to the estimated number of organisms in cultures, 
in order to estimate more accurately the exponential growth point for each 
experiment. The growth rate was monitored by estimation of optical density, to 
provide similar readings and hence a similar concentration of bacteria. 
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All these experiments were essential for learning microbiology techniques, and 
gaining an insight into the structure of bacteria, the best protocol of fixation, and 
why a 2.5% glutaraldehyde in RK buffer should be employed for the remaining sets 
of experiments. The effect of an antimicrobial was demonstrated upon the 
exponential growth and by ultrastructural examination after using silver nitrate, 
showing how growth of planktonic cells can be effectively inhibited if its 
concentration is sufficient. 
Growth of biofilm developed with 6 hours which confirmed that any analysis of the 
effect of antimicrobials in dressings should include the time points starting from 3 
hours, and the statistical analysis demonstrated that biofilm should be grown to 72 
hours to visualise any significant difference in further models. The initial bacterial 
concentration was, however, not significant when examined by SEM. 
 The growth of biofilm on inert, non-biological surfaces is less likely to accurately 
reflect the growth found in wounds, despite the apparent success of utilising 
surfaces such as poloxamer hydrogel in various models (Gilbert et al., 1998; 
Percival et al., 2007). Inert surfaces use non-biological substrata for biofilm 
attachment, and Luppens and Ten Cate (2005) demonstrated that biofilm 
development can be regulated by the type of substrata to which it attaches. A study 
of biofilm in wound healing is more likely to benefit from an in vitro model that more 
closely mimics the physiology of human wounds. Some have evaluated dressings 
using cell lines such as epithelial cells and fibroblasts (Cochrane et al., 1999; 
Walker et al., 2011) but these are limited in size for use in many experiments, and 
are complex and expensive.  An in vivo meat model facilitates multiple sample 
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collection from a standard, more controllable surface, over variable time points. 
The surface of a wound is also complex. However, a meat model can more closely 
reflect this topography compared to non-biological surfaces. Using this porcine 
meat model allowed for multiple tests, and an endless supply of material, for use in 
this study. 
Architectural analysis of any biofilm is impractical unless the whole structure can 
be kept intact. Although there have been some justified comments that CLSM is 
the best way to view biofilm without treatment-induced structural changes 
(Lawrence et al., 1991), the agar model with its sandwiching technique presented 
in this chapter, has helped to maintain whole biofilm layers together in both LM and 
TEM methods. This makes it a good model, not only for further LM and EM 
comparative studies, but also for the next chapter of studies on wound dressings 
and their effectiveness at preventing bacterial biofilm growth. This chapter has 
already confirmed that bacteria can begin to form a biofilm within hours, and that it 
will try to invade into the surrounding host tissue. Debridement of biofilm in a 
wound cannot be guaranteed, and neither can a wound area be made completely 
sterile. Hence there will always be some small clusters of biofilm or planktonic cells 
present, even with the most careful debridement of a wound. Demonstrating that 
some of these dressings are indeed effective against planktonic growth and early 
biofilm formation could help to provide evidence of how they can help a wound to 
heal, to the extent that the patient/host is able to ’kick-start’ the normal healing 
process and eliminate the bacterial infection.  
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3.1 Introduction 
The deleterious effects of microbes in wounds have been recognized for many 
years, and it is becoming more widely recognised that bacteria do not exist simply 
as solitary cells, but as communal organisms. The presence of biofilm is becoming 
increasingly recognised by clinicians as a primary cause of delayed wound healing 
and wound infection. Consequently, this type of wound is both detrimental to the 
patient, as well as a major drain on health budgets. 
The cost to the NHS of wound care is substantial (as explained in more detail 
Chapter 1.12) due to the length of time wounds can exist. The Government’s 
Quality, Innovation, Productivity and Prevention agenda 2012, focused on reducing 
harm and expenditure in wound care, especially around pressure ulcer formation, 
estimated to cost over £140,000 per case. A quicker healing wound reduces the 
need for more dressings and nursing care (Harding et al, 2001). The primary 
wound contact dressing can have an extremely important effect on a wound and 
ultimately on the cost of patient care. Most modern dressings have been developed 
to incorporate an element of moisture retention to the wound, in keeping with 
Winter’s theory on moist wound healing (Bryan, 2004). 
The addition of antimicrobial agents to wound dressings continues to be used to 
reduce the risk of wound infection, yet the presence of protective mechanisms 
adopted by biofilm bacteria means it is much more difficult to penetrate through this 
defence and reduce increasing wound chronicity (examples of some of the 
dressings used today are found in Appendix 10). The in vitro simulated chronic 
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wound model developed and discussed in Chapter 2, has now been used to 
evaluate current wound dressings containing antimicrobials, including silver, iodine 
and polyhexamethylene biguanide to demonstrate how effective they were against 
prevention and removal of a bacterial infection. 
 
3.2 Control dressings chosen for the wound model study 
3.2.1 Gauze 
Gauze, originally made from silk, has been produced for centuries (Daunton et al., 
2012). By the early 20th century it was developed with substances such as 
petroleum jelly (Pinnegar and Pinnegar, 1986). More commonly made today from 
open weave cotton or viscose, these dressings often resulted in trauma to the 
healing epidermis at dressing changes (Jones, 2005). Gauze is now often used as 
a primary dressing beneath many of the medical dressings produced, or as a 
secondary dressing helping to hold some antimicrobials in place (Blome-Eberwein 
et al., 2009). Some modern dressings have been designed using gauze 
impregnated with an antimicrobial and claim success in reducing the polymicrobial 
burden (Motta et al., 2004). Consequently, gauze (Systagenix, Gatwick,UK) was 
chosen as one of the non-antimicrobial wounds dressings included in this study.   
3.2.2 A non-silver Hydrofiber® dressing (NSHD) 
Another non-antimicrobial control dressing is NSHD, (AQUACEL®, ConvaTec, 
Deeside, UK) which is composed of sodium carboxymethyl cellulose fibres that 
form a gel on contact with fluid. It is produced as flat non-woven pads and may be 
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applied to exuding lesions or granulating wounds. This dressing was chosen as a 
second non-antimicrobial dressing for direct comparison to two silver containing 
Hydrofiber dressings and as a comparison with the gauze control. A literature 
review by Barnea et al., (2004) has suggested that patients treated with this 
dressing experienced significantly less pain and a rapid rate of epithelialisation. 
The dressing has been shown to remain in place for 7 days, which was a lower 
frequency of changes than most dressings, and hence was more cost effective 
(Armstrong et al., 1997). 
 
3.3 Silver antimicrobial dressings chosen for the wound 
model study 
3.3.1 Silver Dressings 
Silver is a well-known antimicrobial. It has existed in the metallic form for 
thousands of years for use in vessels, and as a covering for surfaces to protect 
against infection (Rovee et al, 2003). However, in the metallic (or elemental) form 
silver cannot kill bacteria as it is un-reactive. It is in the positive, ionic form that 
silver demonstrates more effectiveness against microbes (Demling and Desanti, 
2001). When exposed to aqueous environments, silver ions can become detached 
rapidly from their respective salts (e.g. silver sulphate, silver chloride). Elemental 
silver needs to form an intermediate stage, usually silver oxide, which dissociates 
to form silver ions. This can occur when exposed to air or fluid. Silver ions are 
thought to be transported into the cell and cause disruption of the cell’s energy 
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production by binding to proteins and interfering with enzyme function and cell 
replication (Lansdown, 2002).  
There have been Cochrane reviews performed on the widespread use of silver 
dressings. Two reviews, one by Bergin et al., (2006) and another by Storm-
Versloot  (2010), concluded that there was insufficient clinical trial evidence, 
despite the widespread use of silver, to evaluate its effectiveness. Neither could 
they determine cost effectiveness or establish whether silver-containing dressings 
or topical agents promoted wound healing or prevented wound infection. In 2011 a 
review by Toy et al., stated that there was emerging but not conclusive evidence of 
antimicrobial efficacy, with silver type dressings, because there are limited large, 
well-designed random controlled trials. Despite this apparent lack of absolute 
evidence, there are many dressings available containing antimicrobials including 
silver, that are used to manage a wide range of wounds. Below are the list of those 
chosen for the study. 
3.3.2 A silver containing Hydrofiber dressing – SCHD 
SCHD (AQUACEL Ag, ConvaTec Deeside, UK) has been designed for exuding 
wounds, as it combines Hydrofiber Technology with the antimicrobial action of ionic 
silver (1.2% w/w). In the Cochrane review of Storm-Versloot, 2006, the conclusion 
was that of the six trials of silver-containing dressings, there was only one that 
showed a significant difference in healing times associated with diabetic foot ulcers 
(Jude et al., 2007), and the dressing used was AQUACEL® Ag. Research has been 
performed upon this dressing using planktonic bacteria to show the sequestering 
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and antibacterial effect (Newman et al., 2006), and also various studies on its 
effect on biofilm (Percival et al., 2007) and in clinical trials (Caruso et al., 2004). 
The primary reason for including this dressing was to compare it to the newer next-
generation antimicrobial silver dressing as described below. 
3.3.3 A next-generation antimicrobial dressing - NGAD 
Termed as a next generation antimicrobial dressings ( AQUACEL Ag+ Extra™, 
ConvaTec, Deeside, UK), this dressing claims to be nine times stronger and to 
have up to 39% greater absorbency than its predecessor (ConvaTec.com). This 
dressing is also a carboxymethylcellulose dressing with 1.2% ionic silver, but unlike 
the SCHD, it is designed with two dimensional sets of fibres in layers of the 
Hydrofiber. The theory of the mode of action is that, upon contact with a fluid, the 
Hydrofiber forms a gel that surrounds the layers of fibres. The action of the gel still 
allows the dressings to lock in the exudate and fill the wound bed, and the two-
dimensional fibres give strength to the dressing, for easier removal from a wound. 
A combination of a metal chelator to help sequester divalent metal ions found in 
biofilm structure, a surfactant and pH control to help ionic silver move more rapidly, 
are all combined in this dressing (Metcalf et al., 2016), to aid in the disruption of 
biofilm and allow the action of the silver to have greater effect. 
3.3.4 A cellulose ethyl sulphonate fibre silver dressing - CES-SD 
To compare the effect of gelling fibre dressings, another fibre dressing 
DURAFIBER◊ Ag (Smith & Nephew, Hull, UK) was included in the study.  This 
dressing is composed of cellulose fibres combined with cellulose ethyl sulphonate 
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fibres, to form a non-woven dressing that forms a clear gel on contact with fluid. 
This dressing is designed for exudating wounds, to help maintain appropriate 
moisture levels, to help facilitate healing (Forlee et al., 2014). It contains ionic silver 
as an antimicrobial, to prevent or reduce infection, which it claims starts to kill 
bacteria within 30 minutes of contact, and to sustain antimicrobial activity for up to 
7 days (Bullough et al., 2015). 
3.3.5 An alginate carboxymethylcellulose nylon silver dressing – 
ACN-SD 
Fibrous wound dressings have the potential problem of shedding fibres. To prevent 
this Silvercel® Non-Adherent (Johnson & Johnson, Wokingham, UK) has been 
designed with a perforated outer layer of ethylene methyl acrylate, which it claims 
prevents the inner fibres from sticking to the wound (Wounds International, 2012). 
Alginate, a derivate of seaweed has been used to treat wounds as dressings for 
just over 30 years. The high absorption is achieved via strong hydrophilic gel 
formation. Alginate, on its own, is a natural wound dressing and as such the gel 
can be rinsed away by irrigation with saline. The holes in the ACN-SD perforated 
outer layer allow fluid to seep through and be absorbed by a pad composed of a 
high G (guluronic acid) calcium alginate, carboxymethylcellulose, and silver coated 
nylon fibres. This type of dressing is suited to wounds that produce a lot of exudate 
(Clarke, 2012). 
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3.3.6 A nanocrystalline silver dressing NC-SD 
This is a five layered high-density polyethylene mesh dressing, coated with 
nanocrystalline silver (Acticoat 7TM, Smith & Nephew, Hull, UK).  The coating is 
performed using a vapour deposition process and the layers are welded together. 
The nanocrystals measure 15 nanometres across and are between 30 and 50 
atoms, and form a lattice structure resulting in a high energy, meta-stable form of 
elemental silver (Dunn, 2004). This type of dressing requires constant moisture for 
the oxidation process to take place and release the silver cations (Kostenko et al., 
2010), it should therefore suit an exudating wound (www.smith-nephew.com 
accessed 10/11/16). The manufacturers suggest that a constant moist environment 
helps to release a constant flow of silver ions for up to seven days, but that the 
dressing must not dry out, and recommends moistening the dressing with sterile 
water.  
3.4 Other non-silver antimicrobial dressings chosen for the 
wound model study 
3.4.1  A Polyhexamethyl biguanidine dressing - PHMBD 
A PHMB dressing (Suprasorb® X+PHMB, Activa Health Ltd/Lohmann-Rauscher, 
Burton on Trent, UK.) was included in this study. PHMB, sometimes called 
polyhexamide, is a polymer which exerts little toxicity. It has been used for over 60 
years as an antiseptic, and has been used in contact lens solutions, and to sanitise 
swimming pools (Moore et al., 2007). 
  
145 
 
PHMB works by binding to the bacterial cell membrane. As an antimicrobial, it is 
thought to cause complex reactions in the bacterial cell wall, which allows entry of 
the PHMB, reducing wall strength (Hübner et al., 2010). It causes fluidity and 
permeability of the outer membrane, releasing lipopolysaccharides and hence 
causes cell death (Gilbert et al., 1990). 
3.4.2  A Cadexomer iodine dressing - CID 
IodoflexTM is part of a range of Cadexomer iodine dressings (Smith & Nephew, 
Hull, Uk). Iodine is thought to be antimicrobial by causing disruption of the protein 
and nucleic acid structure and its synthesis (Rutala et al., 2008). Cadexomer iodine 
is classed as an iodophor, as it contains iodine complexed with a solubilising 
agent. This is a water-soluble modified starch polymer containing 0.9% iodine 
(w/w) and is produced by the reaction of dextrin with epichlorhydrin coupled with 
ion-exchange groups and iodine. CID consists of cadexomer iodine paste 
incorporating sterile, beads 0.1- 0.3 mm in diameter. The dressing is presented as 
a paste between two layers of a gauze fabric. The theory behind its action is that 
when placed in an aqueous environment the beads take up liquid and swell. As 
they swell the beads release the iodine.  
3.5 Aims and Objectives 
Due to the work already performed (Chapter 2), it was evident that clusters of 
bacteria were observed after 3 hours and biofilm growth was visible within 6 hours.. 
Studies of the biofilm growth on the meat model had already been performed at 24, 
48 and 72 hours, viewed qualitatively and quantified statistically. It was therefore 
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decided that similar time points should be used to perform tests on the 
antimicrobial dressings chosen, in order to compare with the model.           
The specific objectives proposed were: 
 To grow biofilm on the wound model beneath the selection of test 
dressings and view at 3, 6, 12, 24, 48, and 72 hours by LM and SEM  
 To grow biofilm beneath test dressings and view at 24 and 48 hours by 
TEM and CLSM 
 The following would be used as test dressings 
o A gauze control 
o A non silver Hydrofiber 
o A silver containing Hydrofiber 
o A silver containing ‘next generation’ Hydrofiber 
o A silver containing cellulose ethyl sulphonate fibre 
o A silver containing alginate with carboxymethylcellulose  
o A nanocrystalline silver polythene mesh 
o A polyhexamethyl biguanidine cellulose 
o A cadexomer iodine 
 
3.6 Materials and Methods 
P.aeruginosa and S.s aureus were grown to the exponential point (as in 2.3.2) and 
a 1:10 dilution was prepared from each culture in sterile Tryptone Soya Broth 
(TSB). 0.4μ Polyethylene Terephthalate (PET) track-etched membrane cell culture 
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inserts were placed inside the wells of 6 well culture plates. On the inside film 
surface of each insert was placed a thin slice (3mm) of meat cut from a piece of 
sterile back bacon using a sterile number 8 (13mm diameter) cork borer. 50 µls of 
each culture was mixed then pipetted onto the surface of the meat to give a mixed 
culture.  
A smaller sterile number 7 (11mm diameter) cork borer was used to cut out pieces 
of dressings into discs, one for each insert. 5 minutes after applying the bacteria, a 
dressing disc (treated per manufacturer’s instructions) was placed on top of each 
piece of meat in the inserts and flattened gently down, so that the dressing was in 
full contact with the culture and tissue (meat) surface (Figure 3.1).  
 
 
Figure 3.1: Preparing a meat model with dressing  
A dressing disc (D) placed on top piece of a larger disc of meat (M) in an insert (IN) in a 
well (W) and flattened gently, so that the dressing was in full contact with the meat 
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The outer well area of each insert was filled with 2-3 ml of TSB broth until the insert 
was about to float. The plates were incubated with gentle agitation on a flatbed 
mini orbital shaker (50 rpm), at 37C for 3, 6, 12, 24, 48 or 72 hours. For the longer 
time periods of 24, 48 and 72 hours, each morning the TSB culture was topped up 
in the well outside the insert. After each time was ended the models were prepared 
for examination.  
Models for examination by Confocal Laser Scanning Microscopy (CLSM) were 
removed from the wells at selected time points (24 and 48 hours). These samples 
were rinsed gently in sterile distilled water, and then stained with BacLightTM 
Viability Kit and viewed on a Leica TSC SP2 DM IRE2 Confocal Laser Scanning 
Microscope as described in 2.3.14. Samples were examined and images taken.  
Samples to be prepared for Light Microscopy (LM), Transmission Electron 
Microscopy (TEM) and Scanning Electron Microscopy (SEM) at each time point 
had the remaining TSB fluid removed by pipette from the outer well area and 
replaced with 2.5% v/v glutaraldehyde in TSB. This fixative solution was also 
added into the insert, to gently flood the inside but not disturb the meat/dressing 
model in-situ. This was then left for 24 hours at 4C before it was gently replaced 
by RK buffer (as per 2.3.17) (Figure 3.2; Figure 3.3). 
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Figure 3.2: A meat model with gauze dressing after 12 hours of growth 
Model sat in an insert within a well of a clean plate with remnants of TSB culture, ready for 
fixation and processing 
 
 
 
 
 
Figure 3.3: A meat model with NSHD after 24 hours of growth 
Meat with dressing in an insert within a well of a clean plate, with remnants of TSB culture  
 
For SEM specimens, the RK buffer was carefully pipetted from the outside and 
inside of the insert, with as much excess fluid as possible removed from inside the 
insert. The meat/dressing model was lifted out of the insert, and placed back into 
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the well of a clean plate. The model was viewed under a stereo-microscope and 
the dressing carefully removed and placed in an adjacent well.  
 
Figure 3.4: Gauze on meat model viewed under a stereo microscope 
The left image shows the gauze on the meat after 12 hours growth, with the dressing in 
place. Gauze was carefully removed from the model ready for the addition of agar (right 
image) bar 1mm 
Representative pictures of the meat before and after dressing removal are shown 
in Figure 3.4 (gauze) and Figure 3.5 (NSHD). 
 
 
 
Figure 3.5: NSHD on meat model viewed under a stereo microscope 
The left image shows the gauze on the meat after 12 hours growth, with the dressing in 
place. Gauze was carefully removed from the model ready for the addition of agar (right 
image) bar 1mm 
 
Both meat and dressings were processed in-situ for SEM (Figure 3.6). 
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Figure 3.6: Meat and dressings processed in-situ for SEM  
Once processed, samples were placed on to self adhesive carbon tabs which were stuck 
to aluminium SEM stubs, ready for sputter coating and SEM examination 
 
For the LM and TEM culture plates a 3% w/v Agarose solution was prepared and 
allowed to cool but not set. The RK buffer was carefully pipetted from the outside 
and inside of the inserts and as much excess fluid as possible was removed. The 
slice of meat was carefully removed and the base placed on the absorbent material 
to remove excess fluid. Using fine-forceps the meat was carefully tilted and the 
base finely coated with a thin layer of tissue marking dye, using an orange stick, 
before placing back on to the absorbent tissues for a few minutes to absorb the 
excess ink. The dye would help to distinguish the base from the biofilm surface 
after processing, to aid correct embedding. Under a stereo microscope the 
dressing was carefully removed from each model. Whilst still fluid, the agar solution 
was gently poured inside a watch-glass, taking care not to include bubbles, and the 
meat was placed into the agar biofilm side down, but not touching the base of the 
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glass. The agar was allowed to start to set, before more agar was poured over to 
totally cover the meat (Figure 3.7).  
 
 
Figure 3.7: Agar models – meat set in an agar surround 
Meat models were placed in a watch glass and carefully covered with agar which was 
allowed to set. Models were then  processed for LM and TEM 
 
This whole model was left until set then removed from the watch-glass and placed 
in 2.5% v/v glutaraldehyde in RK buffer. This was allowed to fix for 24 hours at 
room temperature before processing for LM or TEM. For TEM, a punch biopsy was 
performed from the centre of 24 and 48 hour models for each dressing, using a 
6mm Stiefel biopsy punch, and pieces processed for TEM. Sections were cut and 
stained as per section 2.3.5 (TEM) and 2.3.6 (LM). 
Growth with all dressings was for 3, 6, 12, 24, 48 and 72 hours. Imaging was taken 
at all times for paraffin wax sectioning. SEM was performed on all hours and 
relevant imaging taken. TEM and CLSM imaging was performed on 24 and 48 hour 
models.  
Growth beneath the dressings, at 24, 48 and 72 hours, was confirmed 
quantitatively by taking LM images at x4 magnification and measuring the area of 
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biofilm using Image J software. Two-sample t-tests and Analysis of Variance 
(ANOVA) statistical tests were conducted using Minitab 17 software to compare 
the means of biofilm areas remaining on the LM models.   
 
3.7 Results 
3.7.1 3-6 hour dressing treated models 
There was little bacterial growth seen by histological examination in any of the 
dressing treated models, all of which had a similar appearance in the 3 – 6 hour 
growth phase at LM, although some had occasional dressing fibres (Figure 3.8 ) 
which had remained stuck to the surface.  
 
 
 
Figure 3.8: 6 hour ACN-SD model by LM with fibres 
Occasional dressing fibres were visualised (black arrows) which had remained stuck to the 
surface of the tissue (x4) 
 
The meat model beneath the NC-SD appeared to have intermittent layers of black 
deposition on the surface (Figure 3.9).  
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Figure 3.9: The tissue beneath the 6 hour NC-SD stained with silver 
It appeared to have intermittent layers of black deposition on the surface  
(black arrows) (x4) 
 
 
There was little difference in the dressings when viewed by SEM, apart from the 
CID, where crystals were present amongst the cadexomer beads appearing almost 
as spikes. These had the characteristic appearance of iodine crystals. (Figures 
3.10-3.13). 
 
 
 
Figure 3.10: 3 hour CID treated model by SEM  
Iodine crystals could be seen as dark patches on and within the  cadexomer beads 
(arrows)  
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Figure  3.11: 3 hour CID treated model with iodine crystals by SEM  
At higher magnifications the structure of the crystals could be seen amongst the 
cadexomer beads appearing almost as spikes  
 
 
 
 
Figure 3.12: 6 hour CID treated model examined by SEM  
After 6 hours only a few dark patches of iodine crystals could be seen (x50) 
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Figure 3.13: 6 hour CID treated model by SEM showing a lack of iodine  
The iodine crystals were almost depleted (white arrow) and possible biofilm was noted 
(green arrow) (x500) 
 
 
3.7.2 12 hour dressing treated models  
Incubation for 12 hours showed an increase in the presence of bacteria in the 
gauze control model (Figure 3.14) but very little in the Hydrofiber dressings 
tested(Figure 3.15) or the PHMBD.  
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Figure 3.14: Biofilm growth beneath gauze at 12 hours by LM 
There was an expected increase in the presence of bacteria in the gauze control model 
(green arrow) (x4) 
 
 
 
Figure  3.15: 12 hour NGAD showing no visible growth by LM 
The suface of the tissue showed no bacterial growth (x10)  
 
The gauze appeared to have a higher content of biofilm growth on its surface at 
SEM (Figure 3.16), with a few of the fibres attached to the surface. SEM of the 
NSHD showed evidence of some gelling property of the colloid fibres (Figure 3.17). 
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Figure  3.16: SEM of 12 hour gauze dressing surface 
The gauze appeared to have bacterial growth at 12 hours between its fibres (x20) 
 
 
 
 
Figure 3.17: SEM of 12 hour NSHD with slight gelling of fibres 
NHSD showed evidence of some gelling property of the colloid fibres (x100) 
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The surface of the tissue under NSHD had several of the looser fibres from the 
dressing stuck to the surface, although the central area was clearer of these fibres 
(Figure 3.18).  
 
 
Figure 3.18: The surface of the tissue below the 12 hour SCHD  
Several of the looser fibres from the dressing stuck to the surface, although the central 
area was clearer of these fibres (x50) 
 
The CES-SD model had a scattering of growth across the whole surface by 12 
hours (Figure 3.19). 
 
 
Figure  3.19: The 12 hour CES-SD by LM 
This model had a scattering of growth across the whole surface by 12 hours (x2) 
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The 12 hour NC-SD model had surface deposition of silver on LM, similar to the 6 
hour model. Between these patches of silver, however, there was an appearance 
of an increase in the presence of bacterial growth (Figure 3.20).  
 
 
Figure  3.20: The 12 hour NC-SD model with more silver deposition 
Surface deposition of silver, similar to the 6 hour model. There was an appearance of an 
increase in biofilm growth between patches of silver (black arrows) (x4) 
 
 
The CID model had no iodine crystals remaining on the surface and there were 
groups of bacteria around the beads. Occasionally these formed sheets or mats, 
similar to those found on the surface of the nutrient fluid above coverslip growth in 
2.4.8 (Figure 3.21; Figure 3.22). 
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Figure  3.21: Tissue surface and cadexomer beads of CID at 12 hours by SEM 
Top left – the surface of the tissue was covered with a scattering of beads on the surface 
but no iodine crystals (x50) 
Top right -  Cadexomer beads were covered in possible biofilm growth (x500) 
Lower left – individual cadexomer beads were shown to have a layer of debris and 
possible biofilm wrapped around them (x2000) 
Lower right -  Biofilm ‘mats’ between cadexomer beads, which appeared similar to biofilm 
surface growth in 2.4.8 – Figure 2.14 (x4300) 
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Figure  3.22: 12 hour CID with cadexomer beads and growth 
CID at 12 hours had bacterial growth around the beads and on the surface of the tissue 
(x2) 
 
3.7.1 24 hour dressing treated models 
24 hour incubation showed a marked difference between the dressings. The 
bacterial growth beneath the gauze was easily visualised with LM as an almost 
continuous layer (Figure 3.23), and bacteria and EPS were evident with SEM 
(Figure 3.24). 
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Figure  3.23: The 24 hour gauze with a continuous layer of biofilm by LM 
24 hour incubation showed bacterial growth, visualised with LM as an almost continuous 
layer (x10) 
 
 
 
Figure  3.24: 24 hour gauze model with SEM with areas of biofilm 
Bacteria in EPS were evident on the surface (x100) 
 
The NSHD control model had a few small groups of bacteria remaining on the 
surface of the tissue (Figure 3.25) which were also present with SEM (Figure 3.26).  
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Figure  3.25: The 24 hour NSHD model by LM 
A few small groups of bacteria remained on the surface of the tissue (x4) 
 
 
 
Figure  3.26: The 24 hour NSHD tissue surface by SEM 
A few small groups of bacteria were present with SEM (white arrows) (x100) 
 
The dressing showed further swelling of the fibres and bacteria were trapped within 
them (Figure 3.27).  
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Figure  3.27: The 24 hour NSHD by SEM 
Further swelling of the fibres. Swelling of fibres is designed to enable the trapping of 
bacteria within them (x200) 
 
The SCHD and NGAD had very few visible bacteria when viewed with LM (SCHD 
shown in Figure 3.28), although the occasional cluster of bacteria was present on 
SEM (Figure 3.29) and TEM (Figure 3.30) with the SCHD, with apparent 
extracellular polymeric substance (EPS).  
 
 
Figure  3.28: The 24 hour SCHD by LM 
The surface of the tissue appeared to have very few visible bacteria (x4) 
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Figure  3.29: The 24 hour SCHD by SEM showing occasional bacterial clusters 
The occasional cluster of bacteria present on SEM and the occasional small fibre (x200) 
 
 
 
Figure  3.30: The 24 hour SCHD by TEM with bacterial clusters 
The occasional cluster of bacteria was present also on TEM models (x 2500) 
 
Closer inspection of the bacteria by TEM showed that many were disrupted (Figure 
3.31).  
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Figure 3.31: Bacteria being disrupted in the 24 hour SCHD by TEM 
The occasional cluster of bacteria was present but closer inspection showed many of the 
bacteria were disrupted (x 40k) 
 
The NGAD model had a few bacteria present, but by viewing with TEM it could be 
seen that these bacteria were planktonic and not surrounded with EPS (Figure  
3.32). 
 
 
Figure 3.32: The 24 hour NGAD with virtually clean surfaces by TEM 
A few bacteria present, but by viewing with TEM it could be seen that these bacteria were 
planktonic and not surrounded with EPS (white arrow) (x2500) 
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CLSM also demonstrated a few small clusters on the SCHD (Figure 3.33) but not 
on the NGAD (Figure3.34).  
 
 
 
Figure  3.33: CLSM of the 24 hour SCHD tissue surface  
A few small clusters were present on the tissue beneath 24 hour SCHD staining green 
(live bacteria), with a combination of red and yellow representing dying bacteria (x40) 
 
 
 
Figure  3.34: CLSM 24 hour NGAD tissue surface with no biofilm 
No visible biofilm was present on the tissue beneath 24 hour NGAD, only the occasional 
planktonic cell was present, some live (green), some dead (red)(x80) 
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The fibres of the Hydrofiber dressings were seen to gel and sequester bacteria 
within them on SEM (Figure 3.35). 
 
 
 
Figure  3.35: The sequestering effect of 24 hour Hydrofiber dressings  
Fibres of the Hydrofiber dressings could be seen beginning to swell and sequester 
bacteria (x500) 
 
The LM of the CES-SD model showed a layer of bacteria with occasional groups 
(Figure 3.36).  
 
 
Figure  3.36: The 24 hour CES-SD model by LM 
A layer of bacteria was observed across the tissue surface with occasional groups  of 
bacterial biofilm (x4) 
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The dressing contained a few bacterial clusters visible within it with SEM (Figure 
3.37), and fibres were again left on the surface of the tissue with bacterial groups 
amongst these (Figure 3.38). 
 
 
Figure  3.37: The 24 hour CES-SD with bacteria 
A few bacterial growths were matted within the dessing (white arrows) (x100) 
 
 
 
Figure  3.38: The 24 hour CES-SD tissue surface by SEM 
Fibres were again left on the surface of the tissue with bacterial groups amongst these 
(x200) 
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CLSM imaging showed areas of live bacteria in groups around fibres, with minimal 
dead staining (Figure 3.39). 
 
 
 
Figure  3.39: CLSM imaging of 24 hour CES-SD and tissue surface 
Areas of live bacteria were found around fibres (left) and biofilm on the tissue surface 
(right) , with mainly live bacteria (green) and minimal dead staining of bacteria present 
(red) (x40) 
 
 
A few small groups were present on the surface of the ACN-SD model (Figure 
3.40) but much of the area appeared to be free of bacteria with LM. There was a 
similar appearance with SEM (Figure 3.41) and TEM (Figure 3.42).  
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Figure  3.40: 24 hour ACN-SD model by LM 
A few small groups were present on the surface of the tissue, but much of the area 
appeared to be free of bacteria when viewed by LM (x4) 
 
 
 
 
Figure  3.41: SEM 24 hour ACN-SD tissue surface by SEM 
Much of the area appeared to be free of bacteria, similar to the LM (x100) 
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Figure  3.42: TEM 24 hour ACN-SD tissue surface (x100) 
Only a few bacteria seen on the tissue surface with only the occasional possible EPS  
 
Bacteria could be seen within the fibres of the dressing and a minimal amount on 
the outer dressing surface (Figure 3.43). CLSM images of the tissue showed the 
presence of bacterial clumps within with live and some dead staining (Figure 3.44)
 
Figure  3.43: 24 hour ACN-SD surface on SEM  
Bacteria could be seen within the fibres beneath the outer surface layer of the dressing 
(x200). 
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Figure  3.44: CLSM images of the tissue beneath the 24 hour ACN-SD  
A presence of bacterial clumps were found, with live bacteria visible (green) and some 
dead (red) (left x40, right x80) 
 
LM of NC-SD showed black areas of silver deposition on the surfaces much 
increased from the 12 hour appearance. Bacteria were present in a few places on 
the surface and groups of bacteria were present below the surface (Figure 3.45).  
 
 
Figure  3.45: LM of NC-SD treated model at 24 hours with darkening of the tissue 
surface 
Areas of silver deposition were increased (black arrows). Bacteria were still present in a 
few places on the surface and groups of bacteria were present in the tissue below the 
surface (green arrows) (x4) 
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The layers of silver and bacterial groups could be seen with TEM, some of the 
bacteria were encased in extrapolymeric substance (EPS) (Figure 3.46; 3.47).  
 
Figure  3.46: TEM of 24 hour NC-SD with silver deposition 
Layers of silver were present as thin black lines with bacterial groups beneath (x2500) 
 
 
 
Figure  3.47: Biofilm under the NC-SD at 24 hours by TEM (x6000) 
Biofilm was found on the tissue surface showing bacteria encased in EPS  
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SEM of the tissue surface showed the impression of the dressing structure in some 
areas, with minimal bacteria where the dressing made contact with the tissue. 
Where there was no dressing contact, bacteria were present in the form of biofilm 
(Figure 3.48; Figure 3.49).  
 
 
Figure 3.48: 24 hour NC-SD tissue surface by SEM 
The impression of the dressing was seen in some areas of the tissue surface with lack of 
bacteria (white arrow). Other areas contained biofilm where there was a lack of dressing 
contact (black arrow) (x200) 
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Figure 3.49: 24 hour NC-SD SEM biofilm on tissue surface 
Where the dressing was not in contact with the tissue, a mixture of both bacteria was 
present (x10k) 
 
The surface and lower fibre layers of the dressing were coated with bacteria 
(Figure 3.50).  
 
Figure 3.50: The surface and lower fibre layers of the NC-SD at 24 hours 
Dressings were coated with bacteria on the surface and also into the dressing structure 
(x20) 
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CLSM of the tissue and the dressing showed the presence of many live bacteria 
(Figure 3.51). 
 
 
Figure 3.51: CLSM at 24 hours of the NC-SD and tissue 
Live bacteria present on the NC-SD (left x40) and on the tissue (right x80) below 24 hour 
NC-SD, showing the presence of many live bacteria in the form of biofilm 
 
PHMBD at 24 hours had few bacteria observed under LM with only the occasional 
small group or thin layer of bacteria (Figure 3.52). 
 
 
 
Figue 3.52: PHMBD treated model at 24 hours with few bacteria apparent in  
LM  
Only the occasional small group of bacteria were present on the surface between a few 
muscle fibres (x4)  
  
179 
 
This was mirrored in the SEM model (Figure 3.53; Figure 3.54) and TEM model 
(Figure 3.55). 
 
 
Figure 3.53: Tissue surface below the PHMBD at 24 hour by SEM  
A thin, flat layer of bacteria was present on the tissue surface (x2000) 
 
 
 
Figure 3.54: PHMBD surface at 24 hour SEM  
Bacteria did not appear to be attached/sequestered on to the dressing (x2000) 
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Figure 3.55: Tissue surface below the PHMBD at 24 hour by TEM  
A thin line of minimal bacteria was presnt with no apparent EPS (x2500) 
 
No EPS was seen on TEM. Areas of live and dead bacteria were present with 
CLSM (Figure 3.56).  
 
 
Figure 3.56: PHMBD tissue surface and dressing at 24 hours by CLSM  
A few live bacteria (green) present on the tissue surface (left) or the dressing (right) but 
most were dying (yellow and red) (x40) 
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The iodine crystals of the CID model were not present after 12 hours and in the 24 
hour model the bacterial growth appeared to have increased. Beads were present 
surrounded by bacteria and EPS in LM, SEM and TEM imaging (Figure 3.57; 
Figure 3.58; Figure 3.59; Figure 3.60).  
 
 
Figure 3.57: The CID tissue surface at 24 hour by LM 
The model appeared to have an increase in bacteria. Beads (blue arrow) could be seen 
surrounded by biofilm (green arrow) on LM (x4) 
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Figure 3.58 The CID 24 hour model by SEM with cadexomer beads 
Most of the beads were enmeshed in biofilm (x500) 
 
 
 
Figure 3.59: An individual cadexomer bead from the 24 hour CID model by SEM 
Even the larger beads had biofilm attached and mats of biofilm in-between (x2000) 
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Figure 3.60: Biofilm growth in the CID 24 hour model by TEM 
Bacterial biofilm was seen between the beads (x2500) 
 
Imaging by CLSM also showed live bacteria between the beads (Figure 3.61). 
 
 
Figure 3.61: Imaging of cadexomer beads by CLSM of 24 hours 
CID showed live bacteria on and around the beads forming biofilm (x40) 
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3.7.2 48 Hour dressing treated models
In the 48 hour models, bacterial growth below the gauze was mainly continuous 
(Figure 3.62), with some areas slightly variable on the surface and some 
penetrating into the lower layers of muscle.  
 
Figure 3.62: The 48 hour gauze models with thick continuous growth by LM 
Bacterial growth below the gauze was mainly continuous (x4)  
 
 
This could also be seen in the TEM models where the bacteria were present in a 
thick layer containing EPS (Figure 3.63). 
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Figure 3.63: 48 hour growth beneath gauze viewed by TEM  
Bacteria in EPS was found in a thick layer upon the tissue surface (x2500) 
 
The gauze dressing was coated in a thick layer of biofilm when viewed with SEM 
(Figure 3.64).  
 
 
Figure 3.64: The 48 hour gauze dressing by SEM 
Dressings were coated in a thick layer of biofilm (x100) 
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The surface of the tissue, when viewed with SEM, was coated in a layer of biofilm 
so thick in most areas, that the tissue was not visible beneath it (Figure 3.65).  
 
 
Figure 3.65: 48 hour gauze tissue surface by SEM 
The tissue surface was coated in an almost continuous thick layer of biofilm such that it 
was difficult to see the tissue surface (x200) 
 
 
Statistical analysis (a two-sample t-test) of the means at 24 and 48 hour for gauze 
showed no significant difference (p= 0.063).  
The NSHD control model had small groups of bacteria remaining on the surface of 
the tissue (Figure 3.66), which was also seen on TEM (Figure 3.67) and SEM 
(Figure 3.68).  
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Figure 3.66: LM of 48 hour NSHD  
Small groups of bacteria remained on the surface of the tissue (x4) 
 
 
 
 
Figure 3.67: 48 hour NSHD by TEM 
Small groups of bacteria remained on the surface of the tissue with possible EPS (x2500) 
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Figure 3.68: The 48 hour NSHD by SEM including model edge 
Small groups of bacteria remaining on the surface of the tissue. Here the edge can be 
viewed on the lower part of the model, where the circular dressing did not cover the 
surface and thick biofilm was able to grow (x100)  
 
The dressing showed some bacteria sequestered within the gelled fibres under 
SEM (Figure 3.69). There was a significant difference (p=0.007) between the 
means at 24 and 48 hours. 
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Figure 3.69: The 48 hour NSHD with swelling of fibres 
Dressings showed fibres sequestering bacteria, with some groups of bacteria on the 
surface (x100) 
 
The SCHD with LM showed the occasional cluster of bacteria especially around a 
few fibres left on the surface of the tissue (Figure 3.70).  
 
Figure 3.70: SCHD at 48 hours by LM 
The occasional cluster of bacteria was present, especially around a few fibres left on the 
surface of the tissue (x4) 
 
A few fibres on the model surface visualised by SEM, gave a similar picture of 
bacteria attached to the fibres (Figure 3.71). TEM showed these groups to contain 
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possible EPS, but with few viable bacteria within it (Figure 3.72). The two-sample t-
test of the 24 and 48 hour means showed a significant difference (p=0.004). 
 
 
Figure 3.71: A few fibres on the 48 hour SCHD tissue surface 
Surfaces visualised by SEM, showed bacteria attached/sequestering into the fibres (x500)  
 
 
 
Figure 3.72: TEM 48 hour SCHD model surface 
This contained possible EPS, but with very few viable bacteria within it (x6000) 
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The NGAD model had minimal bacteria present under LM (Figure 3.73), and this 
was confirmed by TEM. The few bacteria present appeared to be disrupted with no 
viable nuclear material (Figure 3.74). 
 
 
Figure 3.73: The 48 hour NGAD model with clean surfaces below the agar 
Minimal bacteria was seen by LM. The surfaces appeared almost clean (x4) 
 
 
 
Figure 3.74: The 48 hour NGAD model by TEM 
TEM showed very few bacteria. Those present were mostly disrupted (x15k)  
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SEM models showed almost clean surfaces (Figure 3.75).  
 
 
Figure 3.75: 48 hour NGAD tissue surface by SEM 
SEM showed tissue surfaces which appeared to be clean of any biofilm growth (x500) 
 
The means showed no significant differences in 24 and 48 hours (p= 0.201). 
Viewing under CLSM the SCHD and NGAD showed very few viable bacteria 
present on the tissue surface, either live or dead. Similar results were obtained in 
the dressings. (Figure 3.76; Figure 3.77).  
 
  
193 
 
 
 
Figure 3.76: 48 hour SCHD tissue surface and dressing by CLSM 
Left - CLSM of tissue beneath SCHD showed no visible bacterial biofilm although a few 
live bacteria were noted (x40) 
Right - The dressings contained bacteria in both live (green) and dead (red) (x40) 
 
 
Figure 3.77: 48 hour CLSM of NGAD tissue surface and dressing by CLSM 
Left - Tissue beneath NGAD showed no visible bacterial biofilm (x40) 
Right - NGAD showed no visible bacterial biofilm and contained bacteria in both live, dying 
and dead (green, yellow and red) (x40) 
 
The CES-SD model had some groups of bacteria present in the lower layers of the 
tissue, with occasional surface groups of bacteria when viewed by LM (Figure 
3.78) and TEM (Figure 3.79).  
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Figure 3.78: CES-SD 48 hour model by LM 
Groups of bacteria were present as occasional surface groups (x4)  
 
 
 
 
Figure 3.79: 48 hour CES-SD hour model by TEM 
Groups of bacteria were present which appeared to be surrounded by EPS (x6000)  
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Under SEM the dressing contained a few bacterial growths, but the dressing fibres 
were so attached to the surface of the tissue that it was impossible to view the 
tissue surface in any of the samples (Figure 3.80). The 24 and 48 hour means 
were not significantly different (p=0.148).  
 
 
Figure 3.80: The CES-SD tissue surface at 48 hours by SEM 
CES-SD was so attached to the surface of the tissue that it was impossible to view the 
tissue below it (x100) 
 
 
Viewing by CLSM showed fibres, with live bacteria visible around them, with very 
few apparently dead (Figure 3.81).  
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Figure 3.81: CES-SD at 48 hour and tissue surface by CLSM  
Fibres, some coated with bacteria (left x80), mainly live but some dead, were found on the 
model surface,  and clusters of biofilm were found on the tissue surface (right x40) 
 
A few pockets or thin lines of bacteria were present on the surface of the ACN-SD 
model (Figure 3.82). Some dressing fibres remained, visible by LM, some of which 
showed release of silver into the immediate surrounding area (Figure 3.83).  
 
 
Figure 3.82: 48 hour ACN-SD model by LM 
A few pockets or thin lines of bacteria were present on the surface and some dressing 
fibres remained on one model (x4) 
  
197 
 
 
 
Figure 3.83: 48 hour ACN-SD fibres by LM 
A silver containing fibre shed from the 48 hour ACN-SD with small black dots of silver 
release (x100) 
 
This was a similar appearance with SEM (Figure 3.84), but TEM demonstrated that 
some of these small groups were viable biofilm (Figure 3.85). 
 
 
Figure 3.84: SEM 48 hour ACN-SD model 
A few pockets of bacteria were present with a few dressing fibres (x40) 
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Figure 3.85: TEM 48 hour ACN-SD model 
A few small groups of biofilm were found on the tissue surface (x6000) 
Some possible absorption of surface material could be seen within the fibres of the 
dressing (Figure 3.86). Statistical t-tests of this silver dressing found the means of 
biofilm areas of 24 and 48 hours not to be significantly different (p= 0.135).  
 
 
Figure 3.86: SEM 48 hour ACN-SD model  
Some possible absorption of surface material could be seen within the fibres of the 
dressing (x50) 
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There was a similar appearance with CLSM, demonstrating that some of these 
small groups were viable biofilm (Figure 3.87). 
 
 
Figure 3.87: CLSM 48 hour ACN-SD model  
A few pockets of bacteria were present on the tissue and the dressing surface 
 
LM of NC-SD showed silver deposition on the surfaces, with bacteria present in a 
few places on the surface and in the tissue layers below the surface (Figure 3.88).  
 
 
Figure 3.88: LM of NC-SD at 48 hours (x4)  
Silver deposition (black) on the surface and bacteria in the tissue layers below (arrows)  
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Some of these bacteria could be seen with TEM as viable dividing bacteria, 
surrounded by EPS, although there was some nuclear disruption (Figure 3.89).  
SEM of the NC-SD showed the surface and lower fibre layers of the dressing were 
coated with bacteria (Figure 3.90). 
 
 
Figure 3.89: TEM of NC-SD at 48 hours 
Dividing bacteria could be seen surrounded by EPS, but with some nuclear disruption 
(x6000) 
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Figure 3.90: NC-SD surface by SEM 
The surface and lower fibre layers of the dressing were coated with bacteria  
(x100) 
The tissue had patches of bacteria on the surface (Figure 3.91).  
 
Figure 3.91: SEM of NC-SD tissue surface at 48 hours  
The surface of the tissue had patches of bacteria upon it (left)(x2000) 
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There was no statistical significance (p=0.63) between the means at 24 and 48 
hours. CLSM demonstrated a few groups of live bacteria present in the tissue with 
very little evidence of dead bacteria (Figure 3.92). Similar results were shown with 
the dressing. 
 
 
 
Figure 3.92: CLSM demonstrated NC-SD and tissue at 48 hours 
 A few groups of possible biofilm was seen with more live bacteria than dead within them 
 
PHMBD showed bacteria apparent in LM as thin, continuous lines (Figure 3.93) but 
no clusters of bacteria were evident.  
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Figure 3.93: PHMBD at 48 hours by LM 
Occasional thin lines of bacteria were apparent on the surface in LM (x4)  
 
This was confirmed with SEM which showed a thin layer of planktonic bacteria on 
the surface of the tissue and the dressing respectively (Figure 3.94; Figure 3.95).  
 
Figure 3.94: SEM of 48 hour PHMBD tissue surface 
Single bacteria were present on the surface of the tissue (x2000) 
 
  
204 
 
 
 
Figure 3.95: SEM of 48 hour PHMBD surface 
Thin layers of single bacteria were present on the surface of the dressing (x2000) 
This was a similar appearance in the TEM sample (Figure 3.96) such that there 
was no significant difference in the 24 and 48 hour samples (p= 0.079). 
 
Figure 3.96 TEM of 48 hour PHMBD model surface 
A thin layer of bacteria was found on the surface of the tissue (x2500) 
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CLSM showed what appeared to be some planktonic cells in the tissue and the 
dressing, and groups of cells which appeared to be dying (Figure 3.97; Figure 
3.98). 
 
 
Figure 3.97: Tissue surface under 48 hour PHMBD with CLSM  
Planktonic cells were present on the tissue with groups of cells which appear to be dying 
(yellow and red) 
 
 
 
 
Figure 3.98: 48 hour PHMBD surface with CLSM  
Bacteria attached to the dressing which appeared to be dying (yellow and red) 
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The CID model at 48 hours demonstrated an increase in the bacteria and biofilm 
growth in the apparent absence of iodine. Beads were present surrounded by 
bacteria and EPS in LM, and SEM images respectively (Figure 3.99; Figure 3.100). 
 
 
Figure 3.99: The CID sample at 48 hours by LM 
Bacteria and biofilm growth were apparent. Beads were present surrounded by bacteria 
and EPS (x4) 
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Figure 3.100: The 48 hour CID sample with beads by SEM 
Beads were surrounded by bacteria in biofilm and the biofilm extended to the tissue layer 
below(x500) 
 
Beads were present surrounded by bacteria and EPS with TEM and CLSM 
 
Figure 3.101:  TEM and CLSM of 48 hour CID showing biofilm around the beads 
Beads were covered in a layer of biofilm viewed by TEM (left, x2500) and CLSM (right, 
x40) showed this biofilm to contain mainly live bacteria 
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The cadexomer beads were clearly visible within a thick layer of biofilm, with live 
bacteria within it. Minimal dead bacteria were present (Figure 3.101).No significant 
difference (p=0.256) was shown in the 24 and 48 hour samples. 
 
3.7.3 72 hour dressing treated models 
Gauze control models had a variable thickness of biofilm on the surface, 
sometimes appearing in peaks by LM. In some areas biofilm appeared to have 
been removed. Where the gauze dressing had remained stuck to the specimen, 
biofilm was found to be growing within it (Figure 3.102).  
 
 
 
Figure 3.102: 72 hour gauze control models  
There was a variable thickness of biofilm on the surface. In some areas biofilm appeared 
to have been removed (left, x2). Gauze was occasionally stuck to the specimen with 
biofilm growing within it (right, x4) 
 
 
SEM revealed a layer of thick biofilm on the tissue surface, and a gauze dressing 
covered in biofilm (Figure 3.103).  
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Figure 3.103: SEM of 72 hour gauze model surface and dressing 
A thick layer of biofilm covered the tissue surface and was covering the whole dressing 
(right, x100) 
 
Statistical analysis at 48 and 72 hours found there to be no significant difference 
(p=0.552), but comparisons at 24 and 72 hour were significantly different 
(p=0.011). Using a one-way ANOVA test, a Tukey Pairwise comparison also 
showed similar results. The amount of bacterial growth on the surface of the model 
dressed with gauze was found to gradually decrease between 24 and 72 hours 
(Figure 3.104). The difference between the area of biofilm at 24 and 72 hours was 
statistically significant (p=0.022), but not between 24 and 48 hours, or between 48 
and 72 hours. 
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Figure 3.104: Interval plot and Tukey plot of 24 - 72 hour Gauze models  
An interval plot demonstrated how the biofilm growth decreased over time, possibly 
due to debridement of the gauze. Although the 24 and 72 hours pooled standard 
deviations overlap slightly in this figure they were statistically different (p=0.022) 
A Tukey plot showed that with the gauze biofilm growth only the 24 and 72 hour 
differences was statistically significant 
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Bacterial growth on models of NSHD controls had increased, with areas of 
continuous staining of biofilm on the surface by LM (Figure 3.105), which were 
visible with SEM (Figure 3.106).  
 
 
Figure 3.105: Increased growth on models of 72 hour NSHD controls  
Occasional clusters of bacteria were beginning to form (arrows) (x4) 
 
 
 
Figure 3.106: SEM of 72 hour NSHD tissue surface by SEM 
SEM showed increased bacterial growth on the surface of samples with small clusters of 
biofilm appearing (x500) 
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The 72 hour growth was significantly less than the 48 hour growth by Tukey 
pairwise comparison (p=0.005) and with the t-test (p=0.052). The 24 and 72 hour 
comparison were found not to be of significant difference (p=0.230), and the mean 
grouping showed the 24 and 72 hours to be similar (Figure 3.107). 
 
 
 
Figure 3.107a: Interval plot of 24 - 72 hour NSHD models 
Although not containing an antimicrobial, growth was shown to decrease at 72 hours. This 
was likely due to the dressing sequestering the bacteria  
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Figure 3.107b:Tukey plot of 24 - 72 hour NSHD models 
72 hour growth was significantly less than the 48 hour growth by Tukey pairwise 
comparison (p=0.005), but the 24 and 72 hours were similar (p=0.230) 
 
The SCHD showed a similar picture with LM to the 48 hour model with occasional 
clusters of bacteria and a few fibres on the surface of the tissue (Figure 3.108). 
 
Figure 3.108: SCHD at 72 hours by LM with fibres and beginnings of growth 
Occasional clusters of bacteria were present (green arrows) and a few fibres (black 
arrows) on the surface of the tissue (x4) 
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A few fibres on the model surface visualised by SEM, gave a similar picture to the 
LM, with attached bacteria amongst them (Figure 3.109).  
 
 
Figure 3.109: The SCHD tissue surface at 72 hours by SEM 
A few fibres on the model surface were visualised by SEM, with sequestered bacteria 
amongst them (x3000) 
 
The analysis showed the 72 hours not to be significantly different from the results 
of the 48 hour (p=0.160) or the 24 hour (p=0.544) models (Figure 3.110). 
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Figure 3.110: Interval plot and Tukey plot of 24- 72 hour growth of SCHD models 
No significant difference was found between the 24, 48 or 72 hour models 
The interval plot of the SCHD showed a similar pattern to the NSHD with reduced amounts 
of biofilm by 72 hours 
 
 
SCHD 72SCHD 48SCHD24
0.020
0.015
0.010
0.005
0.000
D
a
ta
Interval Plot of SCHD
95% CI for the Mean
The pooled standard deviation is used to calculate the intervals.
  
216 
 
The NGAD model showed almost clean surfaces on LM and SEM (Figure 3.111; 
Figure 3.112). 
 
 
Figure 3.111: The NGAD 72 hour model by LM 
The model showed surfaces clear of bacteria (X4) 
 
 
 
 
Figure 3.112: 72 hour SEM of central area of NGAD model after dressing removal  
SEM and showing the debriding and antimicrobial effect. NGAD models showed almost 
clean surfaces (left, x500) where the dressing was removed. At the edge where there was 
no dressing coverage the biofilm growth could be seen (right, x100) 
 
The analysis showed the 72 hours not to be significantly different from the results 
of the 48 hour (p=0.061) or the 24 hour (p=0.456) models (Figure 3.113).  
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Figure 3.113: Interval plot and Tukey plot of 24- 72 hour growth of NGAD models 
As with the SCHD the NGAD had no significant difference between the 24, 48 and 72 hour 
biofilm growth. An interval plot showed what little growth there was on the model was 
reduced by 72 hours 
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The 72 hour CES-SD samples had groups of bacteria present in the lower layers of 
tissue on each model with LM, combined with a black staining of silver from the 
dressing. On the surface, small clusters of bacteria and fibres were observed by 
LM (Figure 3.114) and SEM (Figure 3.115).  
 
 
Figure 3.114: 72 hour CES-SD model by LM (x4) 
On the surface, small clusters of bacteria and fibres were observed by LM (green arrows)  
 
 
 
 
Figure 3.115: 72 hour CES-SD surface and dressing by SEM 
On the surface, small clusters of bacteria and fibres were observed by SEM (left, x500) 
A few groups of biofilm were present in the dressing with a little fibre swelling (right, x100) 
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The dressing contained a few mats of biofilm and some probable swelling of the 
fibres. Two sample t-tests concluded that the 72hour growth was significantly 
different from both the 24 (p=0.007) and 48 hour (p=0.011) growths with a gradual 
decrease in the amount of biofilm area remaining on the surface. As with gauze, 
CES-SD had 24 and 48 hour showing similar grouping, with Tukey pairwise 
comparison, as did the 48 and 72 hour models (not significantly different), but the 
24 and 72 hour growth were found to be significantly different ( p=0.003).( (Figure 
3.116) 
 
 
Figure 3.116a: Interval plot of 24- 72 hour growth of CES-SD models 
The CES-SD 24 and 72 hour growth were significantly different, with a gradual decrease in 
the presence of biofilm.  
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Figure 3.116b: Tukey plot of 24- 72 hour growth of CES-SD models 
Growth gradually decreased so that the 24 and 72 hour growths were significantly different 
(p=0.003) 
 
 
A few thin lines of bacteria were present on the surface of the ACN-SD model 
(Figure 3.117), and a few dressing fibres were found in some sections 
 
 
Figure  3.117: 72 hour ACN-SD model by LM 
A few thin lines of bacteria were present on the tissue surface (arrows) (x4)  
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. A clear imprint of the dressing on the surface of the model was observed with 
SEM, the bacterial growth being present in the imprint of the holes of the dressing 
(Figure 3.118).  
 
 
Figure  3.118: 72 hour ACN-SD tissue surface by SEM 
An imprint of the dressing on the surface was observed with SEM, bacterial growth being 
present in the imprint of the holes as circular areas (x100) 
 
 
Statistical analysis of this silver dressing found the means of biofilm areas of 24, 48 
and 72 hours not to be significantly different (48 and 72 hour p=0.833; 24 and 72 
hour p=0.173) (Figure 3.119). 
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Figure 3.119: Interval plot and Tukey plot of 24- 72 hour growth of ACN-SD models 
Although an interval plot demonsrtated that there was a slight increase in growth from 24 - 
48 hours which remained almost unchanged, the 24, 48 and 72 hour growths were shown 
not to be significantly different by Tukey plot 
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72 hour growth areas under NC-SD showed bacteria present in a few places on 
the surface in thin layers and silver staining deep into the tissue layers below 
(Figure 3.120).  
 
 
Figure 3.120: 72 hour growth and silver deposition under NC-SD by LM 
Bacteria were present on the surface in thin layers on the surface and black silver staining  
was observed near the surface and deeper into the tissue (x4)  
 
SEM showed the surface of the dressing to be covered, and some of the holes to 
be blocked, by biofilm. The tissue was observed to have the pattern of the dressing 
imprinted on the surface and, where the uppermost surface of the dressings were 
not in contact with the tissue, there were pockets of bacterial on the surface (Figure 
3.121).  
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Figure 3.121: 72 hour growth under NC-SD and on the NC-SD by SEM 
The tissue was observed to have the pattern of the dressing on its surface which, when 
not in contact with the tissue, showed pockets of bacterial biofilm (left, x100) as can be 
seen in these images.. SEM showed the surface of the dressing to be covered and 
blocked by biofilm (right, x50) 
 
Statistical analysis showed the 24, 48 and 72 hour areas of bacterial growth not to 
be significantly different (48 and 72 hour p=0.390; 24 and 72 hour p= 0.201), and 
this was confirmed by Tukey Pairwise comparisons (Figure 3.122). The NC-SD 
treated models showed a gradual decrease in biofilm area over the 24 to 72 hour 
period.  
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Figure 3.122: Interval plot and Tukey plot of 24 - 72 hour growth of NC-SD models 
An intervals plot showed all 24, 48 and 72 hour growth to be similar even though it slightyly 
decreased over time. Tukey pairwise showed the 24, 48 and 72 hour areas of bacterial 
growth not to be significantly different (48 and 72 hour p=0.390; 24 and 72 hour p= 0.201) 
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PHMBD at 72 hours had few bacteria apparent in LM with only an occasional thin 
line of bacteria, but was mainly clean of bacterial growth (Figure 3.123).  
 
 
 
Figure 3.123: PHMBD at 72 hours by LM  
Only an occasional thin line of bacteria appeared on the surface of the tissue (x2) 
 
A similar appearance was observed on the SEM models of tissue, and minimal 
bacterial growth was present on dressings (Figure 3.124).  
 
 
 
Figure 3.124: PHMBD tissue surface and dressing surface at 72 hours by SEM 
The tissue (left, x100) and the dressing surface (right, x50) were mainly clear of bacterial 
growth 
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All the 24, 48 and 72 hour models were shown to be of no significant difference 
from each other (48 and 72 hour p=0.104; 24 and 72 hour p=0.771) (Figure 3.125). 
 
 
 
Figure 3.125: Interval plot and Tukey plot of 24- 72 hour growth on PHMBD models 
Although there was minimal growth and no significant difference between the hours the 
interval plot showed a similar pattern to the NSHD, SCHD and NGAD with a slight 
increase from24 to 48 hours then a decrease to 72 hours. This and a Tukey plot confirmed 
there was no significant difference (48 and 72 hour p=0.104; 24 and 72 hour p=0.771) 
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The CID model at 72 hours demonstrated a continued increase in the amount of 
bacteria and biofilm growth. Beads were still present and observed as surrounded 
by bacteria and EPS in LM and SEM imaging (Figure 3.126; Figure 3.127).  
 
 
Figure 3.126: LM of 72 hour CID showing thick growth 
Bacteria and biofilm growth was much increased with beads present surrounded by EPS 
(x4) 
 
 
 
Figure 3.127: 72 hour CID by SEM 
Many beads were present (left , x50) which were surrounded by bacteria and biofilm (right, 
x500) 
 
According to ANOVA and Tukey analysis there was no significant difference in the 
compared results for 24, 48 and 72 hours, although the two sample t-test showed 
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significant difference between the 24 and 72 hour growths (48 and 72 hour p= 
0.924; 24 and 72 hour p= 0.026) (Figure 3.128).  
 
 
 
Figure 3.128: Interval plot and Tukey plot of 24- 72 hour growth of CID 
CID biofilm was much thicker than in the other dressings and by interval plot and Tukey 
analysis there was no significant difference in the 24, 48 and 72 hours. The two sample t-
test showed significant difference between the 24 and 72 hour growths (48 and 72 hour p= 
0.924; 24 and 72 hour p= 0.026) 
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Dressings statistics were compared using a test for equal variances to look for 
consistency using standard deviations at each of the time points of 24, 48 and 72 
hours (Figure 3.129; 3.130; 3.131).  
 
 
Figure 3.129: At 24 hours, comparing tests for equal variances 
The least consistent dressings were NC-SD, then gauze and then CID 
The most consistent were the NGAD, then SCHD and then NSHD 
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Figure .130: At 48 hours, comparing tests for equal variances 
The least consistent dressings were CID, then gauze and then NC-SD 
The most consistent were the NGAD, then SCHD and then ACN-SD 
 
 
 
Figure 3.131: At 72 hours, comparing tests for equal variances  
The least consistent dressings were CID, then SCHD and then gauze  
The most consistent were the NGAD, then PHMBD, then CES-HD 
 
48hr CID
48hr PHMBD
48hr NC-SD
48hr ACN-SD
48hr CES-SD
48hr NGAD
48hrSCHD
48hr NSHD
48hr gauze
0.70.60.50.40.30.20.10.0
P-Value 0.000
P-Value 0.000
Multiple Comparisons
Levene’s Test
Test for Equal Variances: 48hr All Dressings
Multiple comparison intervals for the standard deviation, α = 0.05
If intervals do not overlap, the corresponding stdevs are significantly different.
72hr CID
72hr PHMBD
72hr NC-SD
72hr ACN-SD
72hr CES-SD
72hr NGAD
72hr SCHD
72hr NSHD
72hr gauze
0.200.150.100.050.00
P-Value 0.000
P-Value 0.000
Multiple Comparisons
Levene’s Test
Test for Equal Variances: 72hr All Dressings
Multiple comparison intervals for the standard deviation, α = 0.05
If intervals do not overlap, the corresponding stdevs are significantly different.
  
232 
 
The dressings varied in consistency with some performing better than others 
depending on the length of time the dressing was applied. Some, such as the 
NGAD and PHMBD were consistent throughout, others such as the gauze and CID 
were inconsistent. The gauze control, the best and the worst dressing from these 
results, at 72 hours, were compared (Figure 3.132). 
 
 
 
Figure 3.132: At 72 hours; the control, the best and the worst performing dressings’ 
tests for equal variances 
Compared to show the consistency, or otherwise, in the dressings’ performance. The 
NGAD variance is small so it performed consistently well. The CID had a large variance, 
performing generally poorly and inconsistently (more inconsistent than the gauze) 
 
Comparative interval plots were done to show the consistency and performance of 
the dressings on the same axes for a clearer comparison at each of 24, 48 and 72 
hours (Figure 3.133).  
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Individual standard deviations are used to calculate the intervals.
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Figure 3.133: Comparative interval plots of all dressings at 24, 48 and 72 hours 
Comparative interval plots demonstrating performance and consistency of dressings, seen 
on the same axes. (Individual standard deviations are used to calculate the intervals) 
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And finally a bar chart was created to compare the Tukey pairwise Comparison 
Means for each dressing at each of the 24, 48 and 72 hours, with dressings put in 
order of the amount of biofilm growth areas beneath dressings. Overall the best 
performing dressings were NGAD, PHMBD  ACN-SD, SCHD in this decreasing 
respective order, as shown in Figure 3.134. 
 
 
 
Figure 3.134: Bar Chart of Tukey pairwise Comparison Means of Biofilm Growth 
Areas Beneath Dressings  
This shows the worst performing (gauze and CID) to best performing in this study (PHMBD 
and NGAD). It also demonstrates that all the dressings except CID had a decrease in 
growth at 72 hours (green bar) 
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3.8 Discussion  
A greater understanding of biofilm presence in wounds is important in wound care 
for the effective treatment and improvement in patient management. Observations 
from this in vitro study demonstrated which dressings were the most effective 
against biofilm formation, when employed on moist tissue surfaces inoculated with 
S. aureus and P. aeruginosa and incubated from 3-72 hours. 
The results from the preliminary experiments on the bacteria, performed in 2.4.7, 
showed that bacteria were starting to form small clusters within 6 hours when 
viewed under SEM. When grown on the surfaces of the tissue models beneath 
dressings, this was very difficult to observe at the LM level, and even with SEM 
much of the growth was incorporated into the surface of the dressings. Whether 
the bacteria were alive was demonstrated in the later time points (e.g. 24-72 hours) 
using CLSM and BacLight staining following 24 and 48 hours of growth, and TEM. 
These overall observations highlight the importance of understanding wound 
dressing structure, which are used to help explain the results obtained throughout 
these studies.  
 
3.8.1 6 hour models 
It was apparent that within the first 6 hours little bacterial growth was observed 
under the NC-SD although, even within that time, some apparent deposition of 
silver was visible under the dressing (Figure 3.9). Similar silver deposition has 
been observed when this dressing was applied to human skin both in vitro (Walker 
et al., 2006) and in vivo (Trop et al., 2006). This would suggest that this dressing 
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does not have the capacity to maintain its silver content once in contact with 
moisture, which may result in excessive amounts being made available that can 
stain wound tissue and be deleterious to wound healing (Ahamed et al., 2008; 
Atiyeh et al., 2007). Further observations at these early time points showed that 
some of the dressings had several fibres left on the model surface (Figure 3.8). 
The other observation was that the CID samples showed a marked loss of iodine, 
with visible iodine crystals released from the cadexomer beads (Figures 3.10-3.13).  
 
3.8.2 12 hour models 
After 12 hours incubation, it was not surprising to see bacterial growth in the gauze 
control model, but there was hardly any growth visible within the other control 
dressing (NSHD). This was probably due to the differences in the respective 
dressing structures. Gauze is essentially 100% cellulose, having very little 
absorbency, due to the cellulose fibres being tightly bound to each other thus 
producing effectively ‘open’ spaces, which as demonstrated allow the bacteria to 
proliferate (Walker and Parsons 2010).  
On the other hand, the NSHD, and indeed all the Hydrofiber-based dressings, 
provide a much less tightly bound structure, and individual fibres can increase their 
thickness by ten-fold before being gelled with neighbouring fibres (Newman et al., 
2006). This gelling capacity also means that the bacteria which are present on the 
wound surface become sequestered within the gelled dressing, resulting in 
reduced bacterial growth (Walker et al., 2003).  
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A similar finding to the gauze, with respect to bacterial growth, was observed with 
the CES-SD, but this growth was more even and may be due to the inability of this 
dressing to gel and conform completely to the tissue surface. There was increased 
silver deposition evident with the NC-SD, as well as areas of increased bacterial 
growth, which may again be due to the relatively inflexible dressing material not 
allowing good intimate contact to take place.  
In the CID samples after 12 hours, no iodine crystals were visible. The CID 
contains 0.9% molecular iodine, physically bound to the cadexomer matrix of a 3-D 
cross-linked polysaccharide starch matrix. The product information for use 
provided (IFU, Smith & Nephew UK. product website) states that exudate is 
thought to cause the beads to swell and release iodine until an equilibrium is 
reached. Each time this equilibrium changes, the iodine will be released until it 
becomes depleted. At this point the dressing would need to be changed. 
Unfortunately, an exuding wound is in a constant state of producing fluid (similar to 
the model used) which may shift the equilibrium, exhausting all the iodine, 
potentially rapidly, if exudation is consistent. If exhausted by 6-12 hours, the 
dressing would have to be replaced on a highly frequent basis to be fully effective. 
If this occurred in a clinical setting, it would increase the expense in terms of 
dressings and patient visits.  
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3.8.3 24 hour models 
24 hour incubation showed a marked difference between the dressings. Due to the 
mesh-like structure acting as a support surface, the bacteria grew within the gauze 
to form a well-established biofilm, wrapping itself around the fibres and gradually 
filling the holes over time. The NSHD at 24 hours however was observed to have a 
few small groups of biofilm growth on the tissue surface, which is likely due to its 
ability to sequester bacteria within the gelled dressing, even though no 
antimicrobial agent is present (Walker et al., 2003). It was therefore expected that 
the silver-containing Hydrofiber dressings should be more efficient in eradicating 
the bacteria than this NSHD, having both a sequestering and antimicrobial effect. 
Both the SCHD and NGAD were even more effective at bacterial control at 24 
hours. The fibres were shown to sequester bacteria, and both had minimal 
amounts of bacteria remaining on the tissue sample that could be visualised by any 
of the microscopical methods, with the NGAD performing marginally better. The 
bacteria viewed by TEM were found occasionally as small clusters in the SCHD, 
but were observed to have poor structure and appeared to be internally disrupting. 
This would be comparable to the findings of the disruption of the nucleoid by the 
addition of silver nitrate to planktonic bacteria, as performed in Chapter 2.4.2. 
The CES-SD results for 24 hours presented fibres stuck to the tissue surface on 
most models, which impeded viewing of some of the SEM models. Although a 
stereo microscope was used to lift off the dressings, some of the fibres were 
difficult to remove from the moist surface of the tissue. Without the stereo 
microscope, the extent of the quantity of these fibres was difficult to visualise. This 
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dressing is designed for one-piece dressing removal due to dressing integrity, 
ensuring that there is no residue left (Barrett, 2012). The product Instructions For 
Use states that it may adhere to lightly exuding wounds, yet this model was 
provided with a constant supply of fluid, and raises the question of how much fluid 
has to be present for the fibres to being to gel. 
The ACN-SD at 24 hours also shed a few fibres, but these were minimal in 
comparison to the CES-SD. There was biofilm-like material within the small inner 
fibres of the dressings, below the outer coverings. There was presence of bacteria 
in patches on the tissue samples beneath these dressings. The outermost surface 
of this dressing has been designed to be a non-adherent layer of hydro-alginate to 
help reduce trauma and pain when removed (Gray, 2009). The silver ions should 
be released through the perforations of the non-adherent layer, from the silver-
coated nylon fibres. However, bacteria were managing to grow in these areas. The 
nylon fibres are amongst alginate fibres, and alginates have been demonstrated to 
swell to varying extents in the presence of fluid (Walker et al., 2006; Walker and 
Parsons, 2010). This would once again suggest the issues of contact with the 
tissue surface, where the openings in the weave of the dressing allowed bacteria to 
grow in the lack of contact, and a lack of sufficient quantity of silver release. It may 
also suggest that the alginate fibres swell and prevent the silver reaching the 
surface. 
The 24 hour NC-SD released silver, but in even more pronounced patches of silver 
deposition, which stained the surfaces of the models. There were groups of 
bacteria present on the surface, in-between these areas of silver deposition. 
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Metallic silver (elemental silver) is a neutral form of silver and is not an 
antimicrobial. It is only in the positively charged form (ionic silver) that it can 
release cations to bind to sites on bacterial cells, and hence become antimicrobial 
(Ovington, 2004). Nanocrystallline dressings require constant moisture for the 
oxidation process to take place and release the silver ions (Kostenko et al., 2010). 
They should therefore suit an exudating wound. It was possible that this silver 
technology, being nanocrystalline, was not releasing sufficient silver ions with 
which to kill the bacteria, and the bacterial load was beginning to increase to such 
an extent that biofilm was now beginning to form. Compared to the other 
antimicrobial dressings, the NC-SD was taking longer to initiate its antimicrobial 
effect, which could be detrimental to wound healing due to biofilm having the 
opportunity to begin to form. 
The PHMBD is recommended for light to moderately exuding wounds (Glover and 
Wicks, 2009), and those critically colonised and infected (Haemmerle et al., 2012), 
and claims to have a cooling and soothing effect with less wound pain (Kingsley et 
al., 2009). The theory of its action is to absorb exudate over the wound but to 
supply moisture to the drier parts of the wound edge, to promote hydration. At the 
same time, it releases the PHMB to kill the bacteria present. The bacteria were 
observed to be in thin lines beneath the dressing, with no apparent EPS by TEM. 
The quantity of bacteria on the surface was more visible on the SEM due to LM 
and TEM being only the equivalent of a representative thin slice across the 
surface. The bacteria were numerous but only in a flat layer, which would suggest 
that bacteria were present in a planktonic form, possibly surface attached, but not 
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as biofilm clusters. It would also suggest that the gap between the dressing and the 
tissue was minimal, only allowing bacteria to grow in the smallest of areas. 
CID beads, although not submersed in a fluid but in a moist environment, became 
pale within 24 hours, and the iodine was shown by SEM to have been apparently 
exhausted. This therefore showed that there was no visible antimicrobial remaining 
amongst the beads. The structure of the iodine-exhausted beads appeared to be 
acting in the same manner as the gauze, in that it was providing a support 
structure on which the bacterial biofilm could grow. 
 
3.8.4 48 hour models 
48 hour growth showed a variation in results in the dressings.  Beneath gauze 
dressings, the tissue was covered in a thick biofilm when viewed by SEM. The LM 
sections showed that in some areas the biofilm was thinner in appearance and this 
may have occurred when the gauze was removed by lifting it off the tissue surface. 
The gauze dressing viewed with SEM was coated thickly by the biofilm, so the 
mesh structure had slightly debrided the samples due to the biofilm being wrapped 
around it, demonstrating that even a basic dressing can have a debriding effect. 
The amount of growth was such that there was no significant difference between 
the mean growth areas of the 24 and 48 hour biofilm (p=0.063). 
The NSHD had a larger presence of bacteria than at 24 hours, but still had nothing 
like the quantity present in the gauze. Similarly, the SCHD had a slight increase in 
the presence of bacteria which were mainly seen in a few of the fibres remaining 
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on a few models. This increase was reflected in the statistical data with a 
significant difference ( NSHD p=0.007; SCHD p=0.004). 
The tissue beneath the NGAD appeared to be almost clean. Only a few bacteria 
were seen under the dressing at TEM and these did not appear to be viable 
bacteria from the structure. CLSM demonstrated that at 48 hours the tissue was 
free of clusters of bacteria and that the dressing contained what appeared to be 
individual live and dead bacteria, and there was no significant increase with 
statistical analysis (p=0.201). This observation would confirm that the dressing 
was, by this time point, sequestering the bacteria away from the tissue. It would 
also support the theory that the Hydrofiber component of the NGAD can debride 
wounds (Queen, 2010). Sibbald (2005) trialled a four week application of the 
SCHD and found it to have a desloughing action. NGAD consists of two layers of 
Hydrofiber stitch-bonded together to provide 50% more absorbency and 9-times 
greater strength than the SCHD (Bugedo et al., 2012). It also contains a metal 
chelator (EDTA), a surfactant (benzethonium chloride) and pH control. The clean 
tissue surfaces would appear to support the claims of this NGAD structure and 
formulation being improved upon compared to the SCHD. Recent studies on 
surfactants have shown the reduction in bacteria and biofilm with their use (Schultz 
et al., 2016). EDTA has been demonstrated to have antimicrobial activity and to be 
useful as an anti-biofilm agent (Percival et al. 2005; Al-Bakri et al., 2009). 
The structure of the CES-SD had not improved by 48 hours (p=0.148) and many 
fibres were still attached to the tissue surface. If the fibres had gelled more 
effectively, then the dressing may have been removed more easily. As such it was 
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virtually impossible to see the tissue surface by SEM, but what could be seen were 
groups of bacteria and possible biofilm around them. Some of the fibres viewed by 
CLSM confirmed this with evidence of growth around the fibres. The growth could 
be followed along individual fibres, which would again confirm that these fibres had 
still not gelled.  
Due to the outer covering of the ACN-SD it was more difficult to view the inner 
fibres. Only a few of these fibres were found attached to the tissue, showing that 
the dressing was mostly intact. The few fibres on the surface showed silver 
deposition, so these were likely to be nylon fibres that had been shed from the 
dressing. There was an increase in growth in the 48 hour ACN-SD, but it was not 
significantly different from the 24 hour growth (p= 0.135).  
The NC-SD growth at 24 and 48 hour was also of no significant difference 
(p=0.63), which would suggest that the silver ions were finally being released from 
the dressing by these time points. The mesh of the dressing is small but the 
surface, holes and lower fibres were coated with bacteria. The silver may have 
begun its antimicrobial effect at this point, but some bacteria were seen to be 
growing in the lower layers of the tissue.  
The PHMBD showed little change from the 24 hour results with thin layers still 
being present beneath the dressing. This once again showed a minimal gap 
between the dressing and the tissue due to its design, but it nonetheless 
demonstrated the presence of some bacteria remaining on the dressing when 
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removed. It did not appear to debride, which would be of concern if the bacteria 
were still viable when a dressing was removed from a wound. 
The CID had made no improvement from 24 to 48 hours, confirming that the 
antimicrobial agent, molecular iodine, had been exhausted. Bacteria were wrapped 
around and encasing the cadexomer beads, indicative of biofilm  formation, 
providing further evidence that the availability of molecular iodine had been 
exhausted. 
 
3.8.5 72 hour models 
72 hour growth showed a reduction in biofilm growth with all dressings, even the 
control dressings, except for the CID. These results were best demonstrated using 
statistical analysis. Pooled standard deviations were used to calculate interval plots 
and the pattern of growth compared for 24, 48 and 72 hours. These plots 
demonstrated the performance and consistency of the dressings,which could be 
seen on the same axes. The difference between the dressings was noted when the 
data of the ANOVA interval plots performed at each of the 24, 48 and 72 hour 
groupings were transferred into Figure 3.134. This figure shows the best and worst 
performing of the dressings according to the analysis. The following is the analysis 
of these statistical results. 
The gauze, CES-SD and the NC-SD-dressed models all had a similar pattern of 
growth. The amount of bacterial growth on the surface of the model dressed with 
gauze was found, surprisingly, to gradually decrease from 0.1519 ± 0.0687 mm2 to 
0.0785 ±  0.0391 mm2, between 24 and 72 hours (Figure 3.104). The difference 
  
245 
 
between the area of biofilm at 24 and 72 hours was statistically significant 
(p=0.022), but not between 24 and 48 hours, or between 48 and 72 hours. Gauze 
has been shown to have slower healing times compared to other dressings (Singh 
et al., 2004) likely due to it causing loss of moisture within a wound (Wu et al., 
1996). This drying out of a wound is contrary to the agreed principle of moist 
wound healing (Jones, 2005). The removal of gauze from a wound is often painful 
and can cause trauma, due to it sticking more to the wound than other dressings 
and creating a non-selective physical debridement (Daunton et al., 2012). This 
debridement effect could be the cause of the gradual decrease in biofilm area on 
these models, where the biofilm and bacteria had become wrapped around the 
lattice-type network of the dressing fibres, causing the drying gauze to pull off 
some of the biofilm. 
The CES-SD-treated models had similar patterns of growth to the gauze (Figure 
3.116), with a gradual decrease in the amount of biofilm area remaining on the 
surface from 0.04372 ± 0.02774 mm2 to 0.01253 ± 0.00472 mm2, between 24 and 
72 hours. As with gauze, CES-SD had 24 and 48 hour showing similar grouping, 
with Tukey pairwise comparison, as did the 48 and 72 hour models (not 
significantly different), but the 24 and 72 hour growth were found to be significantly 
different ( p=0.003). It would seem therefore that the models would have to be 
grown to 72 hours to show any significant reduction in biofilm growth using CES-
SD.  As expected from an interactive dressing (Byrne, 2014), the CES-SD was 
more effective than the gauze, as the overall quantity of the area of biofilm growth 
was smaller than that of the gauze in each instance. This CES-SD claims to form a 
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cohesive gel to keep the wound moist to aid healing and to release ionic silver as 
an antimicrobial (Bullough et al., 2015). The observation with this study, 
demonstrated the fibres of the CES-SD only showing some probable matting at 72 
hours (Figure 3.115). In almost all the CES-SD models there were fibres remaining 
stuck to the sample surfaces and bacteria were present in clusters. The shedding 
and sticking of the CES-SD fibres might suggest that the tissue was not kept moist 
enough by the dressing. However, all the models beneath the CES-SD were 
supplied with plenty of nutrient fluid. This would suggest that the fibres did not swell 
as much as the other dressing types such as the Hydrofibers, that the CES-SD did 
not absorb as much exudate, and that the structure of the dressing was not as 
cohesive as expected. Fibres remaining on a patient’s wound would have to be 
removed, which could cause discomfort and disturb granulation tissue formation 
(Seaman, 2002). 
The NC-SD -treated models followed a similar biofilm growth trend to the gauze 
and CES-SD, by showing a gradual decrease in biofilm area over the 24 to 72 hour 
period (Figure 3.122). The NC-SD resulted in comparative biofilm area means for 
all three times (p=0.386), and it also resulted in a lower quantity of growth 
compared to the gauze and CES-SD. The deeper tissue layers on the model were 
seen to contain dark areas of silver staining not seen in the other ionic silver 
dressing models. NC-SD claims to remain active for a minimum of 3 days 
(www.smith-nephew.com, 2016) and to have rapid and sustained bactericidal 
activity, due to the release of clusters of highly reactive silver cations from the 
nanocrystalline silver as it becomes moistened by exudate (Fong and Wood, 
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2006). This may help to reduce inflammation and promote healing. The amount of 
heavy silver staining present on the surfaces of the sections by LM and TEM was 
clearly visible. Although some clinical studies have stated that it is safe to use 
(Vlachou et al, 2007), and that no evidence has emerged of resistance or 
cytotoxicity to nanocrystalline silver (Dunn and Edwards-Jones, 2004), there are 
still reservations about the absorption of silver in the skin, and there have been 
reports of toxicity, recorded by checking the levels of silver in blood and urine (Trop 
et al., 2006).  
An in vitro study on the effects of silver on keratinocytes and fibroblasts showed 
silver to be highly toxic, with a similar toxic dose range to that of bacteria (Poon 
and Burd, 2004). Silver toxicity was found to cause 10% inhibition of bacteria at the 
lowest concentrations (6.25 x 10-4). Okkyoung et al., (2008) found inhibitions on 
growth by Ag+ ions, based on a prolonged microtiter assay, at about 0.5 mg/L Ag, t 
were 100%. A study on fibroblasts found their contraction rate in this NC-SD to be 
higher than SCHD and ACN-SD (Cochrane et al., 2006). This, therefore, may be of 
concern if wound healing cells are proliferating and trying to re-granulate and re-
epithelialize the wound. The NC-SD notably had a better performance in reducing 
bacterial growth between the later times of 48 and 72 hours, compared to the 24 
hour, which would be consistent with the slower release of the silver ions from the 
nanocrystalline silver compared to the ACN-SD, SCHD, and NGAD, ionic silver 
containing dressings. The disadvantage of this is that the bacteria appeared to 
have grown into the deeper layers of tissue by 48 hours and the dressing was 
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relying on the ability of the silver to penetrate these deeper layers to kill the 
bacteria (Lansdown, 2004). 
The gradual decrease in growth of bacteria and biofilm beneath the CES-SD and 
NC-SD could be a result of the gradual increase in the presence of silver. 
However, although the area of biofilm on the model from the gauze dressings was 
larger than any of the other dressing models, the fact that the gauze model had a 
decrease in growth area suggested that some of this decrease in the silver 
dressings, could have been due to debridement. 
The NSHD control, SCHD, NGAD, ACN-SD and PHMBD all had a similar pattern 
of a small area of growth, which increased slightly from 24 to 48 hours, then was 
decreased in area at 72 hours (Figure 3.107; Figure 3.110; Figure 3.113; Figure 
3.119; Figure 3.125). The NSHD control had the largest increase in growth area at 
48 hrs (which was significantly greater than at 24 hours (p=0.007), which was 
consistent with it not containing any form of antimicrobial, and the decrease at 72 
hours would be consistent with the claims of the fibres continuing to swell, and it 
sequestering and removing biofilm from the surface of the tissue (Bowler et al., 
1999; Jude et al., 2007). The decrease was such that the 72 hour growth was 
significantly less than the 48 hour growth by Tukey pairwise comparison (p=0.005), 
but the mean grouping showed the 24 and 72 hours to be similar (Figure 3.108).  
The prevention of bacterial biofilm growth with NSHD was greater than three of the 
antiseptic containing dressings at 48 hours (CES-SD, NC-SD, CID), and at 72 
hours was more effective than four (CES-SD, ACN-SD, NC-SD, CID). This could 
  
249 
 
be due to the surface of this type of dressing conforming to the shape of the 
surface of the model more than the other dressings, due to its structure and 
composition. Lack of conformation and non-adherence can create fluid-filled 
pockets where bacteria can proliferate under a dressing surface and begin to form 
biofilm (Quinn et al., 1985). Prevention of these pockets by dressing conformation 
would help to prevent biofilm growth. By sequestering, Hydrofiber dressings can 
immobilise bacteria within its gel-like structure (Walker et al., 2003). The ability of a 
dressing to retain bacteria away from the wound is thought to help infection control 
(Tachi et al., 2004) and debriding a wound will lower the bacterial burden (Sibbald, 
2005). This is especially important during dressing changes to prevent dispersal of 
bacteria (Bowler et al., 1999). The dressing is claimed to be easy to remove 
without causing pain or trauma (AQUACEL datacard, www.dressings.org). Results 
from clinical studies have indicated that patients managed with NSHD experienced 
significantly less pain and a rapid rate of epithelialization (Barnea et al., 2004). The 
dressing has been shown to remain in place for 7 days, which is a lower frequency 
of changes than most dressings, and hence is more cost-effective (Armstrong et 
al., 1997). This ability to form cohesive gels was observed in all the Hydrofiber 
dressings (NSHD, SCHD, NGAD) from 24 to 72 hours, showing the ability of this 
dressing to absorb fluid, and hence manage exudate (Williams, 1999).  
The addition of silver ions as an antimicrobial to this dressing in the form of the 
SCHD, improved its ability to keep bacterial growth to the third lowest level of the 
dressings in this study at all time points (no significant difference between 24, 48 
and 72 hours, as shown by Tukey plots (Figure 3.110). The newer NGAD showed 
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the least bacterial growth of all the dressings tested at all time points (again, no 
significant difference between 24, 48 and 72 hours, as shown by Tukey plots, 
Figure 3.113).  
Four dressings, SCHD and NGAD, ACN-SD and PHMBD, all had similar 24, 48 
and 72 hour grouping patterns with Tukey pairwise comparison when viewed by 
interval plots which were not significantly different (SCHD p=0.057; NGAD 
p=0.129; ACN-SD p=0.263; PHMBD p=0.068). ACN-SD, comprising of an outer 
layer of ethylene methyl acrylate, claims to overcome the problems of adherence 
and fibre shed, maintaining its structural integrity (Galea, 2015). Although the CES-
SD was found to shed the most fibres, there were a few fibres found on the surface 
of the ACN-SD meat models, visualised best by SEM. There also appeared to be 
pockets of bacteria forming in the holes of the outer dressing, which could 
conclude that the dressing did not conform completely to the surface of the tissue.  
Walker et al. (2003) studied the sequestration function of the NSHD compared to 
alginate dressings, with SEM. Using a technique of progressively lowering the 
temperature during processing for SEM, the study showed how the CMC fibres 
hydrated to form a cohesive gel, immobilising some of the bacteria within them, 
whereas alginate fibres were not fully hydrated and their rate of gel formation was 
slower. The alginates formed a patchwork of gelled areas and not a gelled matrix 
structure. TEM and CLSM demonstrated that these growths were of biofilm type 
with viable bacteria and EPS. 
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 Parsons et al., (2005) tested dressings in wound fluid and measured the levels of 
antimicrobial effect, silver content and release. ACN-SD was found to have a 
higher content of silver but a much lower release than NC-SD, and a comparable 
kill rate of bacteria in wound fluid (planktonic bacteria). The ACN-SD overall 
performance in this present study, in prevention of biofilm growth, was better than 
the NC-SD. During the practical work it was also noted that the tissue under the 
ACN-SD 72 hour models appeared to be shrunken when compared with the other 
dressings. The thickness of the tissue was checked for consistency and all images 
at x2 with LM at 72 hours showed a thickness average of 1.907 mm. The ACN-SD 
showed a mean thickness of 0.946 mm, demonstrating a possible shrinkage of the 
tissue beneath the dressing, compared to all the other dressings. This would 
suggest that the model was not kept as moist beneath the dressing. Models of 
timed growth were performed for several dressings in the same instance for 
comparison.  
The PHMBD performed marginally better than the SCHD at controlling biofilm 
formation, with no significant difference in the biofilm areas measured over the 24-
72 hours (48 and 72 hour p=0.104; 24 and 72 hour p=0.771). As a low risk 
antiseptic, PHMB is used in a variety of products such as swimming pool cleaners, 
contact lens cleaning solutions and cosmetics (Jones, L., and Senchyna, M., 
2007), and is considered safe and well tolerated (Gray et al., 2010), although a 
case of allergic reaction has been noted (Kautz et al., 2010). Its product guide does 
recommend removal of slough, and wound bed preparation before use, and 
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recommends treatment of the underlying condition to promote granulation and 
epithelialization in wound management.  
Any bacteria seen on the PHMBD models were usually in the presence of a thin 
line, and not as clusters of bacteria. A clinical study by Wild et al., (2010) found this 
dressing to be particularly comfortable for patients. They compared it with the 
SCHD used in this study and found both dressings to demonstrate both cleansing 
and debridement properties. The surface of the PHMBD is smooth and cold to the 
touch, and moist and remained relatively flat throughout the models when viewed 
by SEM. This smooth surface could have contributed to the bacteria being present 
as a thin layer. However there was no great number of bacteria observable on the 
dressing surface by SEM viewing. The PHMBD may have assisted in the 
prevention of the biofilm formation and, with the antiseptic effect of PHMB and the 
limited contact of the dressing interface, prevented the bacteria from forming in 
pockets beneath it, as in some of the other dressings. This meat model had a 
relatively flat surface by nature, with occasional indents on the surface. A wound 
surface with all its imperfections might not be so forgiving for a flat surfaced 
dressing.  
The CID had a different pattern of growth to any of the other dressings when 
examined by Tukey pairwise comparisons (Figure 3.128). The CID performed 
poorly in this study, with a continual increase in growth of biofilm, though there was 
no significant difference in biofilm formed between each time point (p=0.284). At 72 
hours the biofilm growth area for the CID was not dissimilar from the gauze 
dressing (0.07732 ± 0.05567 mm2 CID, 0.07847 ± 0.03908 m2 gauze).  It is claimed 
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to be antimicrobial and to remove slough and debris to clean the wound bed, and is 
recommended for use in wounds such as wet ulcers and diabetic foot ulcers (Smith 
& Nephew Professional products). The beads, which are said to absorb debris and 
remove it from the wound bed (Jones, 2000), were surrounded by a layer of biofilm 
at 24 hours which was visible by all microscopical methods, and stained mainly 
with the green-live stain when viewed by CLSM. The beads were not irrigated by 
the force of fluid added to the model, unlike the clinical setting where the data card 
suggests removal of the beads to ‘cleanse’ it (Iodoflex datacard, 
www.dressings.org). This would have been difficult to compare with the other 
dressings, as none of the other models were cleansed. This step was immaterial 
when the amount of biofilm growth was noted at 24 hours, as this amount of growth 
might have been present if this was a real wound.  
It is also suggested on the data card that the secondary carrier layer can be left in 
place when the dressing is applied to a wound. The carrier layers are made of 
gauze. From the results of this chapter, it has been shown that gauze allows 
bacteria to grow within its mesh. The inclusion of gauze as part of the dressing 
could allow the bacterial biofilm to obtain an even better hold in the wound. A more 
sequestering dressing might be more appropriate, as long it did not sequester the 
molecular iodine from the beads. But as visible iodine was found to last only up to 
12 hours in the CID, it might help to hold the iodine in situ a while longer. The 
dressing would have to be renewed regularly (e.g. every 12 hours), which is 
clinically unrealistic and would require a constant refreshed supply of molecular 
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iodine. Small amounts of iodine are relatively harmless, but iodine can be toxic to 
human cells and absorbed systemically from constant use (Grey, et al., 2002).  
The consistency of the performance (whether good or poor) of the different 
dressings was evident when a test for equal variances was performed for each 
time slot (Figure 3.129; Figure 3.130; Figure 3.131). The NGAD and the PHMBD 
behaved more consistently than the other dressings throughout. The NC-SD was 
consistent from 48 hours but not at 24 hours. This was probably due to the slower 
release of silver ions from this type of dressing (Heggers et al., 2005) needing the 
oxidation process to take place before it could release the silver ions into the model 
(Kostenko et al., 2010). Other dressings with silver ions rather than nanocrystalline, 
appeared to have a more controlled release of the silver and hence were 
consistent more quickly, especially in the earlier stages of growth. 
 
3.9 Conclusion 
In order for a dressing to be effective it should perform several functions. A 
dressing should help to control exudate levels whilst keeping a wound moist. The 
dressing should control the bacterial load (Sood et al., 2014), and perform some 
debridement by removing the bacteria, either physically by sequestering or 
antiseptically by silver, iodine, PHMB or some other chemical means that does not 
cause damage to the patient tissues and their overall health. .  
The best performing dressing in this study was the NGAD which presented almost 
clean surfaces on SEM, and this was confirmed by the statistical analysis. This 
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dressing contained silver ions, as with the SCHD, but claims to have extra 
absorbency and strength, and anti-biofilm formulation. This may have helped in 
sequestering bacteria to prevent their growth and spread and in debriding the 
model. This was especially noted in the images of the 48 and 72 hour models 
(Figures 3.75; Figure 3.112), but overall statistical analysis showed it had the least 
bacterial growth beneath all the dressings used. The worst performing was the 
CID. By 24 hours there was a large amount of biofilm growth around the 
cadexomer beads in all the models, with very little evidence of the presence of 
iodine. 
It was seen on physical removal of some dressings that there were differing 
degrees of debridement, and biofilm could be seen attached to the dressings 
removed, when viewed with SEM. Some dressings had absorbed some of the 
biofilm into their structure. This was particularly seen in the swelling of the 
Hydrofiber dressings. Unfortunately, it was not possible to perform TEM on the 
dressing alone to view the depth of absorption/sequestration, due to their structural 
nature not being conducive to TEM sectioning, as shown in the earlier chapter with 
bacterial growth on a gauze surface (Chapter 2.3.15). Some dressings left residual 
debris which in a wound may encourage colonisation and present an infection risk 
(Daunton et al., 2012). The CID relies on rinsing to remove the beads and debris 
from a wound. During the processing for SEM, despite gentle methods, one would 
expect the beads to be rinsed away by the washing steps in the processing, but 
they remained on the surface. The beads are 0.1-0.3 mm in diameter so may be 
difficult to remove by the naked eye. Lack of bead removal may therefore leave 
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biofilm bacteria on the surface of wound tissue in a clinical setting. In this study the 
CID was not an efficient dressing, and constant replacement would be neither cost-
effective, clinically realistic, nor a safe alternative compared to other dressings in 
this study. A clinical study on this dressing found it to reduce the bacterial 
bioburden and decrease the wound size, although none of the wounds completely 
healed over the 6 week study (Schwartz et al. 2013). The dressing was changed in 
the study between 5 and 16 times per week, which this study shows would be 
necessary due to the constant exhaustion of the iodine. 
The observations made, from the results of biofilm growth beneath the various 
dressings in this chapter, highlight the importance of dressing selection to deal with 
the increasing likelihood of bacterial and/or biofilm presence in wounds. 
Considering the fact that the dressings were placed upon planktonic bacteria, the 
dressings should have eliminated all bacterial growth and prevented biofilm 
formation beneath. The nature of the spread of the bacteria on this model was 
designed to ensure that some bacteria remained on the edges, outside the area of 
the dressing, to grow unimpeded. If the dressing leached its antibacterial contents 
immediately and into the surrounding area, all bacteria on the model would have 
been killed. The speed with which bacteria grow (as shown in the graphs of 
chapter 2) is swift and their prevention depends on the ability of a dressing to 
release its antimicrobial and make it available at the dressing-wound interface. 
Even the smallest numbers of bacteria have the ability to multiply and form biofilm 
and possibly cause infection. Appropriate wound dressings should be selected 
following debridement and wound cleansing (Attinger et al., 2006). The cleansing 
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needs to be thorough, to remove as many bacteria as possible including planktonic 
and biofilm forms, before the selection of a dressing which should depend on the 
original status of the wound (Keast and Lindholm, 2012). The dressing should 
prevent biofilm formation. In this study the bacterial biofilm was seen to form at the 
edges of all the models where it was not protected from a dressing. This 
demonstrated that the original bacterial load had spread across the surface of the 
tissue as expected. This acted as a good control area for each dressing, and 
demonstrated that none of the dressings released its antiseptic properties into the 
surrounding tissue that was not in immediate contact with the dressing. This shows 
the importance of thorough cleansing, and that any dressings cover the whole area 
of a wound, including the peri-wound area, and ideally conform to a wounds’ 
shape.  
Dressings such as ACN-SD, although resulting in a low biofilm formation, allowed 
small pockets of bacterial growth to take place on the tissue surface, possibly due 
to limited intimate contact of the tissue with the dressing (Jones et al., 2004). In 
these pockets biofilm may develop and thrive. Similar results on an agar plate 
model were shown by Bowler et al. (2010). The model in this study was designed 
with a flat slice of meat, but the surface had the natural shape of the muscle with 
small indents and crevices to which an ideal dressing should be able to conform. 
These studies, in conjunction with other published data (Bowler et al., 2010; 
Walker and Parsons, 2010, Walker et al., 2011), suggest that dressing technology 
and construction may be important factors in determining the antimicrobial activity 
of dressings. Dressings have varied responses due to their technological 
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differences, including the antimicrobial type, content and mode of release (Parsons 
et al., 2005). 
Therefore from the above, it can be concluded that any dressings in this study 
which would appear to have absorbed biofilm away from the wound and deeper 
into the dressing would, in theory, be the better dressings of choice for a chronic 
wound. The best performing dressings, when comparing the bacteria and biofilm 
load, by measuring the area of these upon the surface of the model designed, were 
those of NGAD, PHMBD, ACN-SD, SCHD in this decreasing respective order as 
shown in the Figure 3.134. The most cost-effective dressings would be those 
demonstrating effectiveness against biofilm formation, removal of any biofilm and 
bacteria present, and consistency in performance. 
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Chapter 4 
General Discussion 
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4.1 Discussion  
Wound healing is a normal biological process in the human body, and is usually 
described in four phases: haemostasis, inflammation, proliferation, and re-
epithelialization. Patient factors can affect this healing process such as 
oxygenation, infection, age, stress, diabetes, obesity, medications, alcoholism, 
smoking, and nutrition (Guo and DiPietro, 2010). A good wound clinic works to 
combine many aspects of a wound on a patient, taking the individual’s health into 
consideration. Their vascular system, immune system and general health can all 
contribute to the chronicity of a wound and how quickly it might heal. Unless a 
wound is managed well from the start, an infection can take hold, and patients who 
go home with an apparently healing wound can return to clinic with it chronically 
infected. In a recent clinical study by Hurlow et al. (2016) it was found that 75% of 
wound beds contained microbial biofilms, despite the use of some currently 
available antiseptic wound dressings and an effort to provide biofilm-based wound 
care. In wound management, biofilm must now be considered as a major barrier to 
healing. Biofilm-based wound care is of great importance in the clinical setting, and 
it is important that strategies suppress, and ideally remove biofilm, and they should 
not damage host defences and healing mechanisms. An established principle of 
phase-adapted wound management is the acronym T.I.M.E. (Schultz et al, 2003). 
It takes four fundamental principles of wound treatment together: Tissue 
management (including debridement), Infection control, Moisture balance (i.e., 
exudate control) and the prevention of damage to the edge of a wound. If a wound 
becomes colonized or infected it can become chronic (i.e., non-healing) and 
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practitioners need to select an appropriate antimicrobial dressing (Schultz et al., 
2003). Several factors influence the choice of a dressing. Some of these are: 
management of exudate, maintaining a moist environment, microbial 
sequestration, promoting debridement, conforming to maintain intimal contact with 
a wound surface, and using an antimicrobial to manage colonization or infection 
that does not harm the patient or irritate the wound. 
Exudate management is relevant to the quality of life of a patient (Dowsett, 2008). 
The World Union of Wound Healing Societies positioning document (2016) states 
that from the patient’s perspective, the key issues are that a wound dressing 
remains in place, prevents leakage, reduces odour and reduces pain (Chadwick 
and Rastogi, 2016).   A lack of control of exudate can lead to problems of 
continuous dressing changes which leads to increased costs (White and Cutting, 
2006). Exudate production is the natural result of inflammation in the early stages 
of a wound. It is when a wound becomes chronic that exudate increases to a level 
that can be detrimental to its healing, especially in the presence of colonisation or 
infection. The management of exudate by the use of advanced wound dressings 
can depend on the level of exudate and whether the wound is infected (White and 
Cutting, 2006). In cases of severe exudate production, compression therapy, 
negative pressure wound therapy, and some form of elevation and exercise may 
be recommended, especially for lower limb wounds (Kunimoto et al., 2001). 
However, there are limitations to these methods, especially in wounds with delicate 
peri-wound edges. Most commercial wound dressings are categorised as suitable 
for light, moderate or heavily exuding wounds and claim they work by absorption of 
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exudate, absorption then gelling, or absorption then retention away from the 
wound, and most can also be used to a degree with some form of applied 
compression. What matters is that as well as removing the exudate, the dressing 
should keep the wound moist (Winter, 1962; Bishop et al., 2003; McColl et al., 
2007). Maintaining a moist wound facilitates the wound healing processes. It helps 
to increase the rate of breakdown of dead tissue (autolytic debridement), prevents 
cell death by dehydration, encourages the formation of blood vessels (Field and 
Kernstein, 1994), and increases the rate of epithelialisation (Jones et al., 2006). 
The principle of moist wound healing is that it mimics the interstitial fluid which 
would normally be maintained by the integrity of the skin (Bishop et al., 2003). 
Maintaining a moist wound environment, whilst controlling exudate, is a delicate 
balance. Too much moisture and maceration of the wound edge may occur; too 
little and the wound will not heal in a timely manner, with the possibility of scarring. 
The best way to create the best balance of moisture in a wound is to assess it 
regularly and ensure the dressing in use suits the wound, i.e., ensure that it is 
removing sufficient moisture without the wound drying out (Yarwood-Ross, 2013). 
Regular assessment is also useful in checking that the wound has not become 
infected. If this is suspected, an antimicrobial dressing should be employed.  
The addition of antimicrobial agents, such as silver, iodine or PHMB, to wound 
dressings continues to be used to reduce the risk of wound infection (Landis, 
2008), yet the presence of protective mechanisms adopted by biofilm 
microorganisms means it is much more difficult for antimicrobial agents to 
penetrate through this defence (Serralta et al., 2001), and to manage wound 
  
263 
 
chronicity (Cowan, 2011). The decision of which antimicrobial dressing to employ 
can be based on verifiable observation or experience rather than theory, and is 
often focused on treating a critically colonized wound and infection (Landis, 2008) 
where  the balance in a wound is tipped in favour of the bacteria and wound 
healing is compromised. Knowing what to look for is a skill, combining both clinical 
knowledge and wound healing expertise (Sibbald et al., 2006). The mere addition 
of silver to a non-antimicrobial dressing may not necessarily be sufficient to ensure 
antimicrobial activity (Walker et al., 2011). The use of ionic silver as an 
antimicrobial agent is generally accepted and it has been used in a variety of 
topical preparations including solutions (silver nitrate), creams (silver sulphadizine), 
and silver-containing dressings (as used in the present study). Topical preparations 
are still in use today in some clinics, as a cautery agent, or for the use in the 
removal of hypergranulation tissue (British Columbia Provincial Nursing Skin and 
Wound Committee, 2013). What is in question for clinicians is partly the type of 
antimicrobial used, but mainly the characteristic of the dressing and its delivery of 
the antimicrobial to the wound (Mooney et al., 2006). If a dressing cannot make the 
antimicrobial agent available effectively then its presence is pointless. Also, it 
should not release an antimicrobial too freely. Any substance that is freely soluble 
may present toxicity issues, or may be diluted in an exuding wound and thus the 
effective concentration will be reduced. 
Ideally a wound dressing should facilitate autolytic debridement by the host's own 
proteolytic enzymes and phagocytic cells (Panuncialman and Falanga, 2009). 
Some research has even suggested that low levels of bacteria may contribute to 
  
264 
 
wound healing by producing proteolytic enzymes that help wound debridement and 
stimulate the release of proteases from neutrophils (Ovington, 2003). The problem 
with not having a clean wound, however, is that it risks becoming colonized or 
chronically infected, especially in those patients that are immunocompromised, and 
the ultimate goal of treatment of a wound is that it does not become infected and 
heals (American Diabetes Association, 1999). Assisted debridement aids the host 
wound healing process (Schultz, et al., 2003), but the presence of biofilm in the 
wound bed can cause a chronic inflammatory reaction, resulting in more damage 
to the surrounding host tissues (Hurlow and Bowler. 2009). No method, as yet, 
completely debrides a wound, so biofilm would still be likely to exist (Young, 2011). 
Absorption would be a better process, as the biofilm would be sequestered out of 
the wound and into closer contact with any antimicrobial a dressing might contain, 
thus reducing  microbial and biofilm burden, allowing the wound to attempt to heal.  
Some of the ideal characteristics of a dressing are that it is strong, comfortable and 
conformable (Jones et al., 2006). The structure should be such that it can be 
removed easily and painlessly from a wound. Dressings that fail to do so can 
increase the risk of colonization or infection, especially if they leave residual debris 
in a wound (Daunton et al., 2012). Dressing structure can be a contributory factor 
in the effectiveness of a dressing making available its antimicrobial contents, but 
conformability is also essential as it helps reduce pockets where microbial 
proliferation can occur, or dead spaces where excess fluid can build up and cause 
tissue maceration (Walker and Parsons, 2010). To maximise antimicrobial potency, 
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a dressing should conform to each wounds’ unique topography by so-called 
intimate contact, in order to maximise exposure.  
The observations made, from the results of biofilm growth beneath the various 
dressings examined in this study, highlight the importance of dressing selection to 
deal with the increasing likelihood of microbial and/or biofilm presence in wounds. 
The preliminary work of fixation was necessary to examine the best fixation 
methods for bacteria, in order to obtain high quality images at the ultrastructural 
level. One of the best methods of preservation of bacteria for TEM studies is cryo-
substitution, as shown in Hobot et al. (1985) with striking images of the detailed 
structure of the planktonic bacterium. However, this method uses expensive 
equipment that is not always accessible, and is limited to use by other 
microscopical techniques. The fixation and processing methods used in this study 
allowed the high quality images to be produced. The Agar Sandwich model 
developed in this study allows the researcher to view the whole biofilm without 
loss, at the LM and TEM level. The biofilm was encased and protected from the 
harsh processing methods in LM and TEM. The models were then available for LM 
histological staining techniques, as well as the possibility of the paraffin block being 
used for techniques such as immunocytochemistry and in situ hybridisation.  
Studying the planktonic growth at the earlier stages by SEM demonstrated that 
bacteria begin to form a biofilm within a few hours. This has been suggested in 
other in vitro studies where, during the first few hours clusters or microcolonies of 
cells form as the consequence of individual cells twitching across the surface 
towards each other (O’Toole et al., 2000). This demonstrated that biofilm can form 
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early on a suitable surface, so clinically a wound must be kept clean from the start 
to reduce the risk of microbial attachment, contamination, colonization or infection. 
It has also been shown that biofilm can re-form daily, likely within hours, so regular 
debridement is important (O’Toole et al., 2000; Wolcott et al., 2009; Metcalf and 
Bowler, 2013). These early time-point studies guided selection of the time slots at 
which the growth on the models would be staged.  
The examination of various surfaces allowed a choice of one which could provide a 
suitable surface to be used in all of the microscopy methods, without any 
noticeable artefactual processing damage. The model used for the growth of the 
biofilm was developed to mimic an exuding wound. The tissue and insert surface 
were continually supplied with nutrients to keep the surface moist, to examine 
whether the dressings could cope with a level of moisture typical of a chronic 
wound. 
As an in vitro model, examining the activity of dressings upon bacterial and biofilm 
growth, it performed consistently well as supported by statistical analyses. Various 
in vitro models have been designed for examining the anti-biofilm effect of 
dressings, and some are designed to examine specific attributes of a dressing, but 
this novel model was designed to be used for the variety of microscopical methods 
of LM, TEM, SEM and CLSM. Unlike many models it allowed bacteria to develop 
from planktonic cells, rather than placing a dressing upon already cultured biofilm. 
This allowed for the demonstration of how bacteria, if not eradicated from a wound, 
can find a way of re-colonizing the area if the antimicrobial and retention capability 
of a dressing are not adequate. The continuous supply of exudate demonstrated 
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how an antimicrobial agent can be diluted and exhausted if not in continual supply.. 
The limitations to any in vitro model, including this one, are that with an in vivo 
wound model the host’s biological processes are present. In vitro models allow 
biofilm to grow unimpeded by a host defence, and therefore dressings should in 
theory be less effective clinically. However, a recalcitrant wound is in a constantly 
repetitive inflammatory state and the host’s defence is not as effective, but rather 
can actually be damaging to its own tissue. Biofilm releases antigens which 
stimulate the production of antibodies from the host, but these antibodies will only 
respond to the surface antigens and will often fail to penetrate into the matrix of the 
biofilm and will cause host tissue damage (Davis et al., 2006). The host’s 
polymorphonucleocytes, in response to not being able to ingest biofilm, will release 
pro-inflammatory enzymes, proteases (e.g. matrix metalloproteinases and 
cytokines). This chronic inflammatory response unfortunately does not destroy the 
biofilm, but causes more damage to the surrounding host tissue (Hurlow and 
Bowler, 2009). Therefore, in vitro models have their use. By developing wound 
models, dressings can be examined without any biological variables which may 
present in a clinical environment and under controlled situations decisions can be 
made on which dressing is appropriate to different types of wound. 
Wet-to-dry gauze was traditionally used to dress wounds but is now considered to 
be disruptive to wound healing because this dressing is likely to allow wound tissue 
and or biofilm to grow into the dressing resulting in a atraumatic removal for the 
patient (Daunton,  et al., 2012). Hence it is no longer widely used in the UK (Jones 
et al., 2006). It does also not create an optimal moist environment, for which other 
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newer dressings have been designed. Gauze has still been used in some studies 
to compare with other dressings, and has always been shown to be less cost-
effective and detrimental to healing, with wounds showing up to 72% more healing 
with more advanced dressings (Harding et al., 2000; Daniels et al., 2001; Singh et 
al., 2004). The amount of biofilm production in the gauze wound model in this study 
showed that it acted as a bacterial support and did not prevent biofilm growth. 
The NSHD has been shown to be successful in the improving healing rates of 
wounds in in vivo studies (Hoekstra et al., 2002), and in clinical studies compared 
with gauze and alginates (Robinson, 2000; Foster, 2000). This agrees with the 
findings of the present study, where the NSHD performed better than the silver-
containing ACN-SD at the 24 and 72 hour stages. Ionic silver, as opposed to silver 
compounds (e.g. silver nitrate), has lower toxicity, and the use of ionic silver in the 
Hydrofiber dressing (SCHD) showed improved bacterial and biofilm removal in the 
model, as it has in numerous studies (O’Neil et al., 2003; Ip et al., 2006; Saba et 
al., 2009; Barnea et al., 2010; Harding et al., 2012), including in burn wound care 
(Caruso et al., 2004; Muangman et al., 2010). The introduction of NGAD, a relative 
newcomer to wound management in comparison to the other dressings, has been 
quickly followed with recent studies which have suggested that clinically the NGAD 
can facilitate wound healing (Woo et al., 2014; Harding et al, 2015; Walker et al., 
2015;  Kammerlander et al., 2015; Metcalf et al., 2016a; Metcalf et al., 2016b). The 
‘Extra’ element of the NGAD is in reference to its enhanced strength (two layers 
stitch-bonded in the Z-direction, and each layer stitch bonded in the XY-direction) 
compared to standard Hydrofiber dressings, as also found in AQUACEL Extra. 
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This extra strength has been studied clinically and found to have improved exudate 
control compared to the previous AQUACEL dressing (NSHD) and other dressings, 
with less strike-through (Tickle, 2012; Rafter et al, 2015). The modality of these 
dressings also reduces seepage and peri-wound maceration (Karlock, 2004). The 
+ element of this dressing refers to three actions in the dressing. The first a metal 
chelator helps to sequester divalent metal ions thought to hold the biofilm polymer 
structure together. The second is a surfactant, used to reduce surface tensions 
within the dressing and to have a detergent-like effect on biofilm to loosen it. The 
third is a pH control of 5.5 to help the 1.2% ionic silver move more rapidly into the 
biofilm and hence increase the antimicrobial activity.  All three are combined in this 
dressing in an optimum concentration (Metcalf et al., 2016). In a study by Halstead 
et al., (2016) a comparison was made of honey dressings with a selection of silver 
dressings, including the NGAD. The NGAD was found to result in a significantly 
reduced biofilm biomass compared to the other dressings. This is a similar finding 
to that observed in the present study. Previous clinical evaluations have 
demonstrated the clinical effectiveness of NGAD (Woo et al., 2014; Harding et al, 
2015; Walker et al., 2015;  Metcalf et al., 2016a; Metcalf et al., 2016b; Bowler, 
2015), and these in vitro studies help to further elucidate its mode of action, by 
suggesting that it helps to reduce biofilm.  
Independent evidence-based wound care is essential for clinical practices and is 
increasingly prominent in governmental health agendas (WUWHS, 2007). 
Laboratory  and clinical studies on the CES-SD used in this study have been 
limited and appear to have been performed by the manufacturer. Clinical studies 
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(Green, 2013; Forlee et al., 2014; Bullough et al., 2015) have used the CES-SD 
and found some success in management of wounds, but the studies were on a 
limited number of patients, and with no comparison to another dressing. Cellulose 
fibres have found a broad application in medical textile field owing to the 
adsorption, antistatic behaviour, and good mechanical properties. However, 
cellulose fibres provide an excellent surface for microorganisms' growth (Ristić et 
al., 2011). Despite the adsorption characteristics of the CES-SD, and it being 
designed for exudating wounds (Forlee et al., 2014), the CES-SD did not appear to 
absorb as much exudate as some of the dressings, such as the Hydrofibers, 
resulting in a lack of fibre swelling and in fibre shedding on to the tissue. 
Reviews and studies on alginate dressings recommend it due to its haemostatic 
and gelling properties (Paul and Sharma, 2001). An in vitro study by Barnett and 
Varley (1987) showed that the ratio of alginate to wound fluid is critical, especially 
in later healing stages. Doyle et al. (1996) showed that alginate dressings may 
improve some cellular aspects of normal wound healing, but not others, with 
cellular reactions, such as an increase in fibroblasts proliferation but a decrease in 
proliferation in keratinocyte and microvascular cell, being provoked by calcium 
alginate. An in vitro comparison of the ACN-SD used in this study, with the SCHD, 
was performed by Bell and Hart (2007). They found that the ACN-SD kept its 
integrity better, but that this caused adherence to the wound tissue. A study by 
Lipp et al. (2010) concluded that only the silver-containing dressing (ACN-SD) 
contained fewer bacteria than the NSHD, but that neither eradicated bacteria 
completely. Walker et al. (2011) studied the effect of low adherent dressings on 
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microbial growth. They suggested that the results showed the outer, perforated 
surface created limited contact of the simulated wound surface with the 
antimicrobial dressing within the dressing. This was apparent in this study with 
areas of growth in the apparent holes of the dressing by SEM. 
Comparisons of NC-SD and SCHD have shown that they have a similar ability to 
kill planktonic pathogens (O’Neil et al., 2003). Keratinocytes and fibroblasts are 
susceptible to concentrations of silver that are lethal to bacteria (Poon and Burd, 
2004) and hence the visible deposition of nanocrystalline silver in the NC-SD 
model was of concern. This study showed that the silver was only starting to take 
effect by 72 hours and that there was a steady increase in the visual amount of 
silver. A clinical study by Vlachou et al. (2007) showed the silver levels in serum to 
increase to a maximum of 56.8 μg/l after nine days, with dressing changes every 
three days. A similar study found silver serum levels were positively associated 
with the size of burns (Wang et al., 2009b), but that they only reduced to an 
undetectable level after 6 weeks. Another study (Wang et al., 2009a) found that 
cutaneous tissue staining due to silver was a common finding of this NC-SD. 
Therefore cytotoxic effects of high-silver dressings may be of concern.  
PHMB cytotoxicity and resistance is virtually non-existent (Kingsely et al., 2009) 
and the PHMBD has been shown to be well tolerated (Gilliver, 2009). A study on 
the action of PHMB on bacterial cells and mammalian cells found that PHMB could 
enter bacterial cells and effect  the DNA, whereas mammalian cells trapped the 
PHMB nanoparticles within endosomes and the DNA was not affected (Chindera et 
al., 2016). A study comparing PHMBD with SCHD and NC-SD (Haemmerle et al., 
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2012) found all the dressings to reduce the bacterial load and to be comparable, 
although it suggested that the PHMBD reduced it faster (by day 3, in 25% of 
wounds). The results of this present study also showed a greater reduction in 
bacterial biofilm by 72 hours in the PHMBD compared to all the dressings tested 
except the NGAD. The action of PHMB in dressings and the maximum level of 
toxicity need to be fully confirmed, but a recent review (Hurlow, 2017) concluded 
that PHMB dressings are an effective barrier to bacterial colonisation and infection.  
Various studies have compared the CID to other dressings in a favourable light, 
such as Akiyama et al. (2004). The Akiyama study was upon bacterially inoculated, 
cut wounds of mice with various times of addition of the dressing. Although there 
would likely have been biofilm present, as in the present study, the molecular 
iodine may not have been diluted as the samples would not have been exposed to 
the exudative state of a chronic wound. However, this study compared the CID to a 
variety of antimicrobial and non-antimicrobial dressings, and was not considered 
effective with this exuding model. In vivo studies on this dressing include that of 
Hansonn (1998). The study compared a CID to two non-antimicrobial dressings - a 
hydrocolloid dressing and gauze- with similar results in exudation control, 
comparable dressing changes and more slough formation in the iodine and gauze 
dressings. This could be compared to the results in the present study of CID and 
gauze after 72 hours. There was no apparent microscopical work performed on the 
slough in the Hansonn study, which might have given more information as to 
whether there was any biofilm amongst the slough, the gauze or the cadexomer 
beads. Some clinicians and scientists use the terms “biofilm” (viable microbial 
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tissue) and “slough” (largely non-viable host-derived tissue) interchangeably, and 
some research proposes that programmed host cell death and autolysis are critical 
for the timing of microbial biofilm development and dispersion, suggesting that 
slough will contain biofilm as well as dead cells (Ma et al., 2009). Although this was 
visualised to some extent in this study, further studies need to be performed on the 
exact nature and relationship between biofilm and slough to help the development 
of more effective wound management protocols.  
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4.2 Conclusion  
The following objectives have been achieved: 
 demonstrating the exponential point, and the effect of the addition of an 
antimicrobial agent; 
 obtaining the best methods of preservation and processing, for the 
visualisation of bacteria by various microscopy techniques, including: 
o finding a suitable processing protocol and observe planktonic 
bacteria by TEM; 
o observing the effect of silver nitrate on bacterial ultrastructure by 
TEM; 
o finding a suitable processing protocol and observe planktonic 
bacteria by SEM; 
o establishing an appropriate concentration of bacteria to provide a 
confluent biofilm.  
 trialling surfaces for suitability to investigate initial biofilm growth; 
 evaluating surfaces that would allow adequate biofilm growth;  
 developing a novel, challenging meat model for culturing biofilm to view at 
24, 48, and 72 hours by LM, TEM and SEM;  
 using the model to test the efficacy of different dressings against biofilm 
formation, as determined by LM and SEM at 3, 6, 12, 24, 48 and 72 hours, 
and by TEM and CLSM at 24 and 48 hours. 
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Wound dressings need to reduce the impact of biofilm. This novel, challenging 
model has allowed the evaluation of a selection of dressings against an exuding 
colonized model wound, although it cannot fully reflect the reality of clinical 
practice. Current treatment strategies can only try to reduce the impact of biofilm 
and cannot completely rid a wound of it (Hurlow et al., 2016). The need for 
cleansing after debridement has been shown, by this model, to be important to 
remove as many bacteria as possible, as biofilm was shown to form within hours. 
Caution must be employed when using antimicrobial agents, and dressing choices 
must match the wound type, including exudate and microbial load. This model has 
shown how some dressings deposit excessive amounts of silver on a wound 
surface, without it having a more pronounced antimicrobial effect than those 
containing ionic silver. Excessive silver staining can make it difficult to examine a 
wound, especially in those patients with darker skin pigmentation (Karlock, 2004). 
The demonstration of the effect of cadexomer iodine in the model showed how this 
antimicrobial agent, when diluted by exudate as happens clinically, needs to be 
continually refreshed. The wound model in the agar sandwich method was 
designed for use in LM and TEM methods, and processing of the LM models was 
achieved using a routine histological processing schedule. This could be applied to 
clinical samples, if they were available, to demonstrate the thickness of a biofilm on 
the surface of a wound debridement sample (Oates et al., 2014) or tissue biopsy 
(Malone and Swanson, 2017). 
All interactive dressing materials should have the ability to manipulate one or 
multiple aspects of a wounds environment. Deciding which to use will depend on 
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the wound, and the wound characteristics may change with time. Combining 
dressings or using dressings that are multifaceted may give the best solution to 
healing a wound (Sood et al., 2014). However, the decision of choice should be 
ultimately on an evidence-based approach, and on clinical experience in examining 
wounds. Therefore, research such as this, and education in wound care in clinics, 
is essential in more effectively managing patients with these often debilitating 
wounds.  
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4.3 Limitations to the study and future recommendations 
 
 Only two bacterial species were examined in this study yet chronic wounds 
harbour numerous species of microorganism. This model could therefore be 
used to study other biofilm-forming microbes. 
 Only silver, PHMB and iodine antimicrobial agents were studied. Some early 
work was performed on a Manuka honey-gauze type dressing but, due to 
the variety of honey dressings available, it was not considered a 
representative dressing for testing. The study could be repeated on a 
selection of honey dressings for comparison against the best performing 
dressings of this study. 
 Charcoal dressings are claimed to help reduce wound toxicity and facilitate 
healing (Ovington,  2003). This model could be used to assess the ability of 
these dressing types, and others, to prevent biofilm formation. 
 Only a routine haematoxylin and eosin stain was used in LM. A mixture of 
the bacteria was visualised with LM, TEM and SEM. Other histological 
stains and immunocytochemistry and molecular techniques could be 
performed on the histological models prepared, to differentiate the bacteria 
and visualise their location within the biofilm. This would also demonstrate if 
a particular dressing was more effective at eradicating one bacterial type 
over another. 
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 CLSM and TEM were only performed on the 24 and 48 hour models. These 
techniques could be performed at 12 and 72 hours to give a broader set of 
information as to the rate of the biofilm formation or reduction. 
 X-ray micro-analysis could be used to find the extent of silver deposition in 
the tissue, as well as histological staining techniques for silver and iodine. 
Studies on the penetration of these antimicrobials could also be performed 
on models without a bacterial load, purely to demonstrate the depth of 
diffusion/penetration. 
 Although the dressings were challenged with continuous simulated wound 
exudate, the absorption rate of the exudate was not measured. This could 
be performed using the model and measuring the amount of nutrient 
required to keep the dressings saturated over 72 hours. 
 The meat was a relatively flat surface for biofilm development so this could 
be modified to be more curved, undulating or irregular, to assess the 
conformability of the dressings. 
 The speed and cost of results of certain laboratory scientific studies has 
been criticised (Hurlow, 2012). The agar sandwich model could be applied 
to clinical samples. A fresh wound biopsy could be gently fixed then 
transferred into the agar for processing. This could then be examined in LM 
and TEM for biofilm growth, and could be compared to clinical work such as 
that of Hurlow et al. (2016). If used on punch biopsies, this model could be 
processed and examined for light microscopy within 24-48 hours. 
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Appendix I: Tryptone Soy Broth and Agar plates  
 
TSB 
Made up as 3% (6g plus 200mls double distilled water). Pour powder carefully into 
a flask containing the water ensuring it does not touch the sides, and stir well on 
magnetic stirrer. If using for growth cultures place cotton wool in the neck of the 
flask. Cover mouth of flask with aluminium foil. Autoclave.  
 
Agar Plates 
Make up TSB and when mixed add 2% agar. 
Each plate holds 20mls approx. Each universal holds 10mls approx 
Do not make up too many at a time, max 20 plates. Autoclave in flask 
Put plates with smallest diameter side as base. Lift lid slightly and pour in 
agar/TSB, taking care not to introduce possible contamination, and cover. 
When set, invert and store in sealed plastic bag in fridge. 
 
Agar Plates 
Make up 3% TSB as above and when mixed add 2% agar (4g).  
Cover mouth of flask with aluminium foil. Autoclave. 
Swirl flask gently to ensure agar has mixed thoroughly. Allow agar/TSB mix to cool 
slightly. Put Petri dish plates with smallest diameter side as base. Lift lid slightly 
and pour in agar/TSB, taking care not to introduce possible contamination, and 
cover. Each plate holds 20mls approx. 
When set, invert and store in sealed plastic bag at 4c 
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Appendix 2: Autoclaving 
Pour water over stumps in base. Put in pan and add items. 
Put on lid and tighten screws alternately until on firmly. Switch on. 
Ensure value at front is shut and valve on top is open. 
When hissing starts the temperature should be between 80-100ºc. 
Close top valve and wait for the temperature to reach 121ºc with the pressure in 
the red. Time for 15mins then switch off and allow to cool before opening, about 
30mins. 
Autoclaving (Dixons Express Autoclaver – Dixons Surgical Ltd) 
Open and pour water over stumps in base. Put in pan and add items. 
Put on lid and tighten screws alternately until on firmly. Switch on. 
Ensure value at front is shut and valve on top is open. 
When hissing starts the temperature should be between 80-100ºc. 
Close top valve and wait for the temperature to reach 120ºc with the pressure in 
the red. 
Time for 15mins then switch off and allow to cool before opening, approximately 
30mins. 
Appendix 3: RK buffer 
  Total 
A 0.59g NA Acetate 
1.47g Na Barbitone 
50ml distilled water 
50ml 
B 0.1N HCl 70ml 
C 8.5%w/v NaCl  1.7g in 20ml 20ml 
D 1MCaCl2.2H2O          1.47g in 10ml 2.5ml 
E distilled water 110ml 
 
Add totals together and check for pH 6- 6.1 
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Appendix 3: Preparation of agar pellets from cultures 
Agarose 
Pipettes 
Small diameter piece of plastic tubing 
Preparations of cultures should be available, received fixed to filter and put in agar: 
Prepare 10ml of 3% agarose solution. Warm up to dissolve thoroughly and keep 
warm in the heater. Put labelled 1.5 ml microcentrifuge tubestubes in heater ready 
and prepare labelled vials. 
Put a filter in the vacuum mechanism that is smaller than the organism to be 
captured. Screw on the top and pour some of the culture in – enough to fill up to 
5ml approx. Turn on tap and allow vacuum to work. When the culture has filtered 
through stop vacuum by turning off tap, and remove top. 
Using a spatula, scrape off some of the culture and place in  1.5 ml microcentrifuge 
tubes tube. 
Add a few drops of agar and mix well. Place in heater. 
Remove filter and wash everything thoroughly. 
 
To make pellets: 
Insert metal rod into plastic tube and place into mix in microcentrifuge tubes. Pull 
up rod until agar mix is pulled up into the tube. Allow to cool. Using the rod, push 
the agar core out. Top and tail the core. Chop up carefully into small pellets and 
process. 
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Appendix 4: TEM processing schedule using LR White 
(Newman and Hobot 1987; 2001) 
LR White Resin Processing Schedule for Transmission Electron 
Microscopy 
STEP REAGENT TIME(min) 
1 Distilled Water 10 
2 Distilled Water 10 
3 50% ethanol 30 
4 70% ethanol 30 
5 70% ethanol 30 
6 2:1 LR White:70% ethanol 30 
7 LR White 30 
8 LR White 30 
9 LR White 30 
10 LR White Overnight 
0.64ml of LR White accelerator was added to 10ml of LR White and 
mixed thoroughly on ice, pipetted into gelatin capsules, then specimens 
dropped into base of capsules and cap added. Blocks left at 5C 
overnight then placed in 50C oven for 2 hours. 
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Appendix 5: Histological processing schedule 
Processing schedule for Thermo Scientific Excelsior Tissue Processors  
Program 1: “Routine Overnight”                   Duration: 14:41hours  
Stage Reagent Temperature Time Drain Vacuum 
1 IDA Ambient / 37° 1:00 30 On 
2 IDA Ambient / 37° 1:00 30 On 
3 IDA Ambient / 37° 1:00 30 On 
4 IDA Ambient / 37° 1:00 30 On 
5 IDA Ambient / 37° 1:30 30 On 
6 IDA Ambient / 37° 1:30 60 On 
7 Xylene Ambient / 37° 1:10 30 On 
8 Xylene Ambient / 45° 1:10 30 On 
9 Xylene Ambient / 45° 1:10 60 On 
10 Wax 62° 1:20 60 On 
11 Wax 62° 1:20 60 On 
12 Wax 62° 1:20 60 On 
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Appendix 6: Staining Procedure for Light Microscopy 
Haematoxylin and Eosin Staining Programme 
STEP REAGENT TIME(min) 
1 - 0:00 
2 Xylene 1:30 
3 Xylene 1:30 
4 Xylene 1:30 
5 Xylene 1:30 
6 Alcohol 1:30 
7 Alcohol 1:30 
8 Water Wash 1:30 
9 Haematoxylin 1:30 
10 Haematoxylin 1:30 
11 Water Wash 1:30 
12 Acid alcohol 0:40 
13 Water Wash 1:30 
14 Scott’s Tap Water Solution 0:30 
15 Water Wash 1:30 
16 Eosin 1:30 
17 Water Wash 0:30 
18 Alcohol 1:00 
19 Alcohol 1:00 
20 Xylene 1:30 
21 Xylene Coverslip slides 
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Appendix 7: Processing Schedule for Scanning Electron 
Microscopy using Hexamethyldisilazane 
 
Hexamethyldisilazane Processing Schedule 
STEP REAGENT TIME(min) 
1 50% ethanol 5 
2 70% ethanol 5 
3 100% ethanol 5 
4 100% ethanol 5 
5 Hexamethyldisilazane 5 
6 Hexamethyldisilazane 5 
7 Hexamethyldisilazane 5 
8 Air dry overnight 
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Appendix 8: Sputter coating samples with gold 
Turn plug on at the wall. Close chamber vent (clockwise) 
Open top and put stub in the centre (1 large per go) 
Close the lid ensuring it fits on properly (must not touch top ring of lid) 
Press lid down and switch on 
Turn from ‘standby’ to ‘pump’. Turn on argon cylinder 
Allow chamber vacuum to get to 0.1 (approx 10mins) 
Set the cycle time to 2 ½ minutes 
 
Purge with argon 
 Open purge – needle on chamber vacuum drops 
 Allow 10-15 seconds 
 Reclose and wait for needle to reach 0.1 
Repeat these steps 5 times 
After 5th purge allow needle to reach between 0.15 and 0.1 
Immediately  
 turn switch to sputter 
 turn deposition control to get 15mA 
 turn purge to keep it at a constant15mA 
 
Ensure the needle does not waver from 15mA  
- if the needle goes right turn the purge dial right 
- if the needle goes left turn the purge dial left 
 
When timer finishes, it will switch off from coating. Turn the switch to standby 
Turn the deposition control back to 12 o’clock and close purge valve 
Open chamber vent. Switch off. Take out samples and close lid. Reclose chamber 
vent. Switch off at wall. Turn off argon cylinder 
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Appendix 9: Helber Chamber counter 
Ensure the slide is clean, wash with methylated spirit if necessary. 
Drop 10 μl of culture within the engraved circle on the slide. 
Slide cover slip onto the slide, pressing firmly but gently on the edges. 
If the cover slip has been correctly positioned, Newtons rings (colour diffraction) 
will be seen in the contact area between the cover slip and the slide. 
Examine the slide under the  microscope with lowered illumination. Extreme 
caution when coarsely adjusting the focus, as the cover slip is delicate. 
Count the number of cells lying within 50 small squares. 
Cells crossing the lower horizontal or left hand vertical borders are counted as 
being in that square while those crossing the upper or right hand boundaries are 
ignored.  
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Appendix 10: Table of some wound dressings in use 
 
Dressing 
name 
Dressing 
materials 
Antisepti
c 
Antiseptic 
form 
Concentra
tion of 
antiseptic 
In 
vitro evidence 
for anti-
biofilm 
effectiveness 
Clinical evidence 
for dressing 
effectiveness 
AQUACEL 
Ag+ Extra 
(ConvaTec) 
CMC 
(Hydrofiber), 
Tencel 
strengthening 
fibres 
Silver Ionic 1.2% w/w Parsons 2014; 
Bowler & 
Parsons 2016; 
Parsons et al 
2017 
Woo et al 2014; 
Harding et al 
2015; Walker et al 
2015; Metcalf et 
al 2016; Metcalf 
et al 2017 
AQUACEL Ag 
(ConvaTec) 
CMC 
(Hydrofiber), 
Tencel 
strengthening 
fibres 
Silver Ionic 1.2% w/w Percival et al 
2007; Thorn et 
al 2009; 
Bowler et al 
2012 
Hurlow & Bowler 
2009; Thorn et al 
2009; Hurlow & 
Bowler 2012; 
Oates et al 2014; 
Hurlow et a 
2014;Walker et al 
2015 
Acticoat Rayon/polyest
er core 
Silver Nanocryst
alline 
~10% Ammonda et 
al 2011; 
Bourdillon et 
al 2017 
Miller et al 2011; 
Tsang et al 2015; 
Tsang et al 2017 
Mepilex Ag Absorbent 
polyurethane 
foam dressing 
with SafetacTM 
Technology 
 
silver silver 
sulphate 
1 - 2% Halstead et al 
2015 
  
Silver 
Sulphadiazin
e 
Sulpa drug 
used as a 
cream 
Silver  Silver 
sulphadiazi
ne 
1% Bjarnsholt et 
al 2007 
  
UrgoClean 
Ag 
non-adherent 
dressing of 
poly-
absorbent 
fibres with 
lipido-colloid 
particles 
 
      Desroche et al 
2016 
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Dressing 
name 
Dressing 
materials 
Antisepti
c 
Antiseptic 
form 
Concentra
tion of 
antiseptic 
In 
vitro evidence 
for anti-
biofilm 
effectiveness 
Clinical evidence 
for dressing 
effectiveness 
Polyhaxamet
hylene 
biguanide 
(PHMB) 
based 
dressings 
Hydrophilic 
polyurethane 
foam dressing 
with 
polyhexameth
ylene 
biguanide or 
present in 
solution 
PHMB PHMB 
solution 
0.1% - 
0.5% 
Concentrat
ions 
depending 
on product 
Lipp et al 
2010; 
Erberlein et al 
2012; Shoukat 
et al 2015; 
Phillips et al 
2015 
Reitsma et al 
2001;Seipp et al 
2005; Kirker et al 
2009 
Iodoflex/Iod
osorb 
A 3D cross-
linked 
polysaccharid
e starch 
matrix 
(Cadexomer), 
contining 0.9% 
iodine 
physically 
bound to the 
cadexomer 
matrix 
Iodine Cadexome
r iodine 
(releases 
molecular 
iodine) 
0.90% Thorn et al 
2009; Phillips 
et al 2015; 
Fitzgerald et al 
2017 
Miller et al 2011; 
Fitzgerald et al 
2017 
SilverCel Hydro-
alginate 
dressing with 
EasyLIFTTM 
Precision Film 
Technology 
      Lipp et al 2010   
Inanidine Chemical 
complex of 
povidone, 
hydrogen 
iodide, and 
elemental 
iodine 
Iodine Solution/oi
ntment 
Usually at 
10% 
Hoekstra et al 
2017 
 
Honey  Usually 
medical 
grade 
Manuka 
Variety of 
componen
ts present 
in 
respective 
formulatio
ns 
 Camplin & 
Maddocks 
2014; Phillips 
et al 2015; 
Shoukat et al 
2015; 
Halstead et al 
2016 
Tsang et al 2015; 
Tsang et al 2017 
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